azathioprine has been researched along with mycophenolic acid in 948 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.11) | 18.7374 |
| 1990's | 102 (10.76) | 18.2507 |
| 2000's | 407 (42.93) | 29.6817 |
| 2010's | 326 (34.39) | 24.3611 |
| 2020's | 112 (11.81) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Azzarone, A; Carrieri, G; Cillo, U; Fagiuoli, S; Francavilla, A; Gasbarrini, A; Scotti-Foglieni, C; Starzl, TE; Zeng, QH | 1 |
| Dayton, JS; Mitchell, BS; Thompson, CB; Turka, LA | 1 |
| McDonald, CJ | 1 |
| Fujisaki, S; Irish, W; Miyazawa, H; Murase, N; Starzl, TE; Tanabe, M; Todo, S | 2 |
| Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
| Asselin, I; Guérette, B; Kinoshita, I; Lille, S; Roy, R; Tremblay, JP; Vilquin, JT | 1 |
| Azzarone, A; Francavilla, A; Starz, TE; Zeng, QH | 1 |
| Ascher, NL; Busuttil, RW; Deierhoi, M; Gonwa, TA; Kauffman, R; Klintmalm, GB; McDiarmid, S; Poplawski, S; Roberts, J; Sollinger, H | 1 |
| Ascher, NL; Freise, CE; Hebert, M; Kauffman, RS; Lake, JR; Nikolai, B; Osorio, RW; Roberts, JP | 1 |
| Book, BK; Kimball, JA; Norman, DJ; Pescovitz, MD | 1 |
| Gonwa, TA | 1 |
| Gopinathan, SK; Kfoury, AG; Renlund, DG; Taylor, DO | 1 |
| Halloran, PF; Langman, LJ; LeGatt, DF; Yatscoff, RW | 1 |
| Bayle, F; Cantarovich, D; de Vries, MJ; Lang, P; Le Pogamp, P; Lebranchu, Y; Louis-Touizer, C; Monroe, T; Nuijten, MJ; Touraine, JL; Vialtel, P | 1 |
| Langman, LJ; LeGatt, DF; Yatscoff, RW | 1 |
| Ekberg, H; Olausson, M; Ostraat, O; Qi, Z; Tufveson, G | 1 |
| Gruessner, RW | 1 |
| Hochgelerent, EL; Hymes, LC; Larsen, CP; Lowance, DC; Neylan, JF; O'Brien, DP; Pearson, TC; Warshaw, BL; Whelchel, JD | 1 |
| Best, JH; Garrison, LP; Sullivan, SD | 1 |
| Sayegh, MH; Vella, JP | 1 |
| Confavreux, C; Moreau, T | 1 |
| Anjum, MR; Bowley, JN; Drafts, HH; Humphries, AL; Mulloy, LL; Wynn, JJ | 1 |
| Burke, GW; Ciancio, G; Miller, J; Roth, D; Xenos, EX | 1 |
| Neylan, JF | 1 |
| Alfrey, EJ; Dafoe, DC; Krieger, NR; Lee, CM; Scandling, JD | 1 |
| Boucek, MM; Campbell, D; Hall, P; Luna, M; Pietra, B; Shaffer, E; Sondheimer, H | 1 |
| Aradhye, S; Arenas, J; Barker, C; Brayman, KL; Deng, S; Grossman, R; Naji, A; Shaw, L; Weber, M | 1 |
| Anderson, L; Bartlett, ST; Farney, AC; Fink, J; Johnson, LB; Kuo, PC; Lim, JW; Schweitzer, EJ; Weir, MR; Wiland, A; Yoon, S | 1 |
| Aspeslet, LJ; Gallant, HL; Yatscoff, RW | 1 |
| Bumgardner, GL; Elkhammas, EA; Ferguson, RM; Henry, ML; Pelletier, RP; Yenchar, J; Yilmaz, S | 1 |
| Büsing, M; Heimes, M; Klempnauer, J; Kozuschek, W; Martin, D; Schulz, T | 1 |
| Corry, RJ; Egidi, MF; Gritsch, HA; Jordan, ML; Randhawa, PS; Scantlebury, VP; Shapiro, R; Sugitani, A; Vivas, CA | 1 |
| Conti, DJ; Freed, BM; Isenberg, A; Shen, GK; Singh, TP | 1 |
| Budde, K; Fritsche, L; Giessing, M; Morgera, S; Neumayer, HH; Schröder, K; Sperschneider, H; Stein, G | 1 |
| Hesse, CJ; IJzermans, JN; Smak Gregoor, PJ; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W | 1 |
| Mendez, R | 1 |
| Bandini, S; Bertoni, E; Conti, P; Dedola, G; Di Maria, L; Moscarelli, L; Piperno, R; Rosati, A; Salvadori, M; Tosi, P; Zanazzi, M | 1 |
| Conti, DJ; Hahn, A; Isenberg, A; Shen, GK; Singh, TP | 1 |
| Bhaduri, S; Cahn, J; Chang, T; Katznelson, S; Perez, RV; Rudich, SM | 1 |
| Artemiou, O; Birsan, T; Dekan, G; Klepetko, W; Kupilik, N; Thaghavi, S; Wolner, E; Zuckermann, A | 1 |
| Corwin, CL; Fabrega, AJ; Hunsicker, L | 1 |
| Carl, S; Staehler, G; Wiesel, M | 1 |
| Alfrey, EJ; Dafoe, DC; Lee, CM; Markezich, AJ; Scandling, JD | 1 |
| Trotter, JF | 1 |
| Drangstveit, MB; Gruessner, AC; Gruessner, RW; Humar, A; Sutherland, DE; Wrenshall, L | 1 |
| Donadio, C; Giordani, R; Lucchesi, A; Puccini, R; Rizzo, G | 1 |
| Böhler, T; Budde, K; Fritsche, L; Giessing, M; Neumayer, HH; Schröder, K; Sperschneider, H; Stein, G; Türk, H | 1 |
| Burke, JF; Dunn, SR; Francos, GC; Islam, MS | 1 |
| Binder, L; Braun, F; Grupp, C; Hanack, U; Lorf, T; Müller, GA; Ringe, B; Sattler, B | 1 |
| Kass, RM; Kramer, M; Levine, M; Ross, DJ; Ruzevich, S; Waters, PF | 1 |
| Alderman, E; Bourge, R; Costanzo, M; Dureau, G; Eisen, H; Hummel, M; Ipe, D; Johnson, J; Keogh, A; Kobashigawa, J; Mamelok, R; Mancini, D; Mentzer, R; Miller, L; Ratkovec, R; Renlund, D; Smart, F; Valantine, H | 1 |
| Cantu, E; Galantowicz, ME; Gerow-Smith, R; Jorgensen, B; McGregor, C; O'Hair, DP; Schulman, LL | 1 |
| Aspeslet, LJ; Yatscoff, RW | 1 |
| Munn, SR; Nguyen, JH; Paya, CV; Sarmiento, JM; Velosa, JA | 1 |
| Chiewsilp, P; Jirasiritham, S; Kochakarn, W; Leenanupunth, C; Mavichak, V; Sumethkul, V | 1 |
| Aichbichler, BW; Fickert, P; Hinterleitner, TA; Petritsch, W; Wenzl, HH | 1 |
| Böttiger, Y; Brattström, C; Groth, CG; Säwe, J; Tydén, G; Wilczek, HE | 1 |
| Opelz, G | 1 |
| Binswanger, U; Rochat, P; Schwarzkopf, AK; Senn, B; Weinreich, T | 1 |
| Abouna, GM; al Arrayed, AS; Awad, CK; Farid, E; Sharqawi, SA; Tantawi, M | 1 |
| Armitstead, JA; Baker, GM; First, MR; Jang, R; Martin, JE; Myre, S; Schroeder, TJ | 1 |
| Antoniadis, A; Gakis, D; Papachristou, F; Sotiriou, I; Takoudas, D | 1 |
| Binswanger, U; Candinas, D; Schwarzkopf, AK; Weinreich, T; Wüthrich, RP | 1 |
| D'Alessandro, AM; Knechtle, SJ; Odorico, JS; Pirsch, JD; Sollinger, HW | 1 |
| Enk, AH; Knop, J | 1 |
| Becker, C; Germann, T; Hildner, K; Märker-Hermann, E; Meyer zum Büschenfelde, KH; Neurath, MF; Schlaak, JF; Schmitt, E | 1 |
| Ambühl, PM; Binswanger, U; Candinas, D; Schwarzkopf, AK; Weinreich, T; Wüthrich, RP | 1 |
| Corry, RJ; Egidi, F; Fung, JJ; Gritsch, HA; Jordan, ML; Khanna, A; Scantlebury, VP; Shapiro, R; Starzl, TE; Vivas, CA | 1 |
| Krummenauer, F; Meyer zum Büschenfelde, KH; Neurath, MF; Peters, M; Schlaak, JF; Wanitschke, R | 1 |
| Barrou, B; Benalia, H; Bitker, MO; Chatelain, C; Golmard, JL; Gorichon-Radideau, E; Manighetti, J; Mouquet, C; Ourahma, S; Pastural, M | 1 |
| Benfield, MR; Stablein, D; Tejani, A | 1 |
| Benfield, MR; Bynon, S; Eckhoff, D; Harmon, W; Herrin, J; Kohaut, E; Symons, JM | 1 |
| Seikaly, MG | 1 |
| Benfield, M; Neu, AM | 1 |
| Artemiou, O; Birsan, T; Dekan, G; Klepetko, W; Taghavi, S; Wisser, W; Wolner, E; Zuckermann, A | 1 |
| de Alava, E; Errasti, P; Lozano, MD; Panizo, A; Pardo-Mindán, FJ; Sola, I | 1 |
| Briegel, J; Deutsch, O; Fürst, H; Kur, F; Meiser, BM; Müller, C; Reichart, B; Reichenspurner, H; Schwaiblmair, M; Treede, H; Vogelmeier, C; Welz, A | 1 |
| Baluarte, HJ; Butani, L; Palmer, J; Polinsky, MS | 1 |
| Abdulbaki, A; el-Ghoroury, M; Oh, H; Provenzano, R | 1 |
| Bianchetti, MG; Ferrari, P; Mazzola, BL; Rodoni, L; Truttmann, AC; Vannini, SD; Wermuth, B | 1 |
| Alvárez-Cienfuegos, J; Girala, M; Gómez-Manero, N; Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Sangro, B | 1 |
| Kfoury, AG; Renlund, DG; Sharma, RC; Taylor, DO | 1 |
| Andres, A; Campistol, JM; Gomez de la Camara, A; Herrero, JC; Martinez, MA; Mazuecos, A; Morales, JM; Oppenheimer, F; Osuna, A; Segura, J | 1 |
| Anguita, A; Deheza, R; Goldberg, JL; Iturzaeta, A; Maldonado, L; Morrone, G; Repetto, HA; Rodriguez-Rilo, L; Vazquez, LA | 1 |
| Alonso, A; García Meseguer, C; Martinez Débora, MJ; Navarro, M; Vanegas, JJ | 1 |
| Busquets, J; Fabregat, J; Figueras, J; Gil-Vernet, S; Jaurrieta, E; Lama, C; Pares, D; Rafecas, A; Ramos, E; Torras, J | 1 |
| Blasco, T; Dalmau, R; Delgado, JF; Escribano, P; Gómez-Sánchez, MA; Hernández, J; Morales, JM; Sáenz de la Calzada, C; Sánchez, V; Sotelo, T; Tello, R; Velázquez, T | 1 |
| Castells, E; Espinoza, C; Esplugas, E; Garcia, A; Gomez-Hospital, JA; Manito, N; Niubó, J; Perez, JL; Ribas, M; Roca, J; Rufí, G; Saura, E | 1 |
| Jurewicz, WA | 1 |
| Donadi, MO; Esmeraldo, RM; Oliveira, ML; Pinheiro, PM; Ponte, CN | 1 |
| Bush, WW | 1 |
| Friedman, G; Jacobs, M; Kaplan, B; Meier-Kriesche, HU; Mulgaonkar, S; Vaghela, M | 1 |
| Deol, HS; Tuch, BE; Wright, DC | 1 |
| Carrier, M; Pellerin, M; Pelletier, GB; Pelletier, LC; Perrault, LP; Robitaille, D; White, M | 1 |
| Barrou, B; Benalia, H; Bitker, MO; Chatelain, C; Grimaldi, A; Mouquet, C; Ourahma, S; Richard, F | 1 |
| Griesmacher, A; Grimm, M; Laufer, G; Mallinger, R; Seebacher, G; Weigel, G; Zuckermann, A | 1 |
| Grinyó, JM | 1 |
| Budde, K; Neumayer, HH; Schötschel, R; Waiser, J | 1 |
| de Kuiper, P; IJzermans, JN; Vaessen, LM; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W | 1 |
| Abreu, MT; Hassard, PV; Kam, LY; Targan, SR; Vasiliauskas, EA | 1 |
| Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield, C; Sorensen, J; Stegall, M; Tolzman, D; van Veldhuisen, P; Wachs, M | 1 |
| Jensik, SC; Mendez, R; Miller, J; Pirsch, JD | 1 |
| Dockrell, DH; Munn, SR; Paya, CV; Sarmiento, JM; Schwab, TR | 1 |
| Di Landro, D; Marchini, F; Sarzo, G | 1 |
| Ancona, E; Baldan, N; Cadrobbi, R; Furian, L; Marchini, F; Parise, P; Rigotti, P; Sarzo, G | 1 |
| Galle, PR; Krummenauer, F; Mayet, WJ; Neurath, MF; Orth, T; Peters, M; Schlaak, JF; Wanitschke, R | 1 |
| Conti, DJ; Hahn, A; Isenberg, AL; Shen, GK; Singh, TP | 1 |
| Broelsch, C; Fischer, L; Gahlemann, C; Gundlach, M; Rogiers, X; Sterneck, M | 1 |
| Carrier, M; Mathieu, P; Pellerin, M; Pelletier, G; Pelletier, LC; Perrault, L; Robitaille, D; White, M | 1 |
| Malinowski, K; Waltzer, WC; Ye, H | 1 |
| Belitsky, P; Kiberd, B; Lawen, J; MacDonald, A; Mahalati, K; McAlister, V; West, K | 1 |
| Agodoa, LY; Cibrik, D; Hanson, JA; Kaplan, B; Leichtman, AB; Magee, JC; Meier-Kriesche, HU; Ojo, AO; Wolfe, RA | 1 |
| Andrés, A; Campistol, JM; Herrero, JC; Morales, JM | 1 |
| Ambühl, PM; Binswanger, U; Cicvara, S; Wüthrich, RP | 1 |
| Halloran, PF | 1 |
| Henry, ML; Melzer, JS; Merion, RM; Sollinger, HW; Sutherland, DE; Taylor, RJ | 1 |
| Bustos, D; Ferraris, JR; Prigoshin, N; Ramirez, JA; Redal, MA; Tambutti, ML | 1 |
| Flores, F; Kerdel, FA | 1 |
| Leigh, JE; Sirois, D; Sollecito, TP | 1 |
| Abu-Elmagd, K; Bond, G; de Vera, ME; Demetris, J; Fung, J; Mazariegos, G; Reyes, J; Schaefer, N; Starzl, TE; Vargas, H; Wu, T | 1 |
| Barth, C | 1 |
| James, PD; Richardson, PD; Ryder, SD | 1 |
| Chan, KW; Chan, TM; Fang, GX; Ji, YL; Lai, KN; Lau, CS; Li, FK; Tang, CS; Tong, MK; Wong, AK; Wong, RW | 1 |
| Falk, RJ | 1 |
| Baert, FJ; Rutgeerts, PJ | 1 |
| Cibrik, DM; Hanson, JA; Kaplan, B; Leichtman, AB; Meier-Kriesche, HU; Ojo, AO; Punch, JD | 1 |
| Elston, DM | 1 |
| Cieciura, T; Gradowska, L; Kamiñska, B; Lao, M; Nowacka-Cieciura, E; Paczek, L; Pazik, J; Rowiñski, W | 1 |
| Liming, W; Youhua, Z; Zhinlian, M | 1 |
| Cheng, XJ; Fu, SJ; Wang, Y; Yu, L | 1 |
| Bang, BK; Kim, SY; Kim, YS; Koh, YB; Moon, IS; Park, JH; Yang, CW | 1 |
| Chan, HW; Lee, W; Tong, KL; Tsang, WK; Yeung, S | 1 |
| Lou, HX; Suhail, SM; Vathsala, A; Woo, KT | 1 |
| Ishikawa, N; Shimmura, H; Tanabe, K; Toda, F; Tokumoto, T; Toma, H | 1 |
| Chalermsanyakorn, P; Jirasiritham, S; Mavichak, V; Sumethkul, V | 1 |
| Broelsch, CE; Fischer, L; Gahlemann, CG; Malago, M; Rogiers, X; Sterneck, M | 1 |
| Belmont, HM | 1 |
| Bedrossian, J; Bererhi, L; Chalopin, JM; Ducloux, D; Janin, A; Kreis, H; Legendre, C; Mihatsch, M; Morelon, E; Noël, LH; Puget, S; Thervet, E | 2 |
| Dias, L; Guimarães, S; Henriques, AC; Martins, L; Pereira, MC; Sarmento, AM | 1 |
| Ammor, M; Benoît, G; Boubenider, S; Charpentier, B; Djeffal, R; Droupy, S; Durrbach, A; Eschwege, P; Hafi, A; Hammoudi, Y; Hiesse, C; Kriaa, F; Von Ey, F | 1 |
| Butani, L; Makker, SP | 1 |
| Dassopoulos, T; Hanauer, SB | 1 |
| Kahan, BD; Mahalati, K | 1 |
| Cibrik, DM; Hanson, JA; Kaplan, B; Leichtman, AB; Magee, JC; Meier-Kriesche, HU; Ojo, AO; Rudich, SM | 1 |
| Griesmacher, A; Laufer, G; Mueller, MM; Weigel, G; Zuckermann, AO | 1 |
| Book, BK; Gerbeau, C; Girault, D; Kaplan, B; Kovarik, JM; Legendre, C; Pescovitz, MD; Salmela, K; Sollinger, HW; Somberg, K | 1 |
| Gangl, A; Miehsler, W; Moser, G; Reinisch, W; Vogelsang, H | 1 |
| Callen, JP | 1 |
| Asztalos, L; Balzs, G; Berczi, C; Fedor, R; Kincses, Z; Locsey, L; Szabo, L | 1 |
| Caspers-Velu, LE | 1 |
| Bismuth, H; Freeman, R; Kalayoglu, M; Klintmalm, G; Langnas, A; Levy, G; Mamelok, R; McDiarmid, S; McMaster, P; Neuhaus, P; Punch, J; Rabkin, J; Wang, W; Wiesner, R | 1 |
| Fathi, M; Gerbase, MW; Nicod, LP; Spiliopoulos, A | 1 |
| Furness, PN; Jain, S; Metcalfe, M; Nicholson, ML; White, SA | 1 |
| de Kuiper, P; IJzermans, JN; Smak Gregoor, PJ; Vaessen, LM; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W | 1 |
| Kaplan, E; Katz, P; Merhav, H; Nakache, R; Weinbroum, A | 1 |
| Meisterling, LD; Schweizer, RT | 1 |
| Borka, P; Járay, J; Máthé, Z; Perner, F; Remport, A; Toronyi, E | 1 |
| Burdick, JF; Koyama, I; Kyo, S; Nagashima, N; Ogawa, N; Shalabi, A; Watanabe, T | 1 |
| Amerika, D; Bicans, J; Chapenko, S; Folkmane, I; Murovska, M; Rosentals, R | 1 |
| Weir, MR | 1 |
| Baz, MA; Davis, RD; Edwards, LJ; Lawrence, CM; Miralles, AP; Palmer, SM; Rea, JB; Sanders, L; Staples, ED; Tapson, VF; Zander, DS | 1 |
| Ancelet, D; Blancho, G; Cantarovich, D; Daguin, P; Dantal, J; Giral, M; Hourmant, M; Josien, R; Nguyen, JM; Soulillou, JP | 1 |
| Adu, D | 2 |
| Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M | 1 |
| Jenkins, PG | 1 |
| Barbari, A; Kamel, G; Karam, A; Kilani, H; Masri, MA; Stephan, A | 1 |
| Burdick, JF; Maley, WR; Nagashima, N; Nakamura, M; Ogawa, N; Shalabi, A | 1 |
| Bartlett, ST; Klassen, DK; Oh, JM; Weidle, PJ; Wiland, AM | 1 |
| Endre, Z | 1 |
| Kanda, H; Kubo, K; Mimura, T | 1 |
| Bennett, LE; Hosenpud, JD | 1 |
| Betkowska-Prokop, A; Ignacak, E; Kuźniewski, M; Sułowicz, W; Szymczakiewicz-Multanowska, AM; Uracz, D; Zawilińska, B; Zgórniak-Nowosielska, I | 1 |
| Griesmacher, A; Müller, MM; Seebacher, G; Weigel, G | 1 |
| Dureau, G; Keogh, A; Kobashigowa, J; Rose, ML; Smith, J | 1 |
| Burke, E; Edwards, N; Itescu, S; John, R; Lietz, K; Mancini, D; Michler, R; Oz, M; Rose, E | 1 |
| Colombel, JF; Cortot, A; Cosnes, J; Dewit, O; Hafraoui, S; Lémann, M; Marteau, P; Modigliani, R | 1 |
| Algarra, G; Bernabeu-Wittel, M; Cañas, E; Cisneros, JM; de Alarcón, A; Gentil, MA; González-Roncero, FJ; Naranjo, M; Pachón, J; Pereira, P | 1 |
| Araujo, G; Ferrer, J; Parisi, C; Romeo, L; Sgrosso, JL; Vázquez, MC | 1 |
| Brown, AM; Campbell, SB; Griffin, AD; Hawley, CM; Isbel, NM; Johnson, DW; Nicol, DL; Preston, JM; Purdie, DM; Wall, D | 1 |
| Gonçalves, LF; Manfro, RC; Ribeiro, AR; Veronese, FV | 1 |
| Bicans, J; Chapenko, S; Folkmane, I; Murovska, M; Rosentals, R | 1 |
| Coosemans, W; Evenepoel, P; Kuypers, DR; Maes, BD; Pirenne, J; Vanrenterghem, YF | 1 |
| Harringer, W; Haverich, A; Pichlmaier, MA; Strüber, M; Teebken, OE | 1 |
| Bäckman, L; Burke, JT; Kreis, H; Morales, JM; Taylor, R; Wilczek, H | 1 |
| Dunn, DL; Gillingham, KJ; Gruessner, RW; Humar, A; Kandaswamy, R; Matas, AJ; Najarian, JS; Paraskevas, S; Payne, WD; Ramcharan, T; Sutherland, DE | 1 |
| Abbs, IC; Alba, P; Cuadrado, MJ; D'Cruz, DP; Hughes, GR; Karim, MY; Khamashta, MA | 1 |
| Forsythe, JL; Oniscu, GC; Wayman, MR; Whitworth, CE | 1 |
| Böhler, T; Budde, K; Fritsche, L; Geissler, S; Hallebach, G; Neumayer, HH; Waiser, J | 1 |
| Hansen, HE; Heinsvig, EM; Jørgensen, KA; Madsen, M; Madsen, S; Pedersen, AR; Poulsen, JH; Povlsen, JV | 1 |
| Bicknell, GR; Jain, S; Metcalfe, MS; Nicholson, ML; Saunders, RN; Waller, JR | 1 |
| Ankersmit, J; Burke, E; Edwards, N; Itescu, S; John, R; Lietz, K; Mancini, D; Schuster, M; Suciu-Foca, N | 1 |
| Bechstein, WO; Dette, K; Lübke, P; Pridöhl, O; Woeste, G; Wullstein, C | 1 |
| Abdelhalim, FM; Baron, PW; Concepcion, W; Cutler, D; Hasan, SM; Ojogho, ON; Sahney, S | 1 |
| Chenhsu, RY; Min, DI; Wu, YM; Zimmerman, MB | 1 |
| Billerey, C; Bresson-Vautrin, C; Chalopin, JM; Ducloux, D; Motte, G; Rebibou, JM; Saint-Hillier, Y; Vautrin, P | 1 |
| Bernard, PH; Merville, P; Morel, D; Neau-Cransac, M; Potaux, L; Revel, P; Saric, J | 1 |
| Hayward, C; Keogh, AM; Kusano, K; Macdonald, PS; Savdie, E; Spratt, PM; Tedoriya, T; Wilson, M | 1 |
| Akaydin, M; Demirbaş, A; Erdoğan, O; Ersoy, FF; Gürkan, A; Süleymanlar, G; Tuncer, M; Yakupoğlu, G | 1 |
| Ghods, AJ; Miladipour, AH; Nejadgashti, H | 1 |
| Broumand, B; Ganji, MR; Hakemi, M; Najafi, I; Shahebrahimi, K | 1 |
| Böswald, M; Brandis, M; Bulla, M; Burghard, R; Dippell, J; Greiner, C; Jungraithmayr, T; Kirste, G; Klare, B; Klaus, G; Leichter, H; Misselwitz, J; Patzer, L; Querfeld, U; Rascher, W; Staskewitz, A; Tönshoff, B; Wiesel, M; Zimmerhackl, LB | 1 |
| Daniel, V; Dietrich, H; Ernst, W; Feustel, A; Friemann, S; Grimm, H; Heilke, M; Li, D; Opelz, G; Padberg, W; Rainer, L; Staak, A; Streller, S; Weimer, R; Zimmermann, T; Zinn, S | 1 |
| Arias, M; Medina, J; Sadek, S; Sennesael, J; Squifflet, JP; Vogt, B | 1 |
| Czaja, AJ | 2 |
| Brennan, DC; Hardinger, KL; Jendrisak, MD; Lowell, JA; Miller, BW; Schnitzler, MA; Shenoy, S; Wang, CD | 1 |
| Benabdallah, L; Bruneel, MF; Carron, PL; Kreis, H; Morelon, E; Noël, LH; Peraldi, MN; Rerolle, JP | 1 |
| Asztalos, L; Bachleda, P; Hickey, D; Klinger, M; Kokot, F; Nagy, KK; Navratil, P; Ostrowski, M; Perner, F; Rutkowski, B; Studenik, P; Szenohradsky, P; Vitko, S; Wałaszewski, J; Włodarczyk, Z | 1 |
| Aravot, D; Izbicki, G; Kramer, MR; Sahar, G; Saute, M; Shitrit, D; Sulkes, J | 1 |
| Alvarez, E; Bañares, R; Barrio, J; Clemente, G; de Diego, A; Núñez, O; Palomo, J; Pérez Calle, JL; Salcedo, M | 1 |
| Hoffmann, J; Zeitz, M | 1 |
| Callaway, A; Pistorius, A; Willershausen, B | 1 |
| Anarat, A; Bayazit, AK; Bayazit, Y; Gonlusen, G; Noyan, A | 1 |
| Offermann, G | 1 |
| Böswald, M; Bulla, M; Burghard, R; Dippell, J; Greiner, C; Helmchen, U; Jungraithmayr, T; Kirste, G; Klare, B; Klaus, G; Leichter, HE; Michalk, DV; Mihatsch, MJ; Misselwitz, J; Plank, C; Querfeld, U; Staskewitz, A; Tönshoff, B; Weber, LT; Wiesel, M; Zimmerhackl, LB | 1 |
| Claas, FH; de Kuiper, P; Smak Gregoor, P; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W; Witvliet, MD | 1 |
| Balow, JE; Langford, CA | 1 |
| Kushwaha, SS; Mayer, DF | 1 |
| Dunn, DL; Gillingham, K; Gruessner, RW; Humar, A; Kandaswamy, R; Matas, AJ; Najarian, JS; Paraskevas, S; Payne, WD; Sutherland, DE | 1 |
| Gordon, RD; Hochberg, AM; Kaplan, B; Liebman, MN; Meier-Kriesche, HU; Morris, JA; Steffen, BJ | 1 |
| Brennan, DC; Craig, KE; Hardinger, KE; Lowell, JA; Schnitzler, MA | 1 |
| Fine, RN; Fivush, BA; Furth, SL; Ho, PL; Neu, AM | 1 |
| Petri, M | 1 |
| Asensio Peinado, C; Bravo Soto, JA; Cerezo Morales, S; Esteban de la Rosa, RJ; García Olivares, E; Luna del Castillo, JD; Osuna Ortega, A | 1 |
| Balal, M; Karayaylali, I; Paydas, S; Seyrek, N | 1 |
| Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M | 1 |
| Pariente, A | 1 |
| Dück, N; Heiligenhaus, A; Hudde, T; Koch, J; Michel, D; Steuhl, KP | 1 |
| Al-Uzri, A; Kling, PJ; Yorgin, PD | 1 |
| Coghlan, JG; Kingdon, E; Mukerjee, D; Vanderpump, M | 1 |
| Balshaw, R; Chong, M; Kalo, Z; Keown, P; Khorasheh, S; Korn, A; Marra, C | 1 |
| Bleyer, AJ; Cherikh, WS; Johnson, CP; Maghirang, J; Myron Kauffman, H | 1 |
| Burgos, FJ; Fernández, M; Marcén, R; Ortuño, J; Pascual, J; Rivera, ME; Tato, A; Tenorio, M; Teruel, JL; Villafruela, JJ | 1 |
| Breuer, K; Heratizadeh, A; Kapp, A; Werfel, T | 1 |
| Warholm, C; Wilczek, H | 1 |
| Durlik, M; Foroncewicz, B; Gradowska, L; Krawczyk, A; Lewandowska, D; Mucha, K; Nazarewski, S; Paczek, L; Pazik, J; Pliszczynski, J; Szmidt, J; Walaszewski, J | 1 |
| Boratynska, M; Klinger, M; Kusztel, M; Madziarska, K; Patrzalek, D; Szyber, P; Zmonarski, SC | 1 |
| Braun, WE | 1 |
| Múzes, G | 1 |
| Bart, PA; Gainon, J; Waeber, G | 1 |
| Androudi, S; Brazitikos, P; Christen, W; Fiore, T; Foster, CS; Iaccheri, B; Meniconi, M | 1 |
| Achour, A; Bouraoui, S; Dhia, BN; Elmay, M; Frih, A; Guedri, Y; Skhiri, H; Souani, Y | 1 |
| Mansoori, D; Mehrsai, AR; Pourmand, G; Taheri, M | 1 |
| Albert, S; Bhogal, BS; Black, MM; Oyama, N; Powell, AM; Sakuma-Oyama, Y | 1 |
| Anhalt, GJ; Cummins, DL; David, M; Kouba, DJ; Mimouni, D; Nousari, CH | 1 |
| Jeffery, JR; Karpinski, ME; Leslie, WD; Nickerson, PW; Rush, DN | 1 |
| Derweesh, I; Flechner, SM; Goldfarb, D; Krishnamurthi, V; Mastroianni, B; Modlin, CS; Novick, A; Savas, K; Zhou, L | 1 |
| Buyan, N; Cingi, E; Dalgic, A; Dalgic, B; Derici, U; Hasanoglu, E; Kitapci, M; Ozkaya, O; Sindel, S | 1 |
| Pleyer, U | 1 |
| Gill, JS; Johnson, N; Mix, CH; Pereira, BJ; Tonelli, M | 1 |
| Goldsmith, D; Jagodzinski, P; Lizakowski, S; Rutkowski, B; Simmonds, HA; Slominska, EM; Smolenski, RT | 1 |
| Carrey, EA; Edbury, S; Goldsmith, D; Jagodzinski, P; Simmonds, HA; Smolenski, RT | 1 |
| Mueller, XM | 1 |
| Dannenberg, O; Haverich, A; Heublein, B; Oppelt, P; Pethig, K; Wahlers, T | 1 |
| Capdevila, L; Carrera, M; Garcia del Moral, R; Gentil, MA; Gomez Ullate, P; Gonzalez Molina, M; Jesus Alferez, M; Seron, D; Sola, E | 1 |
| Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M | 1 |
| Antikainen, M; Hedman, M; Holmberg, C; Neuvonen, M; Neuvonen, PJ | 1 |
| Gleeson, M; Guney, S; McCaughan, GW; Zekry, A | 1 |
| Ferrazzi, P; Fiocchi, R; Gamba, A; Mammana, C; Merlo, M; Sebastiani, R; Terzi, A | 1 |
| Cattaneo, D; Perico, N; Remuzzi, G | 1 |
| Erbay, B; Ersoz, S; Erturk, S; Keven, K; Kutlay, S; Sahin, M; Sengul, S | 1 |
| Fernandes, B; Figueiredo, A; Mascarenhas, R; Reis, JP; Tellechea, O | 1 |
| Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C | 1 |
| Contreras, G; Leclercq, B; Lenz, O; O'Nan, P; Pardo, V; Roth, D; Tozman, E | 1 |
| Austin, HA; Balow, JE | 1 |
| Black, MM; Reynaert, S | 1 |
| Rosenkrantz, WS | 1 |
| Carroll, KL; Illichmann, M; Stangl, JR; Striker, R | 1 |
| Eisen, H; Ross, H | 1 |
| Brunt, EM; Di Bisceglie, AM | 1 |
| Bismuth, J; Canet, S; Chong, G; Garrigue, V; Lesnik, A; Mourad, G; Taourel, P | 1 |
| Gordon, C; Yee, CS | 1 |
| Christopher-Stine, L; Fine, DM; Gelber, AC | 1 |
| Farhey, Y; Hess, E | 1 |
| Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA | 1 |
| Jagodziński, P; Lizakowski, S; Rutkowski, B; Słomińska, E; Zdrojewski, Z | 1 |
| Encke, J; Sauer, P; Stremmel, W; Uhl, W | 1 |
| Lo, A | 1 |
| Copin, MC; Glowacki, F; Hazzan, M; Labalette, M; Noel, C; Provot, F; Pruvot, FR; Roumilhac, D | 1 |
| Kari, JA; Trompeter, RS | 1 |
| McDonald, RA; Nemeth, TL; Smith, JM | 1 |
| Bergé, F; Chong, G; Deminière, C; Durand, D; Merville, P; Morel, D; Mourad, G; Potaux, L; Rostaing, L | 1 |
| Crabtree, J; Formea, CM; Fujita, S; Hemming, A; Howard, R; Karlix, JL; Myers-Huentelman, H; Reed, A; Wu, R | 1 |
| Chu, AH; Gordon, RD; Gotz, VP; Kaplan, B; Meier-Kriesche, HU; Morris, JA; Steffen, BJ | 1 |
| Takeda, Y; Tomino, Y | 1 |
| Li, H; Li, Y; Lu, Y; Wang, K; Wei, Q; Yang, Y; Zhang, H | 2 |
| Lou, HX; Vathsala, A | 1 |
| Heath, M; Raugi, GJ | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| Bermejo, J; Bouza, E; Carbone, J; Catalan, P; Fernández-Cruz, E; Fernàndez-Yáñez, J; Muñoz, P; Palomo, J; Rodríguez-Molina, JJ; Sarmiento, E | 1 |
| Hommann, M; Kornberg, A; Küpper, B; Scheele, J; Tannapfel, A | 1 |
| Neuberger, J; Perry, I | 1 |
| Kobashigawa, J; Lindenfeld, J; Lowes, BD; Mestroni, L; Miller, GG; Page, RL; Shakar, SF; Wolfel, EE; Zolty, R | 1 |
| Dirks, NL; Huth, B; Meibohm, B; Yates, CR | 1 |
| Aringer, M; Derfler, K; Graninger, WB; Hörl, WH; Jiménez-Boj, E; Schmaldienst, S; Smolen, JS; Stummvoll, GH | 1 |
| Höcker, B; Tönshoff, B; Weber, LT | 1 |
| Cransberg, K; Davin, JC; Lilien, MR; Marlies Cornelissen, EA; Nauta, J; Stijnen, T; Van Hoeck, KJ | 1 |
| Baczkowska, T; Durlik, M | 1 |
| Ebel, H; Grebe, SO; Lange, H; Mueller, TF; Troeltsch, M | 1 |
| Asztalos, L; Bachleda, P; Hickey, D; Kalmar, KN; Klinger, M; Kokot, F; Navratil, P; Ostrowski, M; Perner, F; Rutkowski, B; Studenik, P; Szenohradszky, P; Vitko, S; Walaszewski, J; Wlodarczyk, Z | 1 |
| Atasever, A; Bacakoglu, F; Basak, K; Basoglu, OK; Duman, S; Guzelant, A; Sayiner, A; Toz, H | 1 |
| Joh, JW; Kim, SJ; Lee, DS; Lee, HH; Lee, KW; Lee, SK | 1 |
| Chan, TM; Li, FK; Mok, MY; Tang, CS; Tse, KC | 1 |
| El-Sayed, O; Ferketich, AK; Leier, CV; Magorien, RD; Orsini, A | 1 |
| Albert, ED; Banas, B; Friedrich, N; Lederer, SR; Sitter, T; Welser, G | 1 |
| Angus, PW; Gow, PJ; Hong, MKh; Jones, RM; Vaughan, RB | 1 |
| Chi-Burris, KS; David, KM; Gordon, RD; Gotz, VP; Morris, JA; Steffen, BJ | 1 |
| Valantine, H | 1 |
| Burroughs, AK; Davidson, BR; Davies, S; Dhillon, AP; Emery, V; Griffiths, P; Leandro, G; Papatheodoridis, GV; Patch, DW; Quaglia, A; Rolando, N; Rolles, K; Sabin, CA; Samonakis, DN; Teixeira, R; Thalheimer, U; Triantos, CK | 1 |
| Barker, CV; Chandrakantan, A; Julian, BA; Ratanapanichkich, P; Said, M | 1 |
| Allison, AC | 1 |
| Contreras, G; Metz, D; Nahar, N; Tozman, E | 1 |
| Dugan, C; Emre, S; Gondolesi, G; Kerkar, N; Morotti, RA; Rumbo, C; Shneider, BL | 1 |
| Hirano, T; Saito, K; Saito, N; Satoh, H; Sugiyama, K; Takahashi, K | 1 |
| Basta Jovanovic, G; Blagojevic, RN; Djukanovic, LD; Dokic, ZM; Lezaic, VD; Marinkovic, J; Radivojevic, DM; Ristic, S | 1 |
| de Kuiper, P; Ijzermans, JN; Rischen-Vos, J; van Besouw, NM; van de Wetering, J; van der Mast, BJ; Weimar, W | 1 |
| Basic-Jukic, N; Brunetta, B; Bubic-Filipi, LJ; Kes, P; Pasini, J; Puretic, Z | 1 |
| Balshaw, R; Carreño, CA; Keown, PA; Machnicki, G; Otero, A; Toselli, L | 1 |
| Akiyama, Y; Aramaki, O; Ikeda, Y; Inoue, F; Kitajima, M; Matsumoto, K; Niimi, M; Shibutani, S; Shimazu, M; Shirasugi, N | 1 |
| Date, H; Shimizu, N | 1 |
| Cantarell, C; Gentil, MA; González-Roncero, F; López, M; Marco, J | 1 |
| Hibi, T; Hisamatsu, T | 1 |
| Alderman, E; Bourge, R; Constanzo, MR; Dureau, G; Eisen, HJ; Gordon, R; Hummel, M; Johnson, J; Keogh, A; Kobashigawa, J; Mamelok, R; Mancini, D; Mehra, M; Mentzer, R; Renlund, D; Valantine, H; Wang, W | 1 |
| Sieb, JP | 1 |
| Benfield, MR; Harmon, WE; McDonald, R; McIntosh, M; Rose, S; Stablein, DM; Tejani, A | 1 |
| Habuchi, T; Hayase, Y; Inoue, T; Matsuura, S; Murakami, M; Satoh, S; Suzuki, T; Tada, H; Togashi, H; Tsuchiya, N | 1 |
| Ao, JH; Dong, J; Gao, JP; Hong, BF; Li, YT; Lu, JS; Xiao, XR | 1 |
| Ahmed, M; Foster, CS; Kiss, S; Letko, E | 1 |
| McCune, WJ; Riskalla, MM | 1 |
| Abbs, IC; Cuadrado, MJ; D'Cruz, DP; Hughes, GR; Karim, Y; Khamasta, MA; Pisoni, CN; Sanchez, FJ | 1 |
| Kogata, Y; Kumagai, S; Nakazawa, T | 1 |
| Abouljoud, M; Attallah, N; Goggins, M; Nori, U; Parasuraman, R; Venkat, KK; Zasuwa, G | 1 |
| Bodemer, C | 1 |
| Bacal, F; Bocchi, EA; das Dores Cruz, F; Issa, VS; Moreira, LF; Moreira, SA; Pires, PV; Ramires, JA; Silva, CP; Stolf, NA; Strabelli, T | 1 |
| Holder, AL; Lawson, C; Rose, ML; Smith, J; Stanford, RE | 1 |
| Benedetti, E; Briars, L; John, E; Knight, PS; Kraft, KA; Lumpaopong, A; Oberholzer, J; Sankary, HN; Testa, G; Verghese, P | 1 |
| Meyrier, A | 1 |
| Kovarik, JM; Starling, RC | 1 |
| Carpenter, HA; Czaja, AJ | 1 |
| Braun, WE; Cook, D; McMahon, JT; Myles, J; Protiva, D; Weinstein, D | 1 |
| Basiri, A; Fereshtenejad, M; Golnari, P; Hoseini, R; Otukesh, H; Rezai, M; Sedigh, N; Sharifian, M; Simfroosh, N | 1 |
| Alves, H; Monteiro, MS; Norton, SM; Oliveira, JG; Osório, E; Pestana, M; Teixeira, JF | 1 |
| González-Posada, JM; Hernández, D | 1 |
| Kruis, W | 1 |
| Ciancio, G; Gonwa, TA; Miller, J | 1 |
| Kobashigawa, JA; Meiser, BM | 1 |
| Buell, JF; Gross, TG; Woodle, ES | 1 |
| Triemer, H | 1 |
| Contreras, G; Fornoni, A; Lenz, O | 1 |
| Habuchi, T; Horikawa, Y; Inoue, T; Kakinuma, H; Matsuura, S; Numakura, K; Saito, M; Satoh, S; Suzuki, T; Tada, H; Tsuchiya, N | 1 |
| Gross, WL; Hellmich, B; Lamprecht, P | 1 |
| de Groot, K; Jayne, D | 1 |
| Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T | 1 |
| Kandus, A; Kotnik, V; Kovac, D | 1 |
| Deray, G; Foltz, V; Isnard-Bagnis, C; Mercadal, L; Ourahma, S | 1 |
| Felipe, CR; Franco, M; Garcia, R; Medina-Pestana, J; Moreira, SR; Park, SI; Pinheiro-Machado, P; Silva, LA; Tedesco-Silva, H | 1 |
| Agafonova, S; Budnikova, N; Pasov, S; Prokopenko, E; Scherbakova, E; Vatazin, A | 1 |
| Barrou, B; Kornprobst, M; Nicolas, JC; Rampini, C | 1 |
| Bruckner-Tuderman, L; Hofmann, SC | 1 |
| Harada, T; Kanekake, H; Nishikido, M | 1 |
| Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W | 2 |
| Robak, E; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Ault, BH; Gaber, LW; Hastings, MC; Jones, DP; Lau, KK | 1 |
| Bakkaloglu, A; Bakkaloglu, M; Bayrakci, U; Besbas, N; Kalyoncu, M; Ozaltin, F; Topaloglu, R | 1 |
| Bourge, RC; Gjertson, DW; Gordon, RD; Kobashigawa, JA; Li, H; Mehra, MR; Mentzer, RM; Miller, LW; Smart, FW; Tanaka, K; Tobis, JM; Valantine, HA | 1 |
| Corris, PA; Glanville, AR; Ives, J; Knoop, C; Mamelok, RD; Maurer, J; McNeil, K; Speich, R; Wahlers, T | 1 |
| Bachta, A; Tłustochowicz, M | 1 |
| Kobashigawa, JA; Li, HY; Oeser, B; Tanaka, K; Tobis, JM; Wertman, B | 1 |
| Al-Aly, Z; Bastani, B; Philoctete Ashley, JM; Sachdeva, A | 1 |
| Daebritz, S; Ertl, B; Kaczmarek, I; Knez, A; Meiser, B; Reichart, B; Sadoni, S; Schmauss, D | 1 |
| Fischereder, M; Graeb, C; Jauch, KW; Kammerl, MC; Krämer, BK; Krüger, B; Zülke, C | 1 |
| Assmann, KJ; Berden, JH; Bijl, M; Bruijn, JA; de Glas-Vos, JW; Derksen, RH; Grootscholten, C; Hagen, EC; Ligtenberg, G; van den Wall Bake, AW; van Houwelingen, HC; Weening, JJ | 1 |
| Apostolski, S; Evoli, A; Gilhus, NE; Harms, L; Hart, IK; Hilton-Jones, D; Horge, HW; Melms, A; Skeie, GO; Verschuuren, J | 1 |
| Bohdjalian, A; Devyatko, E; Dunkler, D; Grimm, M; Roedler, S; Weigel, G; Zuckermann, A | 1 |
| Morelon, E; Thaunat, O | 1 |
| Berland, Y; Bonnet, E; Brunet, C; George, FD; Loundou, A; Lyonnet, L; Moal, V; Paul, P; Ravet, S; Sampol, J; Sampol-Manos, E; Vacher-Coponat, H | 1 |
| Ardalan, MR; Asghari, A; Baiaz, B; Estakhr, R; Khosroshahi, HT; Shoja, MM | 1 |
| Kalsi, K; Marinaki, AM; Smolenski, RT; Yacoub, MH | 1 |
| Brown, F; Carroll, RP; Kerr, PG | 1 |
| Agüero, J; Almenar, L; Arnau, MA; Chamorro, C; Martínez-Dolz, L; Moro, J; Rueda, J; Salvador, A; Sánchez-Lázaro, I; Zorio, E | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
| Korman, NJ; Patton, T | 1 |
| Felipe, CR; Franco, MF; Garcia, R; Medina-Pestana, JO; Park, SI; Pinheiro-Machado, PG; Silva, LA; Tedesco-Silva, H | 1 |
| Beissert, S; Böhm, M; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D | 1 |
| Kästner, U; Kuhn, A; Kuhn, C; Markau, S; Osten, B | 1 |
| Arbustini, E; Bini, F; Fietta, AM; Meloni, F; Morosini, M; Pellegrini, C; Solari, N; Vitulo, P | 1 |
| Cooke, ME; Luikart, H; Potena, L; Valantine, HA | 1 |
| Chalermsanyakorn, P; Changsirikulchai, S; Lothuvachai, T; Sumethkul, V | 1 |
| Dietrich, H; Ernst, W; Kamali-Ernst, S; Opelz, G; Padberg, W; Rainer, L; Renner, F; Staak, A; Suesal, C; Weimer, R | 1 |
| Emanuel, C; Lewis, MA; Potts, AJ; Yaqoob, NA | 1 |
| Collett, D; Johnson, R; Raftery, MJ; Rudge, CJ; Shah, S; Thuraisingham, RC; Yaqoob, MM | 1 |
| Franco, A; Merino, E; Paya, A; Rocamora, N | 1 |
| Chhabra, A; Kobashigawa, JA; Li, H; Oeser, B; Tanaka, K; Tobis, JM | 1 |
| Stockfleth, E; Ulrich, C | 1 |
| Barbari, AG; Masri, MA; Stephan, AG | 1 |
| Gustafsson, F; Ross, HJ | 1 |
| Baan, CC; Mol, WM; Velthuis, JH; Weimar, W | 1 |
| Courtney, AE; Fogarty, DG; Maxwell, AP; McNamee, PT; Savage, G; Sinnamon, KT | 1 |
| Banner, NR; Burke, MM; Hamour, IM; Lyster, HS; Rose, ML | 1 |
| Bryan, CF; Murillo, D; Nelson, PW; Shield, CF; Wakefield, MR; Warady, BA; Winklhofer, FT | 1 |
| Chen, N; Lin, Y; Pan, X; Ren, H; Wang, W; Yu, H; Zhang, W; Zhu, B | 1 |
| Beaumont, BW; Copeland, JW; Merrilees, MJ; Pilmore, HL | 1 |
| Jayne, D | 1 |
| Benavente, D; Buckel, E; Contreras, L; Ferrario, M; Fierro, A; Herzog, C; Morales, J; Zehnder, C | 1 |
| Godoy, C; Videla, C | 1 |
| Agarwal, SK; Bhowmik, D; Chatterjee, A; Chaudhary, A; Dash, SC; Dinda, A; Guleria, S; Gupta, S; Kamboj, M; Mahajan, S; Sharma, M; Tiwari, SC | 1 |
| Huang, WY | 1 |
| Costantini, M; Cravedi, P; Donati, D; Ene-Iordache, B; Federico, S; Ganeva, M; Gherardi, G; Gotti, E; Lesti, M; Remuzzi, G; Rigotti, P; Ruggenenti, P; Salvadori, M; Sandrini, S; Segoloni, G; Sparacino, V | 1 |
| Bulla, M; Dippell, J; Fehrenbach, H; Greiner, C; Griebel, M; Helmchen, U; Jungraithmayr, TC; Kirste, G; Klaus, G; Leichter, HE; Michalk, DV; Mihatsch, MJ; Misselwitz, J; Plank, C; Staskewitz, A; Tönshoff, B; Weber, LT; Wiesmayr, S; Zimmerhackl, LB | 1 |
| Assari, S; Moghani-Lankarani, M; Panahi, Y; Pourfarziani, V; Saadat, SH | 1 |
| Assogba, D; Barrou, B; Bitker, MO; Mallet, A; Mercadal, L; Ourahma, S; Tezenas du Montcel, S | 1 |
| Akhyani, M; Balighi, K; Barzegari, M; Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Ghodsi, SZ; Hallaji, Z; Mirshams-Shahshahani, M; Mortazavi, H; Nazemi, MJ; Seirafi, H; Valikhani, M | 1 |
| Marti, HP; Rippin, SJ; Serra, AL; Wüthrich, RP | 1 |
| Ali, Y; Gladman, DD; Ibañez, D; Urowitz, MB | 1 |
| Bunce, C; Dart, JK; Maddison, PG; Phillips, M; Ramsay, A; Rauz, S; Saw, VP; Xing, W | 1 |
| Snell, GI; Westall, GP | 1 |
| Baird, BC; Barenbaum, LL; Goldfarb-Rumyantzev, AS; Habib, AN; Lin, SJ; Shihab, FS; Smith, L | 1 |
| Fargue, S; Ranchin, B | 1 |
| Falger, J; Kemper, MJ; Laube, GF; Neuhaus, TJ; Zingg-Schenk, A | 1 |
| Axon, AT; Chalmers, DM; Everett, SM; Ford, AC; Greer, D; Hamlin, PJ; Palaniappan, S | 1 |
| Hart, IK; Sathasivam, S; Sharshar, T | 1 |
| de Groot, K | 1 |
| Bae, JH; Clavell, AL; Edwards, BS; Frantz, RP; Khalpey, Z; Kremers, WK; Kushwaha, SS; Lerman, A; Raichlin, E; Rihal, C; Rodeheffer, RJ | 1 |
| Beretta, C; Bovo, G; Conter, V; Corti, P; Mieli-Vergani, G; Rovelli, A | 1 |
| Mudge, GH | 1 |
| Abbott, KC; Axelrod, D; Brennan, DC; Buchanan, PM; Burroughs, TE; Dzebisashvili, N; Lentine, KL; Salvalaggio, PR; Schnitzler, MA; Willoughby, LM | 1 |
| Beissert, S; Böhm, M; Bonsmann, G; Frieling, U; Gollnick, H; Hunzelmann, N; Junghans, V; Luger, TA; Meurer, M; Pillekamp, H; Ruzicka, T; Rzany, B; Stadler, R; Sticherling, M; Werfel, T; Zillikens, D | 1 |
| Almeida, JM; Ikeda, MY; Saber, LT | 1 |
| Annemans, L; Hetzer, R; Lemkuhl, H; Ricci, JF; Schulz, U; Tenderich, G; Yang, XL | 1 |
| Gaudy-Marqueste, C | 1 |
| Ilmoja, M; Kahu, J; Kirsimägi, U; Lõhmus, A; Peetsalu, A; Timberg, G | 1 |
| Campbell, S; Chadban, SJ; Chang, SH; McDonald, SP; Russ, GR | 1 |
| Cormier, L; Gigante, M; Iborra, F; Kleinclauss, F; Lechevallier, E; Mouzin, M; Neuzillet, Y; Petit, J; Salomon, L; Terrier, N | 1 |
| Argani, H; Atabak, S; Gachkar, L; Keshtkar-Jahromi, M; Mirchi, E; Mokhtari-Azad, T; Noori-Froothghe, A; Rahnavardi, M; Tara, SA | 1 |
| Anglicheau, D; Beaune, P; Legendre, C; Thervet, E | 1 |
| Bakr, MA; Baz, ME; Gheith, OA; Ghoneim, MA; Ismael, AM; Shehab El-Dein, AB | 1 |
| Fujinaga, S; Hara, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Iorizzo, LJ; Jorizzo, JL | 1 |
| Ginzler, EM; Houssiau, FA | 1 |
| Hughes, D; Liu, C; Mannari, D; Mehta, A | 1 |
| Eguchi, S; Hidaka, M; Kanematsu, T; Nakanuma, Y; Tajima, Y; Takatsuki, M; Zen, Y | 1 |
| Bestard, O; Grinyó, JM; Ibernon, M; Poveda, R; Vidaller, A | 1 |
| Daugas, E | 1 |
| Rischen-Vos, J; van Besouw, NM; van de Wetering, J; van der Mast, BJ; Weimar, W | 1 |
| Daniel, E; Foster, CS; Gangaputra, S; Helzlsouer, KJ; Jabs, DA; Kempen, JH; Levy-Clarke, GA; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE | 1 |
| Dunn, JP; Galor, A; Jabs, DA; Kedhar, SR; Leder, HA; Peters, GB; Thorne, JE | 1 |
| Bystryn, JC | 1 |
| Flossmann, O; Jayne, DR | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, KF; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
| Bertsias, G; Boumpas, DT | 1 |
| Tauber, J | 1 |
| Chueh, SC; Chung, SD; Lai, MK; Tai, HC; Wang, SM | 1 |
| Liu, Z; Wang, P; Wang, X; Wu, C; Xu, H; Zhu, B | 1 |
| Navaneethan, SD; Strippoli, GF; Viswanathan, G | 1 |
| Antonio-Santos, AA; Eggenberger, ER | 1 |
| Ergin, H; Kiziltas, S; Masatlioglu, S; Oguz, F; Sahin, GM; Sahin, S | 1 |
| Collett, D; Johnson, R; Raftery, M; Rudge, C; Shah, S; Yaqoob, MM | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
| Abdollahi, A; Domhan, S; Zeier, M | 1 |
| Chan, TM; Lam, MF; Tang, CS; Tse, KC; Yap, DY | 1 |
| El-Agroudy, AE; El-Dahshan, KF; Gad, ZA; Ghoneim, MA; Ismail, AM; Sheashaa, HA; Shokeir, AA; Wafa, EW | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Mahmoud, K; Shokeir, AA | 1 |
| Bargman, JM | 1 |
| Kappen, JH; Lachman, S; Lesterhuis, W; Mensink, PB; van Daele, PL; van Hagen, PM; van Laar, JA | 1 |
| Broussolle, C; Candessanche, JP; Marignier, R; Ninet, J; Rousset, H; Sève, P; Varron, L | 1 |
| Hu, XP; Ma, LL; Wang, W; Wang, Y; Yang, XY; Yin, H; Zhang, XD | 1 |
| Baba, HA; Gerken, G; Kahraman, A; Maldonado-Lopez, E; Miller, M; Treichel, U | 1 |
| Barcena, L; Knight, SR; Morris, PJ; Russell, NK | 1 |
| Döhler, B; Opelz, G | 2 |
| Craig, JC; McDonald, SP; Webster, AC | 1 |
| Gerrits, JH; van Besouw, NM; van de Wetering, J; Weimar, W | 1 |
| Baran, D; Birnbaum, LM; Cantarovich, M; Chaudhury, P; Herrera-Gayol, A; Lipman, M; Paraskevas, S; Tchervenkov, J | 1 |
| Knoll, GA; Mulay, AV; van Walraven, C | 1 |
| Ahmadpour, P; Ardalan, MR; Azmandian, J; Basiri, A; Einollahi, B; Firoozan, A; Ghadiani, MH; Ghafari, A; Lessan-Pezeshki, M; Makhdoomi, K; Makhlough, A; Nafar, M; Nemati, E; Nourbala, MH; Oliaei, F; Pour-Reza-Gholi, F; Pourfarziani, V; Razeghi, E; Samimagham, HR; Shahbazian, H; Simforoosh, N | 1 |
| Hirayama, K; Kobayashi, M; Koyama, A; Yamagata, K | 1 |
| Koch, M; Kohnle, M; Trapp, R | 1 |
| Friend, PJ; Reddy, S; Roberts, IS; Stratopoulos, C; Zilvetti, M | 1 |
| Aguado, L; España Alonso, A; Fernández, S; Marquina, M; Panizo, C; Pretel, M; Sánchez-Ibarrola, A | 1 |
| Camacho, FM; Coronel-Pérez, IM; Pérez-Bernal, AM; Rodríguez-Rey, EM | 1 |
| Bazardzanović, M; Hasukić, SH; Iljazagić-Halilović, F; Imamović, S; Ljuca, F; Mesić, D; Omerović, S | 1 |
| Andreana, L; Burroughs, AK; Germani, G; Pleguezuelo, M; Tsochatzis, E; Vaghjiani, S; Villamil, F | 1 |
| Abraham, M; Al-Muzairai, I; Al-Otaibi, T; Al-Waheeb, S; Balaha, MA; Halim, MA; Hamid, MH; Johny, KV; Nair, MP; Nampoory, MR; Said, T; Tawab, KA | 1 |
| Arcasoy, SM; Bacchetta, M; Celik, MR; D'Ovidio, F; Eser, D; Lederer, DJ; Sonett, JR; Wilt, J | 1 |
| Chiasson, VL; Mahajan, A; Mitchell, BM; South, S; Tinsley, JH | 1 |
| Chan, WK; Chim, S; Hui, J; Lee, KP; Lee, TL; Leung, LC; Tse, NK; Wong, SN; Yuen, SF | 1 |
| Hanisch, F; Wendt, M; Zierz, S | 1 |
| Kaplan, B; Schold, JD | 1 |
| Burkhart, CN; Morrell, DS; Shaw, MG | 1 |
| Denton, CP; Quillinan, NP | 1 |
| Bakkaloglu, A; Baskin, E; Bayrakci, US; Cakar, N; Demirkaya, E; Ozen, S | 1 |
| Hackshaw, KV; Hebert, LA; McKinley, A; Nagaraja, S; Park, E; Rovin, BH; Spetie, D | 1 |
| Mohapatra, N; Patel, RD; Trivedi, HL; Vanikar, AV | 1 |
| Birmingham, DJ; McKinley, AM; Rovin, BH | 1 |
| de la Rosa García, E; Mondragón Padilla, A | 1 |
| Wimmersberger, Y; Zuercher, D | 1 |
| Cravedi, P; Perna, A; Remuzzi, G; Ruggenenti, P | 1 |
| Pourfarziani, V; Taheri, S | 1 |
| Arnold, DM; Chan, H; Heddle, NM; Kelton, JG; Nazi, I; Santos, A; Warkentin, TE | 1 |
| Heinze, G; Kainz, A; Korbély, R; Oberbauer, R; Schwarz, C | 1 |
| Annapandian, VM; Fleming, DH; John, GT; Mathew, BS | 1 |
| Amann, K; Benz, K; Dittrich, K; Dötsch, J; Ross, S | 1 |
| Choi, SJ; Ji, JD; Lee, YH; Song, GG; Woo, JH | 1 |
| Chinnakotla, S; Goldstein, RM; Klintmalm, GB; Levy, MF; McKenna, GJ; Melton, LB; Onaca, N; Randall, HB; Ruiz, R; Sanchez, EQ | 1 |
| Erwig, LP; Savage, CO | 1 |
| Lopau, K; Riedmiller, H; Rubenwolf, P; Syamken, K; Wanner, C | 1 |
| Bambery, P; Kumar, S; Law, AD; Mahajan, R; Mittal, T; Sharma, A; Singh, S; Wanchu, A | 1 |
| Davaus Gasparetto, T; Marchiori, E; Menezes, P; Zanetti, G | 1 |
| Boehler, A; Hofer, M; Irani, S; Schneider, S; Speich, R; Vogt, P; Weder, W | 1 |
| Aoki, V; Delgado, L; Gabbi, T; Maruta, C; Santi, C; Sotto, M | 1 |
| Abramowicz, D; Andrien, M; Broeders, E; Ghisdal, L; Heylen, C; Lemy, A; Racapé, J; Ryhahi, K; Toungouz, M; Vandersarren, A; Vereerstraeten, P; Wissing, KM | 1 |
| Baptista, A; Couceiro, A; Leite, I; Menezes, N; Tente, D; Varela, P | 1 |
| Procházka, M; Procházka, V; Urbánek, K; Vinklerová, I | 1 |
| McFadden, JP; Wee, JS; White, IR; White, JM | 1 |
| Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Bataille, S; Berland, Y; Dussol, B; Gaudart, J; Indreies, M; Moal, V; Purgus, R; Vacher-Coponat, H; Zandotti, C | 1 |
| Adams, B; Costa, LJ; Lazarchick, J; Medina, AM; Murphy, E; Neville, B; Stuart, R; Willner, IR | 1 |
| Chikaraishi, T; Kimura, K; Matsui, K; Sasaki, H; Shibagaki, Y; Yasuda, T | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Balal, M; Binokay, F; Demir, E; Erken, U; Kurt, C; Paydas, S; Sertdemir, Y; Sikgenc, MM | 1 |
| Adham, M; Boillot, O; Dumortier, J; Guillaud, O; Pittau, G; Salandre, J; Scoazec, JY | 1 |
| Blockmans, D; Cervera, R; D'Cruz, D; de Ramon Garrido, E; Depresseux, G; Fiehn, C; Gilboe, IM; Guillevin, L; Houssiau, FA; le Guern, V; Petrovic, R; Ravelingien, I; Remy, P; Sangle, S; Tektonidou, M; Vasconcelos, C | 1 |
| Bussone, G; Mouthon, L | 1 |
| Ancona, N; Dell'Oglio, MP; Ditonno, P; Divella, C; Grandaliano, G; Pontrelli, P; Rossini, M; Rutigliano, M; Schena, FP; Stifanelli, P; Verrienti, R; Zaza, G | 1 |
| Armstrong, D; Benseler, SM; Branson, H; Elbers, J; Halliday, W; Hawkins, C; Hutchinson, C; Laughlin, S; Westmacott, R | 1 |
| McKiernan, PJ | 1 |
| Ramaiya, KJ; Rao, PK | 1 |
| Appel, GB; Bomback, AS | 1 |
| de Groot, K; Harper, L; Hauser, T; Hiemstra, TF; Jayne, DR; Mahr, A; Neumann, I; Pagnoux, C; Savage, CO; Schmitt, W; Tesar, V; Walsh, M; Wissing, KM | 1 |
| Hoffman, GS | 2 |
| Mitarai, T | 1 |
| Brendel, MD; Bretzel, RG; Burkart, V; Eckhard, M; Hogenkamp, V; Jaeger, C; Pfleger, C; Schloot, NC | 1 |
| Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Konstandin, M; Kristen, A; Müller, S; Sack, FU | 1 |
| Balow, JE; Bertsias, GK; Boumpas, DT | 1 |
| Imamović, G; Osmanović, E; Zerem, E | 1 |
| Ding, X; Fan, X; Feng, X; Hou, J; Pan, X; Qin, G; Song, Y; Tian, P; Tian, X; Xiang, H; Xue, W; Yan, H | 1 |
| Steiner, RW | 1 |
| Martin, LK; Murrell, DF; Villaneuva, EV; Werth, VP | 1 |
| Amoura, Z; Arnaud, L; Zahr, N | 2 |
| Bernard, P; Charneux, J | 1 |
| Bödeker, RH; Daniel, V; Deisz, S; Dietrich, H; Ernst, W; Kamali-Ernst, S; Opelz, G; Padberg, W; Renner, F; Weimer, R | 1 |
| Habas, E; Khammaj, A; Rayani, A | 1 |
| Mayo, MJ | 1 |
| Erkan, D; Levine, AB | 1 |
| Fujikawa, T; Fujita, S; Hemming, AW; Kim, RD; Mizuno, S; Schwartz, JJ; Sorensen, JB | 1 |
| Kobashigawa, JA; Patel, JK | 1 |
| Iida, S; Ishida, H; Miyamoto, N; Setoguchi, K; Shimizu, T; Shirakawa, H; Tanabe, K; Toki, D | 1 |
| Simon, D | 1 |
| Askanase, A; Shum, K | 1 |
| Conlon, PJ; Daly, PJ; Hickey, DP; Little, DM; Mohan, P; O'Kelly, P; Power, R; Raheem, OA; Shields, WP; Zimmerman, AJ | 1 |
| Belperio, JA; Lynch, JP; Wang, T; Weigt, SS | 1 |
| Arora, S; Aukrust, P; Bendz, B; Bøtker, HE; Eiskjær, H; Ekmehag, B; Gude, E; Gullestad, L; Jansson, K; Mortensen, SA; Saunamaki, K; Sigurdadottir, V; Simonsen, S; Solbu, D; Ueland, T; Wennerblom, B | 1 |
| Dall'Era, M | 1 |
| Akbar, HO; Fallatah, HI | 1 |
| Andersson, P; Hindorf, U | 1 |
| Engineer, DP; Godara, SM; Gumber, MR; Jain, SH; Kute, VB; Modi, PR; Munjappa, BC; Patel, HV; Sainaresh, VV; Shah, PR; Shah, VR; Trivedi, HL; Vanikar, AV | 1 |
| Antonini, G; Benedetti, L; Briani, C; Cocito, D; Falcone, Y; Fazio, R; Grimaldi, S; Jann, S; Matà, S; Nobile-Orazio, E; Paolasso, I; Sabatelli, M | 1 |
| Denniston, AK; Murray, PI; Sreekantam, S | 1 |
| Arizon, JM; Barten, MJ; Dong, G; Eisen, HJ; Kobashigawa, J; Lehmkuhl, H; Pelligrini, C; Ross, H; Wang, SS; Zuckermann, A | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Kasperkiewicz, M; Kramer, J; Meier, M; Schmidt, E; Schumacher, N; Shimanovich, I; Westermann, L; Zillikens, D | 1 |
| Dankó, K; Vincze, M | 1 |
| Frew, JW; Martin, LK; Murrell, DF | 1 |
| Frew, JW; Murrell, DF | 1 |
| Ghoneim, MA; Ismail, AM; Kamal, AI; Mahmoud, KM; Refaie, AF; Sheashaa, HA | 1 |
| Kim, HC; Kim, MR; Kim, SC | 1 |
| Appel, GB; Contreras, G; Dooley, MA; Eitner, F; Ginzler, EM; Isenberg, D; Jayne, D; Lisk, L; Olsen, NJ; Solomons, N; Wofsy, D | 1 |
| Houssiau, FA | 2 |
| Aydin, S; Cervera, R; Cosyns, JP; D'Cruz, D; Delahousse, M; Depresseux, G; Fiehn, C; Gilboe, IM; Guillevin, L; Houssiau, FA; Jadoul, M; Karras, A; le Guern, V; Petera, P; Quémeneur, T; Ravelingien, I; Remy, P; Stoenoiu, MS; Tektonidou, M; Vasconcelos, C | 1 |
| Diago Almela, VJ; López Montes, J; Perales, A; Perales-Puchalt, A; Vila Vives, JM | 1 |
| Niaudet, P | 1 |
| Pham, PC; Pham, PT | 1 |
| Callegaro, D; Fujihara, K; Lana-Peixoto, MA; Sato, D | 1 |
| Berland, Y; Brunet, P; Burtey, S; Daniel, L; Dussol, B; Indreies, M; Loundou, A; Moal, V; Moussi-Frances, J; Purgus, R; Vacher-Coponat, H | 1 |
| Appel, GB | 1 |
| Chizzolini, C | 1 |
| Martin, PY; Saudan, P | 1 |
| Lee, EK; Mao, PC; Tseng, PL | 1 |
| Cheng, CY; Shu, KH; Tsai, SF; Wu, MJ | 1 |
| Chocair, PR; Duley, JA | 1 |
| Artifoni, M; Puéchal, X | 1 |
| Bootun, R | 1 |
| Kinder, BW | 1 |
| Jung, IJ; Kim, HJ; Kim, SH; Kim, W; Li, XF | 1 |
| Denniston, AK; Hamada, S; Khan, I; Rauz, S | 1 |
| Paolella, G; Vajro, P | 1 |
| Levitt, J; Nigam, R | 1 |
| Eickenberg, S; Jacobi, AM; Jung, E; Mickholz, E; Nofer, JR; Pavenstadt, HJ | 1 |
| Boumpas, DT; Fanouriakis, A; Krasoudaki, E; Tzanakakis, M | 1 |
| Beck, LA; Denby, KS | 1 |
| Berden, JH; Berger, SP; Bijl, M; de Sévaux, RG; Derksen, RH; van Tellingen, A; Vervloet, MG; Voskuyl, AE | 1 |
| Kallenberg, CG | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Graves, D; Vernino, S | 1 |
| Barona, L; España, A; Fernández, S; Navedo, M | 1 |
| Chadban, SJ; Chapman, JR; Clayton, PA; McDonald, SP | 1 |
| Becker, ML | 1 |
| Basevitz, A; Duek, G; Malnick, S; Melzer, E | 1 |
| Makol, A; Sokumbi, O; Warrington, KJ; Wetter, DA | 1 |
| Hruskova, Z; Tesar, V | 1 |
| Amoura, Z; Aringer, M; Bajema, I; Berden, JH; Bertsias, GK; Boletis, J; Boumpas, DT; Cervera, R; Doria, A; Dörner, T; Ferrario, F; Floege, J; Gordon, C; Haubitz, M; Houssiau, FA; Ioannidis, JP; Isenberg, DA; Jayne, D; Kallenberg, CG; Lightstone, L; Marks, SD; Martini, A; Moroni, G; Neumann, I; Praga, M; Schneider, M; Starra, A; Tektonidou, M; Tesar, V; van Vollenhoven, RF; Vasconcelos, C; Zakharova, H | 1 |
| Baig, A; Contreras, G; Lenz, O; Pop, A; Waheed, AA | 1 |
| Lisk, L; Solomons, N; Sundel, R | 1 |
| Kötter, I; Schmalzing, M | 1 |
| Aggarwal, R; Oddis, CV | 1 |
| Deng, J; Feng, L; Huo, DM; Liao, YH; Wu, QY | 1 |
| Chan, AJ; Lake, JR | 1 |
| Gonzalez, ME; Tan, AU | 1 |
| Abdalla, T; Abderrahim, E; Barbouch, S; Bozouita, A; Cherif, M; Hamida, FB; Karoui, C; Kheder, A; Mzoughi, S; Ounissi, M | 1 |
| Punaro, MG | 1 |
| Craig, JC; Flanc, RS; Henderson, LK; Masson, P; Roberts, MA; Strippoli, GF; Webster, AC | 1 |
| Wagner, JA | 1 |
| Yoshikawa, H | 1 |
| Craig, JC; Flanc, RS; Henderson, L; Masson, P; Roberts, MA; Strippoli, GF; Webster, AC | 1 |
| Karni, A; Kolb, H; Stankiewicz, JM; Weiner, HL | 1 |
| Radhakrishnan, J | 1 |
| Aranow, C; Askanase, A; Bae, SC; Barr, SG; Bernatsky, S; Blanco, I; Boivin, JF; Clarke, AE; Costenbader, KH; Criswell, LA; Dooley, MA; Dreyer, L; Edworthy, SM; Feldman, CH; Fortin, PR; Ginzler, EM; Gladman, DD; Gordon, C; Isenberg, D; Jacobsen, S; Joseph, L; Kamen, DL; Manzi, S; Nived, O; Patel, NM; Peschken, CA; Petri, MA; Rahman, A; Ramsey-Goldman, R; Romero-Diaz, J; Ruiz-Irastorza, G; St Pierre, Y; Sturfelt, GK; Urowitz, MB; Wallace, DJ; Witte, T; Yelin, E | 1 |
| Arcinue, CA; Foster, CS; Lebanan, MO; Radwan, A | 1 |
| Aringer, M; Brinks, R; Fischer-Betz, R; Schneider, M; Specker, C | 1 |
| Chung, SJ; Kang, MI; Kang, Y; Lee, SK; Lee, SW; Park, HJ; Park, YB | 1 |
| Arrossi, V; Chapman, JT; Culver, DA; Mira-Avendano, IC; Parambil, JG; Xu, M; Yadav, R | 1 |
| Azevedo, F; Barreto, F; Cruz, MJ; Morais, P; Santos, P | 1 |
| Atlani, M; Gupta, A; Sharma, RK | 1 |
| Cristelli, MP; Franco, MF; Medina-Pestana, JO; Tedesco-Silva, H | 1 |
| Cho, JH; Choi, JY; Huh, S; Kim, CD; Kim, HK; Kim, YL; Kwon, O; Park, SH | 1 |
| Bijl, M; Brunetta, P; Close, D; Drappa, J; Furie, RA; Guzman, R; Houssiau, FA; Jayne, D; Maciuca, R; Mysler, EF; Rao, K; Shahdad, S; Spindler, AJ | 1 |
| Bartsch, M; Effelsberg, NM; Hässler, F; Hentze, C; Miehle, N; Peter, HH; Salzer, U; Schlesier, M; Sic, H; Thiel, J; Venhoff, N; Voll, RE; Warnatz, K | 1 |
| Alba, P; Babini, AM; Savio, V | 1 |
| Creevy, KE; Smith, JR; Wang, A | 1 |
| Korsten, P; Mirsaeidi, M; Sweiss, NJ | 1 |
| Chmura, A; Ciszek, M; Durlik, M; Foroncewicz, B; Małkowski, P; Mucha, K; Pączek, L; Szmidt, J | 1 |
| Hou, S | 1 |
| Cheifetz, AS; Feuerstein, JD; Feuerstien, JD; Najarian, R | 1 |
| Agarwal, I; Ali, U; Anand, K; Bagga, A; Bal, V; Bhatia, D; Blanc, C; Dinda, AK; Dragon-Durey, MA; George, A; Gulati, A; Gulati, S; Gupta, A; Gurjar, BS; Hari, P; Kotresh, ST; Kumar, M; Ohri, A; Rath, S; Saini, H; Saini, S; Salmona, M; Sethi, S; Singh, G; Sinha, A; Sinha, R; Vijayakumar, M | 1 |
| Agena, F; Azevedo, LS; David-Neto, E; Gamba, C; Gerhard, J; Miraglia, JL; Pierrotti, L; Precioso, AR; Shikanai Yasuda, MA; Tavares Timenetsky, MD | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Bellando-Randone, S; Cappelli, S; Guiducci, S; Matucci-Cerinic, M | 1 |
| Allen, J; Chadwick, PR; Green, D; Lamerton, E; Middleton, R; Mitsides, N; New, D; Redshaw, J; Subudhi, CP; Wood, G | 1 |
| Berland, Y; Burtey, S; Dussol, B; Legris, T; Loundou, A; Moal, V; Picard, C; Purgus, R; Vacher-Coponat, H | 1 |
| Houssiau, FA; Lauwerys, BR | 1 |
| Aleksić, P; Drasković-Pavlović, B; Dujić, A; Hrvacević, R; Ignjatović, L; Jovanović, D; Karan, Z; Kovacević, Z; Maksić, D; Rabrenović, V; Tomić, A; Vavić, N | 1 |
| Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI | 1 |
| Kittleson, MM; Kobashigawa, JA | 1 |
| Cuthbertson, D; Hoffman, GS; Krischer, JP; Langford, CA; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Specks, U; Ytterberg, SR | 1 |
| Bargman, JM; Bose, B; Silverman, ED | 1 |
| Becker, ML; Polk, BI | 1 |
| Gomez-Reino, JJ; Lopez-Canoa, N; Maneiro, JR; Salgado, E | 1 |
| Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA | 1 |
| Joshi, L; Lightman, S; McCluskey, P; Sandhu, S; Talat, L; Taylor, SR; Wakefield, D; Yaganti, S | 1 |
| Greenberg, BM; Levy, M; Mealy, MA; Palace, J; Wingerchuk, DM | 1 |
| Hirai, T; Kawamura, M; Kishikawa, H; Nakazawa, S; Nishimura, K; Ueda, N | 1 |
| Bardin, N; Burtey, S; Chiche, L; Daniel, L; Daugas, E; Dussol, B; Gondouin, B; Hamidou, M; Harlé, JR; Jourde-Chiche, N; Mancini, J; Meulders, Q | 1 |
| Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC | 1 |
| Al Maimouni, H; Gladman, DD; Ibañez, D; Urowitz, MB | 1 |
| Azar, L; Hoffman, GS; Langford, CA; Springer, J | 1 |
| Allen, L; Boyer, TD; Chatrath, H | 1 |
| Ward, MM | 1 |
| Godbold, J; Goldberg, NR; Jabs, DA; Lyu, T; Moshier, E | 1 |
| Chams-Davatchi, C; Daneshpazhooh, M; Esmaili, N; Karimi, A; Mortazavi, H; Toosi, S; Valikhani, M | 1 |
| Beyene, J; Brown, PE; Feldman, BM; Silverman, ED; Tian, SY; Uleryk, EM | 2 |
| Hesselink, DA; van Gelder, T; van Schaik, RH | 1 |
| Akturk, S; Ates, K; Calayoglu, R; Celebi, ZK; Duman, N; Erturk, S; Keven, K; Kutlay, S; Nergizoglu, G; Sengul, S; Yalcı, AK | 1 |
| Bunce, C; Calder, VL; Haskard, DO; Lightman, S; Longhurst, H; Lynn, W; Moots, R; Stanford, M; Taylor, SR; Tomkins-Netzer, O; Yang, D | 1 |
| Chan, TM | 1 |
| Banas, B; Benck, U; Birck, R | 1 |
| Arends, S; Berden, JH; Berger, SP; Bijl, M; de Sévaux, RG; Derksen, RH; Grootscholten, C; Voskuyl, AE | 1 |
| Bindra, MS; Jones, NP; Patton, NA; Tanawade, RG; Tsierkezou, L | 1 |
| Hellmich, B | 1 |
| Fulcher, DA; Lin, MW; O'Connor, K; Ojaimi, S; Schifter, M | 1 |
| Mok, CC; Ng, WL; Siu, YP; To, CH; Tong, KH; Yim, CW; Ying, KY | 1 |
| Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Klein, B; Rivinius, R; Ruhparwar, A; Schmack, B; Thomas, D | 1 |
| Cotton, D | 1 |
| Gennarini, A; Gentile, G; Lacanna, F; Locatelli, B; Mastroluca, D; Remuzzi, G; Rota, G; Ruggenenti, P; Somma, C | 1 |
| Bye, W; Cheng, R; Cooper, A; Kench, J; McNeil, C; Shackel, N; Watson, G | 1 |
| Huang, WW; Jorizzo, JL; Moustafa, FA; Sandoval, LF | 1 |
| Dalla Gassa, A; Granata, S; Lupo, A; Tomei, P; Zaza, G | 1 |
| Balcer, L; Dahodwala, N; Galetta, S; Markowitz, C; Pruitt, A; Torres, J | 1 |
| de Bruin-Weller, MS; Deinum, J; Garritsen, FM; Roekevisch, E; Spuls, PI; van der Schaft, J | 1 |
| Ayala Guttierez, Mdel M; Blockmans, D; Cervera, R; D'Cruz, D; Depresseux, G; Fiehn, C; Gilboe, IM; Guillevin, L; Houssiau, FA; le Guern, V; Ravelingien, I; Remy, P; Sangle, S; Tamirou, F; Tektonidou, M; Vasconcelos, C | 1 |
| Hesselink, DA; van Gelder, T | 1 |
| Bao, H; Chen, YH; Hu, WX; Liu, ZH; Liu, ZZ; Wang, SF; Zhang, HT | 1 |
| Montero, N; Pascual, J | 1 |
| Larsen, FS; Ytting, H | 1 |
| Croyle, L; Morand, EF | 1 |
| Abe, T; Ichimaru, N; Imamura, R; Kaimori, JY; Kakuta, Y; Kato, T; Nonomura, N; Takahara, S; Yamanaka, K | 1 |
| Azar, L; Hoffman, GS | 1 |
| Besada, E; Diamantopoulos, AP | 1 |
| Liu, X; Zhang, M | 1 |
| Campise, M; Giglio, E; Messa, P; Moroni, G; Trespidi, L | 1 |
| Ayoub, I; Rovin, BH | 1 |
| Baughman, RP; Lower, EE | 1 |
| Dhaliwal, HK; Dube, AK; Gleeson, D; Hoeroldt, BS; Karajeh, MA; McFarlane, E; Underwood, JC | 1 |
| Zwiech, R | 1 |
| Karam, S; Wali, RK | 1 |
| Aikawa, A; Hyodo, Y; Sugiyama, K | 1 |
| Hodgson, TA; Shephard, M; Venda Nova, C | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| De Rosa, G; Dubinsky, D; Laborde, HA; Marini, A; Nasswetter, G; Paniego, FM; Vinicki, JP | 1 |
| Akashi, K; Higashioka, K; Kamada, K; Mizuki, S; Oryoji, K; Tsukamoto, H; Yokota, E; Yoshida, K | 1 |
| Mok, CC | 1 |
| Arreola-Guerra, JM; Córdova-Sánchez, BM; Correa-Rotter, R; Mejía-Vilet, JM; Morales-Buenrostro, LE; Uribe-Uribe, NO | 2 |
| Adams, DH; Füssel, K; Hirschfield, GM; Hodson, J; Lohse, AW; Mann, J; Oo, YH; Schramm, C; Than, NN; Weiler-Normann, C; Wiegard, C | 1 |
| Molina-Molina, M; Robles-Perez, A | 1 |
| Goyal, A; Gupta, KL; Gupta, PK; Jaryal, A; Jha, V; Kohli, HS; Kumar, V; Ramachandran, R; Rathi, M; Sakhuja, V; Sharma, A | 1 |
| Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O | 1 |
| Notaro, ER; Sidbury, R | 1 |
| Bazsó, A; Kiss, E; Pálfi, P; Poór, G; Szabó, MZ | 1 |
| Daniel, V; Opelz, G; Trojan, K | 1 |
| Balk, EM; Earley, AK; Schmid, CH; Uhlig, K; Wagner, M; Webster, AC | 1 |
| Gleeson, D | 1 |
| Abou-Ayache, R; Aldigier, JC; Bouvier, N; Bridoux, F; Colosio, C; Ecotière, L; Essig, M; Etienne, I; Gand, E; Hurault de Ligny, B; Javaugue, V; Laurent, C; Le Meur, Y; Rerolle, JP; Thierry, A; Touchard, G; Vuiblet, V | 1 |
| Ji, L; Qin, W; Tang, X; Yang, L; Zhang, X | 1 |
| Bruijnzeel-Koomen, CA; de Bruin-Weller, MS; de Jong, EM; Kievit, W; Politiek, K; Schuttelaar, ML; van den Reek, JM; van der Schaft, J | 1 |
| Wang, L; Zhang, FC; Zhang, X | 1 |
| Anandakkuttan, A; Kannoth, S; Mathai, A; Nambiar, V; Sasikumar, AN | 1 |
| Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL | 1 |
| Thervet, É | 1 |
| Awdishu, L; Joy, MS | 1 |
| Arvaniti, P; Dalekos, GN; Gabeta, S; Gatselis, NK; Koukoulis, GK; Rigopoulou, EI; Zachou, K | 1 |
| Hoek, A; Sanders, JS; Stegeman, CA; Tuin, J; van Beek, AP | 1 |
| Oddis, CV | 1 |
| Arze Aimaretti, L; Arze, S | 1 |
| Benseler, SM; Cabral, DA; Campillo, S; Canter, DL; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Hersh, A; Higgins, GC; Huber, AM; Khubchandani, R; Kim, S; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Lubieniecka, JM; McCurdy, D; Moorthy, LN; Morishita, KA; Muscal, E; Nanda, K; Nielsen, SM; O'Neil, KM; Reiff, A; Ristic, G; Robinson, AB; Sarmiento, A; Shenoi, S; Spalding, SJ; Toth, MB; Twilt, M; Van Mater, HA; Wagner-Weiner, L; Wahezi, DM; Weiss, JE; White, AJ; Yeung, RS | 1 |
| Amiya, E; Endo, M; Hatano, M; Imamura, T; Iriyama, T; Kinoshita, O; Kinugawa, K; Komuro, I; Nagamatsu, T; Nawata, K; Nitta, D; Ono, M; Takahashi, Y | 1 |
| Becker, G; Hughes, P; Kotagiri, P; Martin, A; Nicholls, K | 1 |
| Kim, SH; Lee, HA; Park, SW; Ryu, HS; Seo, YS; Sim, Y; Um, SH; Yim, SY | 1 |
| Gaudio, PA; Huang, JJ; King, BA; Shield, DR; Sinard, J | 1 |
| Córdova-Sánchez, BM; Correa-Rotter, R; Mejía-Vilet, JM; Uribe-Uribe, NO | 1 |
| Dębska-Ślizień, A; Imko-Walczuk, B; Piesiaków, ML; Pikuła, M; Rutkowski, B; Trzonkowski, P | 1 |
| Jones, N | 1 |
| Anderson, R; Bond, M; Coelho, H; Cooper, C; Crathorne, L; Dudley, J; Haasova, M; Huxley, N; Hyde, C; Jones-Hughes, T; Lowe, J; Marks, S; Mujica-Mota, R; Snowsill, T; Varley-Campbell, J | 1 |
| Costenbader, KH; Feldman, CH; Franklin, JM; Guan, H; Kim, SC; Marty, FM; Solomon, DH; Winkelmayer, WC | 1 |
| Fernandez Nieto, M; Jayne, DR | 1 |
| Lee, YH; Song, GG | 1 |
| Christopher-Stine, L; Paik, JJ | 1 |
| Craig, JC; Hodson, EM; Willis, NS; Wong, SC | 1 |
| Hejri, GM; Mahdavi, M | 1 |
| Cui, LY; Fei, YY; Qiao, L; Ren, HT; Wang, Q; Xu, Y; Zhang, Y; Zhao, Y | 1 |
| Chen, H; Feng, H; Lian, Z; Liu, J; Miao, X; Qiu, W; Shi, Z; Wang, J; Zhang, Q; Zhou, H | 1 |
| Aravena, C; Collard, HR; Dubé, BP; Elicker, BM; Fell, CD; Johannson, KA; Jones, KD; Ley, B; Manganas, H; Morisset, J; Ryerson, CJ; Vittinghoff, E; Wolters, PJ | 1 |
| Cordoro, K; Eichenfield, LF; Flohr, C; Lara-Corrales, I; Logan, K; Paller, AS; Proudfoot, L; Schmitt, J; Siegfried, E; Sugarman, J; Tom, W; Totri, CR | 1 |
| Delshad, S; Mirsafaei, HS; Tavakolpour, S | 1 |
| Abraham, S; Augustin, M; Bieber, T; Elsner, P; Fölster-Holst, R; Homey, B; Kleinheinz, A; Novak, N; Schmitt, J; Stephan, V; Sticherling, M; Trautmann, F; Weidinger, S; Werfel, T | 1 |
| Amoura, Z; Cohen-Aubart, F; Grenier, P; Haroche, J; Hie, M; Mathian, A; Miyara, M; Pha, M | 1 |
| Adegunsoye, A; Chen, L; Chung, JH; Hsu, S; Lee, C; Montner, S; Noth, I; Oldham, JM; Strek, ME; Valenzi, E; Vij, R; Witt, LJ | 1 |
| Arnaud, L; Ding, H; Gunnarsson, I; Larsson, A; Mohan, C; Parodis, I; Svenungsson, E; Zickert, A | 1 |
| Andrade, RJ; Bouma, G; Dalekos, GN; de Boer, YS; Floreani, A; Gleeson, D; Heneghan, MA; Hirschfield, GM; Invernizzi, P; Lenzi, M; Liberal, R; Lohse, AW; Macedo, G; Milkiewicz, P; Terziroli, B; van Hoek, B; Vierling, JM | 1 |
| Apostolopoulos, D; Morand, EF | 1 |
| Hyun, JW; Joo, J; Joung, A; Kim, HJ; Kim, SH; Park, EY | 1 |
| Al-Kali, A; Castro, J; Dueck, A; Ertz-Archambault, N; Finn, L; Foran, J; Gauthier, S; Kelemen, K; Kosiorek, H; Marino, R; Mesa, RA; Palmer, J; Sproat, LZ; Taylor, GE; Tibes, R | 1 |
| Chong, JH; Koh, MJA | 1 |
| Robinson, AJ; Scardamaglia, L; Unglik, GA; Varigos, GA; Vu, M | 1 |
| Cropley, A; Weltman, M | 1 |
| Bia, MJ | 1 |
| Davidson, BR; Guerrero-Misas, M; Gurusamy, KS; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
| Benseler, SM; Cabral, DA; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Foell, D; Hersh, AO; Huber, AM; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Li, SC; Lubieniecka, JM; Luqmani, RA; Moorthy, LN; Morishita, KA; Nielsen, SM; Ristic, G; Shenoi, S; Toth, MB; Twilt, M; Yeung, RSM | 1 |
| Davis, LS; Reimold, AM | 1 |
| Clowse, ME; Machen, L | 1 |
| de Bruin-Weller, MS; Fidder, HH; Garritsen, FM; Spuls, PI; van den Broek, MPH; van Zuilen, AD | 1 |
| Castro Salomó, A; Cortés-Hernández, J; Cuquet Pedragosa, J; Mauri Plana, M; Mitjavila, F; Ordi-Ros, J; Ortiz-Santamaria, V; Pérez-Conesa, M; Sáez-Comet, L; Vidal, X | 1 |
| Bellon, H; Heigl, T; Hoet, P; Lammertyn, E; Vanaudenaerde, BM; Vandermeulen, E; Vanhove, T; Verleden, GM; Verleden, SE; Verlinden, L; Verstuyf, M; Vos, R; Vriens, H | 1 |
| Beck, LA; Prezzano, JC | 1 |
| Jaryal, A; Vikrant, S | 1 |
| Kamath, BM; Shah, PS; Valentino, PL; Zizzo, AN | 1 |
| Chan, GCW; Chan, TM; Kwan, LPY; Ma, MKM; Mok, MMY; Tang, C; Yap, DYH | 1 |
| Dąbkowska, M; Demkow, U; Gozdowski, D; Mizerska-Wasiak, M; Olczak-Kowalczyk, D; Pańczyk-Tomaszewska, M; Roszkowska-Blaim, M; Swoboda-Kopeć, E | 1 |
| Chen, J; Chen, N; Fu, P; He, Y; Lin, H; Liu, F; Liu, J; Liu, Z; Ni, Z; Xing, C; Zeng, C; Zhang, H; Zhou, M | 1 |
| Avcin, T; Bader-Meunier, B; Beresford, MW; Brogan, P; de Graeff, N; Dolezalova, P; Feldman, BM; Groot, N; Kamphuis, S; Kone-Paut, I; Lahdenne, P; Marks, SD; McCann, L; Özen, S; Pilkington, CA; Ravelli, A; Royen-Kerkhof, AV; Uziel, Y; Vastert, BJ; Wulffraat, NM | 1 |
| Borok, J; Davis, DM; Lio, P; Spergel, J; Udkoff, J | 1 |
| Maggiore, G; Nastasio, S; Sciveres, M | 1 |
| Anlar, B; Baumann, M; Ciccarelli, O; Deiva, K; Forsyth, R; Ganelin-Cohen, E; Hacohen, Y; Hemingway, C; Hennes, EM; Hintzen, R; Jurynczyk, M; Kalser, J; Konuskan, B; Lechner, C; Leite, MI; Lim, M; Marignier, R; Maurey, H; Neuteboom, R; Palace, J; Poulat, AL; Rostásy, K; Wassmer, E; Wong, YY; Wright, S | 1 |
| Guo, SG; Wang, BJ; Wang, CJ; Yang, Y; Zeng, ZL | 1 |
| Lacour, JP | 1 |
| Brito-Zerón, P; Carballo, I; Cid, MC; Feijóo-Massó, C; Fernández-Codina, A; Fonseca-Aizpuru, E; Fraile-Rodríguez, G; López, C; López-Dupla, M; Martínez-Valle, F; Pinal-Fernández, I; Pinilla, B | 1 |
| Benedetto, C; Biancone, L; Colla, L; Diena, D; Manzione, AM; Marozio, L; Rossetti, M | 1 |
| Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Maitland-van der Zee, AH; van den Broek, MPH; van den Heuvel, JM | 1 |
| Chan, GCW; Chan, TM; Kwan, LPY; Ma, MKM; Mok, MMY; Yap, DYH | 1 |
| Berman, JS; Govender, P; Raghu, G | 1 |
| Fei, Y; Feng, R; Lai, Y; Peng, L; Wang, L; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y | 1 |
| Christopher-Stine, L; Mecoli, CA | 1 |
| de Bock, GH; Erasmus, ME; Klaver, NS; Plasmeijer, EI; Rácz, E; van Bemmel, BC; van der Bij, W; Verschuuren, EAM; Vos, M | 1 |
| Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
| Svensson, Å; von Kobyletzki, LB | 1 |
| Craig, JC; Flanc, RS; Henderson, L; Masson, P; Palmer, SC; Roberts, MA; Singh-Grewal, D; Strippoli, GF; Tong, A; Tunnicliffe, DJ; Webster, AC | 1 |
| Barratt, J; Tang, SCW | 1 |
| Agüera, ML; Aljama, P; Cabello-Jabalquinto, R; Esquivias-Motta, E; Lopez-Lopez, I; Navarro, MD; Rodelo-Haad, C; Rodriguez-Benot, A | 1 |
| Dale, RC; Mohammad, SS; Nosadini, M; Sartori, S; Toldo, I | 1 |
| Collins, J; Costenbader, KH; Feldman, CH; Kawachi, I; Solomon, DH; Subramanian, SV; Xu, C; Zhang, Z | 1 |
| Almer, S; Friis-Liby, IL; Giannakopoulos, G; Nyhlin, N; Sangfelt, P; Verbaan, H | 1 |
| Bonfá, E; Borba, EF; Castro, M; Seguro, LPC; Ugolini-Lopes, M | 1 |
| Yates, M | 1 |
| An, Y; Bi, L; Deng, X; Guo, J; Li, Y; Li, Z; Lin, J; Liu, B; Liu, X; Liu, Y; Lu, X; Mei, Y; Shen, H; Sun, L; Wang, G; Wang, H; Wang, M; Wang, Y; Xiao, W; Xie, R; Xu, D; Xu, H; Yang, X; Yao, Z; Yu, F; Zhang, J; Zhang, Z; Zhao, M; Zhao, Y; Zhou, Y; Zhu, P; Zuo, X | 1 |
| Cirillo, F; Maggiore, G; Malaventura, C; Matarazzo, L; Nastasio, S; Riva, S; Sciveres, M | 1 |
| Dehoorne, J; Herregods, N; Mondelaers, V; Van Coster, R; Van Driessche, B; Verhelst, H; Verloo, P | 1 |
| Cristelli, MP; Dantas, MTC; Felipe, CR; Pestana, JM; Santos, DW; Silva, HT; Tavares, MG; Viana, LA | 1 |
| Arvaniti, P; Dalekos, GN; Gyftaki, S; Hadjigeorgiou, G; Koukoulis, GK; Rigopoulou, EI; Tsimourtou, V | 1 |
| Ballarin, J; Blockmans, DE; Brogan, P; Bruchfeld, A; Cid, MC; Dahlsveen, K; de Zoysa, J; Espigol-Frigolé, G; Harper, L; Hiemstra, TF; Jayne, D; Jones, RB; Lanyon, P; Peh, CA; Tesar, V; Vaglio, A; Walsh, D; Walsh, M; Walters, G | 1 |
| Archer, TM; Dandrieux, JRS; Firestone, S; Mansfield, CS; Narayanan, L | 1 |
| Deng, J; Luo, L; Xie, H; Zhu, L | 1 |
| Doycheva, I; Gulamhusein, AF; Watt, KD | 1 |
| Levy, C; Santiago, P; Schwartz, I; Tamariz, L | 1 |
| Guex-Crosier, Y; Ribi, C; Rossi, DC | 1 |
| Schmidt, E; van Beek, N; Zillikens, D | 1 |
| Chen, HH; Chen, YH; Chen, YM; Hsieh, CW; Hsieh, TY; Hsu, CY; Huang, WN; Hung, WT; Lai, KL; Liao, YW; Lin, CT; Tang, KT; Tseng, CW | 1 |
| Byers, DE; Chen, C; Gelman, A; Hachem, R; Huang, HJ; Kreisel, D; Krupnick, AS; Kulkarni, HS; Tague, LK | 1 |
| Cristelli, M; de Paula, M; Felipe, C; Ferreira, AN; Medina Pestana, J; Tedesco-Silva, H; Viana, L | 1 |
| Andrade, MC; Clemente, G; Fernandez, JD; Fraga, MM; Len, CA; Schinzel, V; Terreri, MT | 1 |
| He, ZB; Huang, TT; Yu, ZJ; Zhang, LL; Zhu, JS | 1 |
| Albayda, J; Casal-Dominguez, M; Christopher-Stine, L; Danoff, SK; Huapaya, JA; Johnson, C; Mammen, AL; Paik, JJ; Pinal-Fernandez, I; Sanyal, A; Silhan, L | 1 |
| Abdelaziz, TS; Ali, AY; Behiry, ME | 1 |
| Akikusa, J; Alsaleem, A; Chiang, GPK; Laxer, RM; Lee, JJY; Limenis, E; Sontichai, W; Yeung, RSM | 1 |
| Pan, L; Wang, Q; Xia, JX; Yang, QR; Zheng, JN; Zhu, GQ | 1 |
| Chen, G; Wang, J; Zhou, D; Zhou, X | 1 |
| Åsberg, A; Chandra, A; Eide, IA; Midtvedt, K | 1 |
| Gomez, A; Hernández-Breijo, B; Johansson, P; Parodis, I; Soukka, S | 1 |
| Fiddler, CA; Parfrey, H; Simler, N; Thillai, M | 1 |
| Aban, I; Allman, PH; Burns, TM; Cutter, G; Duda, PW; Farzaneh-Far, R; Kaminski, HJ; Xin, H | 1 |
| Basso, C; Campochiaro, C; Candela, C; Dagna, L; De Luca, G; Della Bella, P; Esposito, A; Palmisano, A; Peretto, G; Rizzo, S; Sala, S; Sartorelli, S; Thiene, G | 1 |
| Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Gevers, TJ; Pape, S; Schramm, C | 1 |
| Corpechot, C; Elessa, D; Fain, O; Mekinian, A; Thietart, S | 1 |
| Chen, H; Du, Q; Qiu, Y; Shi, Z; Wang, J; Yan, C; Yang, M; Zhang, Q; Zhang, Y; Zhao, Z; Zhou, H | 1 |
| Chan, TM; Yap, DYH | 2 |
| Al-Harbi, T; Alroughani, R; Altintas, A; Bergamaschi, R; Boz, C; Butzkueven, H; Csepany, T; Eichau, S; Ferraro, D; Fragoso, Y; Grand'Maison, F; Granella, F; Havrdova, EK; Hor, JY; Izquierdo, G; Kalincik, T; Karabudak, R; Kister, I; Kunchok, A; Laureys, G; Lechner-Scott, J; Lugaresi, A; Malpas, C; Marriott, M; McCombe, P; Nytrova, P; Olascoaga, J; Onofrj, M; Oreja-Guevara, C; Ozakbas, S; Patti, F; Pucci, E; Simo, M; Singhal, B; Sola, P; Soysal, A; Terzi, M; Trojano, M; Turkoglu, R; Vucic, S; Yamout, B | 1 |
| Delfino, J; Dos Santos, TAFG; Skare, TL | 1 |
| Allen, J; Dimachkie, MM; Jacobsen, B; Muley, SA; Ortega, E; Parry, G; Pasnoor, M; Usman, U; Varon, M; Walk, D | 1 |
| Apiwattanakul, M; Aungsumart, S | 1 |
| Archer, TM; Boothe, DM; Cruz-Espindola, C; Fellman, C; Harmon, R; Mackin, AJ; Mulligan, C; Narayanan, L; Riggs, C; Thomason, JM; Wills, RW | 1 |
| Broen, JCA; van Laar, JM | 1 |
| Silverberg, JI; Singh, P | 1 |
| Chen, D; Gao, J; Li, ZG; Liu, Y; Shen, D; Wang, K; Wang, Y; Wang, Z; Xia, C; Yang, F; Yu, G; Zeng, Q; Zhang, S; Zhu, L | 1 |
| Andrews, PA; Hull, RP; Kingdon, EJ; MacPhee, IAM; Phanish, MK; Popoola, J | 1 |
| Audoin, B; Bourre, B; Ciron, J; Cohen, M; Collongues, N; Deschamps, R; Giovannelli, J; Laplaud, D; Maillart, E; Marignier, R; Outteryck, O; Papeix, C; Poupart, J; Vukusic, S; Wiertlewski, S; Zephir, H | 1 |
| Miloslavsky, EM; Wallace, ZS | 1 |
| Anders, HJ; Aringer, M; Bajema, I; Bertsias, G; Boletis, J; Boumpas, DT; Cheema, K; Fanouriakis, A; Frangou, E; Hollis, J; Houssiau, FA; Jayne, D; Karras, A; Kostopoulou, M; Marchiori, F; Marks, SD; Moroni, G; Mosca, M; Parodis, I; Praga, M; Schneider, M; Smolen, JS; Teng, YKO; Tesar, V; Trachana, M; van Leew, B; van Vollenhoven, RF; Voskuyl, AE | 1 |
| Dong, L; Hu, T; Qin, W; Tan, J; Tang, Y; Tarun, P; Xu, Y; Ye, D; Zhong, Z | 1 |
| Craig, JC; Hodson, EM; Larkins, NG; Liu, ID; Willis, NS | 1 |
| Albogami, Y; Rasmussen, SA; Sarayani, A; Thai, TN; Wang, X; Winterstein, AG | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Agarwal, V; Agrawal, V; Behera, M; Bhadauria, D; Gupta, A; Jain, M; Kurian, J; Kushwaha, R; Prasad, N; Yacha, M | 1 |
| Ho, LY; Leung, MC; Mok, CC; Ng, WL; To, CH; Ying, SKY | 1 |
| Argolini, LM; Binda, V; Caporali, R; Carli, L; Doria, A; Elefante, E; Esposito, C; Frontini, G; Gatto, M; Gerosa, M; Messa, P; Moroni, G; Mosca, M; Saccon, F; Scotti, I; Tani, C | 1 |
| Chen, A; Hall, RP; Miyagaki, T; Streilein, RD; Tedder, TF; Yoshizaki, A | 1 |
| Abdulahad, WH; Dekkema, G; Heeringa, P; Rutgers, A; Sanders, JS; Stegeman, CA; Veldman, J; von Borstel, A | 1 |
| Gaspar, R; Liberal, R; Lopes, S; Macedo, G | 1 |
| Akai, M; Demura, Y; Ishizuka, T; Nakashima, K; Oi, M; Shiozaki, K; Tabata, M; Tada, T | 1 |
| Barbeau, J; Baruah, D; Bausch-Jurken, M; Busalacchi, A; Chen, S; Cool, CD; Feng, M; Hammelev, E; Hintermeyer, MK; Rao, N; Routes, JM; Rymaszewski, A; Simpson, PM; Sosa-Lozano, LA; Verbsky, JW; Woodliff, J | 1 |
| Hodak, E; Leshem, YA; Levi, A; Mimouni, D; Snast, I; Spitzer, L | 1 |
| Chan, TC; Lee, MS; Tu, YK; Yeh, YC | 1 |
| Abbass, A; Boppana, V; Hanson, J; Khalid, S; Lin, H; McCarthy, D | 1 |
| Cortazar, FB; Huizenga, NR; Laliberte, K; Niles, JL; Rhee, EP; Rosenthal, JM; Wallace, ZS; Zonozi, R | 1 |
| Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ | 1 |
| Amoura, Z; Barnett, C; Burriss, SW; Contreras, G; Furie, R; Green, Y; Houssiau, F; Ji, B; Kleoudis, C; Malvar, A; Mok, CC; Roth, DA; Rovin, BH; Santiago, MB; Saxena, A; Teng, YKO; Yu, X | 1 |
| Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
| Amlani, B; Barvalia, U; Elsayed, G; Kanne, JP; Li, Z; McCoy, SS; Meyer, KC; Sandbo, N | 1 |
| Bu, B; Du, C; Duan, RS; Liu, W; Shi, FD; Wang, L; Yang, H; Yang, L; Zeng, P; Zhang, C; Zhang, M | 1 |
| Augustine, J; Avery, R; Baldwin, W; Braun, WE; Brown, K; Fairchild, R; Fatica, R; Goldfarb, D; Herlitz, L; Kiser, W; Li, J; Nakamoto, S; Nally, J; Poggio, E; Schold, J; Stephany, B; Tomford, JW | 1 |
| Hammad, I; Porter, TF | 1 |
| Chotcomwongse, P; Foster, CS; Ittharat, W; Preble, JM; Silpa-Archa, S | 1 |
| Komori, A | 1 |
| Chomicz, L; Mucha, K; Pączek, L; Szaflik, JP; Waszczyk-Łączak, M; Łazicka-Gałecka, M | 1 |
| Gunnarsson, I; Lannfelt, K; Schmidt Mende, J; Sundelin, B; Zickert, A | 1 |
| Choi, MY; Costenbader, KH; Everett, BM; Feldman, CH; Guan, H; Kim, SC; Li, D; Yoshida, K | 1 |
| Bardazzi, F; Filippini, A; Gallo, G; Loi, C; Misciali, C; Patrizi, A | 1 |
| Isenberg, D; Lorenzo-Vizcaya, A | 1 |
| Cho, H; Jang, JH; Kim, JY | 1 |
| Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Abe, K; Aiso, M; Aoyagi, H; Arizumi, T; Asaoka, Y; Isono, A; Kodashima, S; Matsumoto, K; Miki, A; Miura, R; Tachizawa, N; Tanaka, A; Yagi, M; Yamamoto, T | 1 |
| Bayerl, C; Herr, R; Kromer, C; Pino Lopez, J; Schaarschmidt, ML; Schmieder, A | 1 |
| Ahn, SS; Lee, LE; Lee, SW; Park, YB; Pyo, JY; Song, JJ | 1 |
| Bossini, N; Citterio, F; Cravedi, P; Gaspari, F; Gotti, E; Marasà, M; Martinetti, D; Minetti, E; Montanaro, D; Peraro, F; Perna, A; Plati, A; Remuzzi, G; Ruggenenti, P; Sabadini, E; Sandrini, S; Tardanico, R; Villa, A | 1 |
| Hanprasertpong, N; Hirunsatitpron, P; Koonrungsesomboon, N; Noppakun, K; Pruksakorn, D; Teekachunhatean, S | 1 |
| Alfano, G; Cappelli, G; Fontana, F | 1 |
| Audoin, B; Ayrignac, X; Bourre, B; Ciron, J; Cohen, M; Collongues, N; Dauchet, L; Deschamps, R; Durand-Dubief, F; Giovannelli, J; Greenberg, BM; Kim, HJ; Kim, SH; Kleiter, I; Laplaud, D; Maillart, E; Marignier, R; McCreary, M; Papeix, C; Ruet, A; Stellmann, JP; Vukusic, S; Zephir, H | 1 |
| Chotalia, P; Pandya, S; Srivastava, P | 1 |
| Dong, X; Guo, L; Jia, Z; Li, B; Sun, Y; Tan, G; Tian, J; Zhang, L | 1 |
| Acar, H; Fazliogullari, Z; Karabulut, AK; Unver Dogan, N; Uysal, II | 1 |
| Fukushima, N; Iwami, D; Shimizu, T; Shinzato, T; Tabata, K | 1 |
| Johannson, KA; Khor, YH; Lok, SD; Ryerson, CJ; Wong, AW | 1 |
| Feng, K; Ma, J; Wang, H; Yu, H; Zhang, X | 1 |
| Croy, R; Erdman, J; Fitzsimmons, WE; Nimke, D; Schladt, D; Wang, X; Weaver, T; Wolfram, J | 2 |
| Agarwal, V; Aggarwal, R; Chatterjee, R; Gupta, L; Mehta, P; Naveen, R; Rathore, U | 1 |
| Arvaniti, P; Dalekos, GN; Gabeta, S; Gatselis, NK; Koukoulis, GK; Rigopoulou, E; Samakidou, A; Zachou, K | 1 |
| Chen, N; Chen, X; Li, X; Ren, H; Shen, P; Xie, J; Xing, P; Zhang, Q; Zhang, W | 1 |
| Chang, X; Du, L; Huang, W; Li, Q; Li, W; Lu, C; Lu, J; Ma, J; Pan, J; Quan, C; Tan, H; Wang, B; Wang, L; Wang, M; Xia, J; Yu, J; ZhangBao, J; Zhao, C; Zhou, L | 1 |
| Heller, T; Kleiner, DE; Lanis, A; Rider, LG; Shenoi, S; Vittal, A; Volochayev, R | 1 |
| Berthele, A; Giglhuber, K | 1 |
| Jitprapaikulsan, J; Pathomrattanapiban, C; Prayoonwiwat, N; Rattanathamsakul, N; Siritho, S; Tisavipat, N | 1 |
| Amoura, Z; Baumstarck, K; Bouillet, L; Burtey, S; Caudwell, V; Chiche, L; Costedoat-Chalumeau, N; Couzi, L; Daniel, L; Daugas, E; Deligny, C; Dussol, B; Faguer, S; Gobert, P; Gondran, G; Hachulla, E; Huart, A; Hummel, A; Jourde-Chiche, N; Kalbacher, E; Karras, A; Lambert, M; Le Guern, V; Lebourg, L; Loubière, S; Loundou, A; Maillard-Lefebvre, H; Maurier, F; Pha, M; Queyrel, V; Remy, P; Sarrot-Reynauld, F; Verhelst, D | 1 |
| Ayada, I; de Vries, AC; den Hoed, CM; Kamar, N; Li, J; Li, P; Pan, Q; Peppelenbosch, MP; Wang, Y | 1 |
| Almeida, RAMB; Calazans, CAC; Charpiot, IMMF; Costa, KMAH; Cristelli, MP; de Lima, PR; de Sandes-Freitas, TV; Deboni, LM; Ferreira, GF; Ferreira, TCA; Garcia, VD; Manfro, RC; Mazzali, M; Medina-Pestana, J; Modelli de Andrade, LG; Nakamura, MR; Oriá, RB; Pacheco-Silva, A; Requião-Moura, LR; Simão, DR; Tedesco-Silva, H; Viana, LA | 1 |
| Bao, C; Dai, L; Dai, M; Fu, Q; He, L; Li, Z; Lu, L; Sun, L; Wang, S; Wu, C; Xu, J; Zhu, X | 1 |
| Agner, T; Alfonso, JH; de Graaf, M; De Schepper, S; Deleuran, M; Despontin, K; Elenius, V; Ghislain, PD; Huilaja, L; Janmohamed, SR; Johansson, EK; Kvenshagen, BK; Mandelin, JM; Olset, H; Schuttelaar, MLA; Svensson, A; Thyssen, JP; van Tuyll van Serooskerken, AM; Vestergaard, C | 1 |
| Azevedo, LS; David-Neto, E; Pereira, NV; Quaresma, MV; Saldanha, MG; Sotto, MN | 1 |
| Chang, X; Dong, Q; Huang, W; Li, W; Li, X; Lu, C; Lu, J; Quan, C; Tan, H; Wang, L; Wang, M; Xia, J; ZhangBao, J; Zhao, C; Zhou, L | 1 |
| Chen, H; Du, Q; Kong, L; Lang, Y; Lin, X; Shi, Z; Wang, X; Zhao, Z; Zhou, H | 1 |
| Arents, B; Aszodi, N; Avila Valle, G; Barbarot, S; Bieber, T; Brough, HA; Calzavara Pinton, P; Christen-Zäch, S; Deleuran, M; Dittmann, M; Dressler, C; Fink-Wagner, AH; Flohr, C; Fosse, N; Gáspár, K; Gerbens, L; Gieler, U; Girolomoni, G; Gregoriou, S; Kinberger, M; Mortz, CG; Nast, A; Nygaard, U; Redding, M; Rehbinder, EM; Ring, J; Rossi, M; Serra-Baldrich, E; Simon, D; Szalai, ZZ; Szepietowski, JC; Torrelo, A; Werfel, T; Wollenberg, A | 1 |
| Banakou, E; Dalekos, GN; Gatselis, NK; Lyberopoulou, A; Samakidou, A | 1 |
| Antoni, C; Bergner, R; Ebert, MP; Galle, PR; Hetjens, S; Qian, Y; Schlevogt, B; Schmidt, HJ; Sollors, J; Teufel, A; Weis, CA; Woerns, MA | 1 |
| Anderson, N; Beaton, DE; Bingham, KS; Bonilla, D; Choi, MY; Diaz Martinez, JP; Dobrowolski, C; Fazzari, M; Fritzler, MJ; Green, R; Kakvan, M; Katz, P; McGinley, J; Putterman, C; Ruttan, L; Su, J; Tartaglia, MC; Touma, Z; Wither, JE | 1 |
| Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG | 1 |
| Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
| Kridin, K; Ludwig, RJ; Mruwat, N | 1 |
| Bakker, SF; Bartelink, M; Beuers, UHW; Biewenga, M; de Boer, YS; de Jonge, HJM; Drenth, JPH; Gevers, TJG; Gisbertz, IAM; Guichelaar, MMJ; Levens, AD; Pape, S; Pronk, MAMCB; Sebib Korkmaz, K; Sijtsma, MGM; Snijders, RJALM; Soufidi, K; Stoelinga, AEC; van den Berg, AP; van den Brand, FF; van der Meer, AJ; van Gerven, NMF; van Hoek, B; Vanwolleghem, T; Verdonk, RC; Verwer, BJ; Vrolijk, JM | 1 |
| Baracaldo-Santamaría, D; Poole, BD; Quaye, A; Rojas-Rodríguez, LC; Téllez Arévalo, AM; Tellez Freitas, CM | 1 |
| Borradori, L; Cazzaniga, S; Naldi, L | 1 |
| Amber, KT; Kridin, K; Ludwig, RJ; Mruwat, N | 1 |
| Kim, JK | 1 |
| Azzouzi, A; Bayahia, R; Benamar, L; Bouattar, T; Driouch, L; Ouzeddoun, N | 2 |
| Chen, G; Chen, Z; Duan, A; Fang, T; Qiu, Y; Wang, Z; Wu, J; Yin, Z | 1 |
| Chang, X; Li, S; Wang, R; Wu, P; Wu, Y; Zhang, C; Zhang, J | 1 |
| Abuaf, AF; Chaar, WA; Cipriani, VP; Dresser, L; Javed, A; Reder, AT | 1 |
| Ahmed, AS; Biswas, J; Ramdoss, J; Singh, P | 1 |
| Camacho, I; Dave, Y; Eckembrecher, DG; Eckembrecher, FJ; Nouri, K; Patel, S; Shah, H | 1 |
| Basu, A; Cohen, D; Coscia, L; Dube, GK; Gattis, S; Hofmann, RM; Moritz, MJ | 1 |
| Acharya, NR; Artornsombudh, P; Begum, HA; Bhatt, NP; Buchanich, JM; Daniel, E; Dreger, KA; Dunn, JP; Fitzgerald, TD; Foster, CS; Gangaputra, SS; Goldstein, DA; Helzlsouer, KJ; Holland, GN; Jabs, DA; Kaçmaz, RO; Kempen, JH; Khachatryan, N; Kothari, S; Leiderman, YI; Levy-Clarke, GA; Liesegang, TL; Lowder, CY; Maghsoudlou, A; Newcomb, CW; Nussenblatt, RB; Pak, CM; Payal, AR; Pujari, SS; Read, RW; Rosenbaum, JT; Sen, HN; Sobrin, L; Suga, HK; Suhler, EB; Thorne, JE; Washington, TL | 1 |
| Ávila, D; Huertas, J; Mendoza, F; Ordóñez, A; Orozco, E; Sanmartin, D; Tamayo, C | 1 |
| Becker, B; Bernsmeier, C; Böhm, S; Braegger, C; Bresson-Hadni, S; Cerny, A; Cremer, M; De Gottardi, A; Di Bartolomeo, C; Filipowicz Sinnreich, M; Furlano, R; Galante, A; Heyland, K; Kremer, AE; Limoni, C; Ludz, C; McLin, V; Mertens, J; Mieli-Vergani, G; Müller, P; Nydegger, A; Posovszky, C; Righini-Grunder, F; Rock, N; Semela, D; Sokollik, C; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D | 1 |
| Lomanto Silva, R; Magnani, JW; Sattui, SE; Swabe, GM | 1 |
| Jiang, N; Jin, S; Li, M; Tian, X; Wang, Q; Yu, C; Zeng, X; Zhao, J | 1 |
| Avila, MS; Bacal, F; Barone, F; Campos, IW; Fukushima, J; Furquim, SR; Gaiotto, FA; Galante, MC; Galbiati, LC; Mangini, S; Marcondes-Braga, FG; Ohe, LA; Paulo, ARDSA; Seguro, LFBDC; Strabelli, TMV | 1 |
| Goel, A; Kwo, P | 1 |
242 review(s) available for azathioprine and mycophenolic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; Hydroxyurea; Mercaptopurine; Mustard Compounds; Mycophenolic Acid; Psoriasis | 1981 |
Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
Topics: Animals; Azathioprine; Dose-Response Relationship, Drug; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphocytes; Multicenter Studies as Topic; Mycophenolic Acid; Placebos; Prospective Studies; Purines; Randomized Controlled Trials as Topic; Safety | 1996 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Adult; Azathioprine; Calcineurin; Calmodulin-Binding Proteins; Cyclosporine; Cytokines; Drug Monitoring; Graft Rejection; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Methyltransferases; Mycophenolic Acid; Phosphoprotein Phosphatases; T-Lymphocytes; Transplantation Immunology | 1996 |
Emerging treatments in multiple sclerosis: azathioprine and mofetil.
Topics: Azathioprine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Mycophenolic Acid | 1996 |
Drugs that interact with immunosuppressive agents.
Topics: Anti-Bacterial Agents; Anticonvulsants; Azathioprine; Cardiovascular Agents; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Mycophenolic Acid | 1998 |
The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Methylprednisolone; Mycophenolic Acid; Sirolimus | 1998 |
[Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial].
Topics: Adult; Azathioprine; Data Interpretation, Statistical; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Reoperation; Time Factors | 1999 |
Mycophenolate mofetil--is it worth the cost? The in-favor opinion.
Topics: Acute Disease; Azathioprine; Child; Chronic Disease; Cost of Illness; Cyclosporine; Drug Costs; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Technology Assessment, Biomedical; Treatment Outcome | 1999 |
What is the role for mycophenolate mofetil in pediatric renal transplantation?
Topics: Adult; Azathioprine; Cyclosporine; Double-Blind Method; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Treatment Outcome | 1999 |
Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Drug Interactions; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Steroids; Tacrolimus; Transplantation Immunology | 1999 |
Progress with cyclosporine-sparing regimens.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 1999 |
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
Topics: Acute Disease; Azathioprine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Proportional Hazards Models; Risk Factors; Survival Analysis; Time Factors; Transplantation, Homologous | 2000 |
Immunosuppression in older renal transplant patients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Antilymphocyte Serum; Azathioprine; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Quality of Life; Survival Analysis; Tacrolimus; Treatment Outcome | 2000 |
Other novel immunosuppressants.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thioguanine | 2000 |
Medical therapies for ulcerative colitis and Crohn's disease.
Topics: Adjuvants, Immunologic; Aminosalicylic Acids; Antimetabolites; Appendectomy; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mycophenolic Acid; Remission Induction | 2000 |
Initial management of proliferative lupus nephritis: to cytotoxic or not to cytotoxic?
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 1999 |
Evolving treatment strategies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus | 2001 |
Pharmacological surrogates of allograft outcome.
Topics: Animals; Azathioprine; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Sirolimus; Steroids; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
[Treatment of uveitis with immunosuppressives: antimetabolites and alkylating agents].
Topics: Adult; Aged; Antimetabolites; Antineoplastic Agents, Alkylating; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Uveitis | 2001 |
The evidence base for the treatment of lupus nephritis in the new millennium.
Topics: Alkylating Agents; Azathioprine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Nephrology; Plasma Exchange; Randomized Controlled Trials as Topic; Steroids | 2001 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Polymyositis; Steroids; Tacrolimus | 2001 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Models, Animal; Humans; Kidney; Kidney Diseases; Methotrexate; Mice; Mycophenolic Acid; Rituximab; Vasculitis | 2003 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
Topics: Adult; Azathioprine; Creatinine; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Survival Analysis; Transplantation, Homologous | 2003 |
Immunosuppressive drug use in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclophosphamide; Cyclosporine; Female; Fetal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maternal-Fetal Exchange; Mycophenolic Acid; Pregnancy; Pregnancy Complications | 2003 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.
Topics: Anemia; Anemia, Iron-Deficiency; Azathioprine; Bone Marrow; Child; Erythropoiesis; Erythropoietin; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Tacrolimus | 2003 |
Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Clinical Trials, Phase III as Topic; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intravenous; Kidney Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Mycophenolic Acid; Quality of Health Care; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Risk Assessment; Time Factors | 2003 |
[Systemic therapy of atopic dermatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antifungal Agents; Azathioprine; Child; Child, Preschool; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Desensitization, Immunologic; Disease Models, Animal; Double-Blind Method; Histamine Antagonists; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Leukotriene Antagonists; Medicine, Chinese Traditional; Mice; Mice, Nude; Mycophenolic Acid; Ointments; Photopheresis; Phototherapy; Placebos; Probiotics; PUVA Therapy; Randomized Controlled Trials as Topic; Ultraviolet Therapy | 2003 |
Renal transplantation: basic concepts and evolution of therapy.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Fingolimod Hydrochloride; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Receptors, Interleukin-2; Sirolimus; Sphingosine; Tacrolimus | 2003 |
[Treatment of autoimmune hepatitis].
Topics: Azathioprine; Folic Acid Antagonists; Hepatitis, Autoimmune; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Liver Transplantation; Methotrexate; Mycophenolic Acid; Tacrolimus; Tumor Necrosis Factor-alpha | 2003 |
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus | 2003 |
Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Calcineurin Inhibitors; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Transplantation Immunology | 2004 |
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.
Topics: Azathioprine; Calcineurin Inhibitors; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Pharmacogenetics | 2004 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Immunoassay; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Ultrasonography; Ursodeoxycholic Acid | 2004 |
Treating immunobullous diseases: an update.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Skin Care; Skin Diseases, Vesiculobullous | 2004 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
Optimizing the immunosuppressive regimen in heart transplantation.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus | 2004 |
[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Complications; Disease Susceptibility; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nocardia asteroides; Nocardia Infections; Postoperative Complications; Reoperation; Risk Factors; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Immunosuppression and modulation in liver transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Glucocorticoids; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Mycophenolic Acid; Sirolimus; Tacrolimus | 2004 |
Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Postoperative Care; Safety; Sirolimus; Tacrolimus; Transplantation, Homologous | 2004 |
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus | 2004 |
[Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Ribonucleosides; Tacrolimus | 2004 |
Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.
Topics: Azathioprine; Cytomegalovirus Infections; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Mycophenolic Acid; Pain; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Safety; Skin Neoplasms; Time Factors; Vomiting | 2004 |
Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.
Topics: Azathioprine; Clinical Trials as Topic; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Survival Analysis | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Immunosuppression: towards a logical approach in liver transplantation.
Topics: Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Graft Rejection; Humans; Immune Tolerance; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Sirolimus | 2005 |
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Everolimus; Graft Rejection; Growth Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous | 2004 |
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.
Topics: Azathioprine; Black People; Cyclosporine; Cytochrome P-450 Enzyme System; Everolimus; Graft Survival; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; White People | 2004 |
Steroid withdrawal in pediatric and adult renal transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Child; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid | 2005 |
[Immunossupresive drugs in renal transplantation].
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Risk Factors; Rituximab; Sirolimus; Sphingosine; Tacrolimus | 2004 |
Mechanisms of action of mycophenolate mofetil.
Topics: Azathioprine; B-Lymphocytes; Cytokines; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nitric Oxide; T-Lymphocytes; Vascular Diseases | 2005 |
[Lung transplantation].
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporins; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Japan; Living Donors; Lung Transplantation; Methylprednisolone; Monitoring, Physiologic; Mycophenolic Acid; Survival Rate; Tacrolimus; Tissue and Organ Procurement | 2005 |
[Immunosuppressants for therapy of patients with ulcerative colitis].
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Guanine Nucleotides; Humans; Immunosuppressive Agents; Mercaptopurine; Methyltransferases; Mycophenolic Acid; Tacrolimus; Thionucleotides | 2005 |
Myasthenia gravis: emerging new therapy options.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Rituximab; Thymectomy | 2005 |
[Pharmacotherapy of SLE].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclophosphamide; Cyclosporine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Plasma Exchange | 2005 |
[How should severe and chronic atopic dermatitis in children be managed?].
Topics: Azathioprine; Child; Chronic Disease; Dermatitis, Atopic; Humans; Immunologic Factors; Immunosuppressive Agents; Mycophenolic Acid; Severity of Illness Index | 2005 |
Treatment of focal segmental glomerulosclerosis.
Topics: Alkylating Agents; Antimetabolites; Azathioprine; Contraindications; Cyclophosphamide; Cyclosporine; Drug Resistance; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunophilins; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Randomized Controlled Trials as Topic; Tacrolimus | 2005 |
[Evidences in immunosuppression in the maintenance of renal transplantation].
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Mycophenolic Acid; Risk Factors; Sirolimus | 2005 |
[Crohn's disease--standards of treatment 2004].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Prognosis; Remission Induction; Risk Factors; Time Factors | 2005 |
Review of major clinical trials with mycophenolate mofetil in renal transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Child; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; Tacrolimus | 2005 |
Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Mycophenolic Acid | 2005 |
Malignancy after transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous | 2005 |
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisolone; Receptors, Tumor Necrosis Factor; Vasculitis | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Dermatomyositis; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Muscles; Mycophenolic Acid; Paraneoplastic Syndromes; Plasmapheresis; Prognosis; Sex Factors; Time Factors | 2005 |
[Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclophosphamide; Cyclosporine; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Recombinant Fusion Proteins; Ribonucleosides; Sphingosine | 2006 |
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence | 2006 |
[Progress and perspectives in the treatment of systemic lupus erythematosus].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antineoplastic Agents, Alkylating; Azathioprine; Cladribine; Cyclophosphamide; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Vidarabine | 2005 |
[Systemic management of autoimmune anterior uveitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Prednisolone; Uveitis, Anterior | 2005 |
Bullous pemphigoid treatment review.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Cyclophosphamide; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Bullous; Plasmapheresis | 2006 |
Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis.
Topics: Azathioprine; Directed Tissue Donation; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Mycophenolic Acid; Tissue Donors; Treatment Outcome; United Kingdom | 2006 |
Azathioprine, UV light, and skin cancer in organ transplant patients--do we have an answer?
Topics: Azathioprine; Carcinoma, Squamous Cell; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2007 |
Calcineurin inhibitor-free protocols: risks and benefits.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Risk Assessment; Sirolimus; Treatment Outcome | 2007 |
Proliferation signal inhibitors in cardiac transplantation.
Topics: Azathioprine; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Coronary Artery Disease; Dose-Response Relationship, Drug; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Signal Transduction; Sirolimus | 2007 |
Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Infection Control; Leukopenia; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Risk Factors; Severity of Illness Index; Treatment Outcome | 2007 |
Current management of lupus nephritis: popular misconceptions.
Topics: Azathioprine; Cyclophosphamide; Drug Administration Schedule; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid | 2007 |
Immunosuppression for lung transplantation: evidence to date.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus | 2007 |
New treatment strategies for proliferative lupus nephritis: keep children in mind!
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Calcineurin Inhibitors; Child; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Pediatrics; Quality of Life; Randomized Controlled Trials as Topic; Rituximab | 2007 |
Immunosuppressive agents for myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Prednisolone; Randomized Controlled Trials as Topic; Tacrolimus | 2007 |
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Sirolimus; Tacrolimus | 2008 |
The treatment and prognosis of dermatomyositis: an updated review.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Cyclosporine; Dermatomyositis; Drug Administration Schedule; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prognosis | 2008 |
Current treatment of lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Humans; Lupus Nephritis; Mycophenolic Acid | 2008 |
[Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations].
Topics: Azathioprine; Clinical Protocols; Cyclophosphamide; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Mycophenolic Acid; Practice Guidelines as Topic | 2008 |
Update on the management of lupus nephritis: let the treatment fit the patient.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Rituximab | 2008 |
Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Oligonucleotides; Rituximab | 2008 |
Medical treatment options for ocular myasthenia gravis.
Topics: Azathioprine; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid | 2008 |
How did cyclophosphamide become the drug of choice for lupus nephritis?
Topics: Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; History, 20th Century; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid | 2009 |
Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
Topics: Acute Disease; Azathioprine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Proportional Hazards Models; Risk Factors | 2009 |
Management of chronic allograft nephropathy: a systematic review.
Topics: Azathioprine; Biopsy; Calcineurin Inhibitors; Chronic Disease; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
[Treatment of rapidly progressive glomerulonephritis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Plasma Exchange; Pulse Therapy, Drug | 2009 |
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil.
Topics: Azathioprine; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Kidney; Liver Transplantation; Mycophenolic Acid | 2009 |
Membranous lupus nephritis in Chinese children--a case series and review of the literature.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Outcome | 2009 |
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Emollients; Glucocorticoids; Histamine Antagonists; Humans; Immunoglobulins; Immunologic Factors; Infant; Infusions, Intravenous; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy; Primary Health Care; Severity of Illness Index; Treatment Outcome | 2009 |
Disease-modifying treatment in systemic sclerosis: current status.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Azathioprine; Collagen Type I; Connective Tissue Growth Factor; Cyclophosphamide; Evidence-Based Practice; Fibrosis; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Scleroderma, Systemic; Transforming Growth Factor beta; Transplantation, Autologous; Tumor Necrosis Factor-alpha | 2009 |
Can we personalize treatment for kidney diseases?
Topics: Aryl Hydrocarbon Hydroxylases; Azathioprine; Calcineurin Inhibitors; Complement C3; Complement C4; Cyclophosphamide; Cytochrome P-450 CYP2C19; Humans; Kidney Diseases; Leukocytes, Mononuclear; Lupus Nephritis; Mycophenolic Acid; Peptidyl-Dipeptidase A; Precision Medicine; Receptors, Fc | 2009 |
Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
Topics: Azathioprine; Bias; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sensitivity and Specificity; Treatment Outcome | 2010 |
ANCA-associated vasculitides: advances in pathophysiology and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Disease Models, Animal; Disease Progression; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid | 2010 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Interstitial lung disease in systemic sclerosis.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Contraindications; Cyclophosphamide; DNA Topoisomerases, Type I; Four-Dimensional Computed Tomography; Gastroesophageal Reflux; Humans; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Lung Transplantation; Mycophenolic Acid; Prognosis; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Respiratory Function Tests; Rituximab; Scleroderma, Systemic | 2011 |
Updates on the treatment of lupus nephritis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Forecasting; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2010 |
[Immunosuppressive therapies for refractory nephrotic syndrome].
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Polymorphism, Genetic; Ribonucleosides; Rituximab; Tacrolimus | 2010 |
A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Epidermal Growth Factor; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigus; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2011 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Mycophenolic Acid; Niacinamide; Pemphigoid, Bullous; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Tetracycline | 2011 |
Management of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Hypersensitivity; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Purine-Pyrimidine Metabolism, Inborn Errors; Tacrolimus | 2011 |
Clinical assessment and management of cytopenias in lupus patients.
Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukopenia; Lupus Erythematosus, Systemic; Mycophenolic Acid; Pancytopenia; Rituximab; Thrombocytopenia | 2011 |
Systemic therapy of atopic dermatitis in children and adults.
Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid; Recombinant Proteins; Tretinoin | 2011 |
Treatment of lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Nephritis; Mycophenolic Acid; Remission Induction | 2011 |
Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Time Factors | 2011 |
Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Topics: Azathioprine; Clinical Trials as Topic; Drug Monitoring; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Remission Induction; Treatment Outcome | 2011 |
Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Topics: Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Prednisolone; Treatment Outcome | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell Movement; Cyclophosphamide; Cyclosporine; Dermatomyositis; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Paraneoplastic Syndromes; Physical Therapy Modalities; Polymyositis; T-Lymphocytes; Tacrolimus | 2011 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; Evidence-Based Medicine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Medicine, Chinese Traditional; Mycophenolic Acid; Pemphigus; Pentoxifylline; Plasmapheresis; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2011 |
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Multiple Organ Failure; Mycophenolic Acid; Paraneoplastic Syndromes; Pemphigus; Plasmapheresis; Rituximab; Tacrolimus | 2011 |
Treatment of neuromyelitis optica: an evidence based review.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Azathioprine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neuromyelitis Optica; Rituximab | 2012 |
Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Treatment Outcome | 2012 |
New and future therapies for lupus nephritis.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Rituximab | 2012 |
How to treat refractory arthritis in lupus?
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis; Azathioprine; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2012 |
Effects of immunosuppressive therapy on wound healing.
Topics: Animals; Azathioprine; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rats; Sirolimus; Swine; Tacrolimus; Wound Healing; Wounds and Injuries | 2013 |
Nonspecific interstitial pneumonia.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Biopsy; Cyclophosphamide; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Humans; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Lung; Mycophenolic Acid; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Bullous; Prednisone; Rituximab | 2012 |
Recent progress in the treatment of lupus nephritis.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Rituximab; Treatment Outcome | 2012 |
Update on systemic therapies for atopic dermatitis.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kaposi Varicelliform Eruption; Male; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
Topics: Antirheumatic Agents; Azathioprine; Biopsy; Cyclophosphamide; Disease Progression; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Netherlands; Practice Guidelines as Topic; Prognosis; Treatment Outcome | 2012 |
Treatment of ANCA-associated vasculitis, where to go?
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Mycophenolic Acid; Randomized Controlled Trials as Topic | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Immunotherapies in neurologic disorders.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Mitoxantrone; Mycophenolic Acid; Natalizumab; Nervous System Diseases; Peptides; Plasma Exchange; Propylene Glycols; Rituximab; Sphingosine; Tacrolimus | 2012 |
Pharmacogenomics in pediatric rheumatology.
Topics: Antimetabolites; Antirheumatic Agents; Azathioprine; Biological Products; Child; Humans; Methotrexate; Models, Biological; Mycophenolic Acid; Pharmacogenetics; Precision Medicine; Rheumatic Diseases; Rheumatology | 2012 |
The treatment of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Cyclosporine; Hepatitis, Autoimmune; Humans; Mycophenolic Acid | 2012 |
Recent news in the treatment of lupus nephritis.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclophosphamide; Disease Progression; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Induction Chemotherapy; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Rituximab | 2012 |
Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Morbidity; Mycophenolic Acid; Risk Factors | 2013 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunomodulation; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Polymyositis; Randomized Controlled Trials as Topic; Tacrolimus | 2012 |
Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Disease Progression; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Odds Ratio; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2013 |
Immunosuppression in HCV-positive liver-transplant recipients.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Management of severe atopic dermatitis in children.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Baths; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Disinfectants; Humans; Immunosuppressive Agents; Infant; Methotrexate; Mycophenolic Acid; Sodium Hypochlorite; Ultraviolet Therapy | 2012 |
The treatment of systemic lupus proliferative nephritis.
Topics: Antimetabolites; Azathioprine; Biological Products; Child; Guidelines as Topic; Humans; Immunologic Factors; Lupus Nephritis; Mycophenolic Acid; Plasmapheresis; Randomized Controlled Trials as Topic | 2013 |
Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Rituximab | 2013 |
Treatment for lupus nephritis.
Topics: Adult; Azathioprine; Child; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Randomized Controlled Trials as Topic | 2012 |
Role of immunosuppressive therapy for the treatment of multiple sclerosis.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid | 2013 |
L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cooperative Behavior; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interdisciplinary Communication; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Secondary Prevention; Standard of Care; Treatment Outcome | 2013 |
[Mycophenolate mofetil in lupus nephritis treatment].
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid | 2012 |
Nonsteroidal therapy of sarcoidosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Products; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis, Pulmonary; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Pregnancy in renal transplant recipients.
Topics: Anemia; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Herpes Simplex; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Preconception Care; Prednisone; Pregnancy; Pregnancy Complications; Tacrolimus; Toxoplasmosis; Urinary Tract Infections | 2013 |
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Topics: Azathioprine; Biological Products; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Remission Induction; Scleroderma, Systemic | 2014 |
Current management of lupus nephritis.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Nephritis; Mycophenolic Acid; Prognosis; Pulse Therapy, Drug; Quality of Life | 2013 |
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid | 2014 |
Management of the ACC/AHA Stage D patient: cardiac transplantation.
Topics: Allografts; Azathioprine; Cardiotonic Agents; Contraindications; Graft Occlusion, Vascular; Graft Rejection; Heart; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Long-Term Care; Mycophenolic Acid; Neoplasms; Opportunistic Infections; Postoperative Care; Steroids | 2014 |
Ten common mistakes in the management of lupus nephritis.
Topics: Adult; Antimalarials; Azathioprine; Bone Density; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Patient Compliance; Pneumocystis carinii; Pneumocystis Infections; Pregnancy; Pregnancy Complications; Renal Dialysis | 2014 |
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
Topics: Antirheumatic Agents; Azathioprine; Biological Products; Biomarkers; Child; Genome, Human; Genotype; Humans; Methotrexate; Mycophenolic Acid; Pharmacogenetics; Phenotype; Precision Medicine; Rheumatic Diseases | 2013 |
Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis.
Topics: Adult; Azathioprine; Disease Management; Humans; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2014 |
Current and prospective pharmacotherapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Liver; Mycophenolic Acid; Rituximab; Salvage Therapy; Sirolimus | 2014 |
Recent clinical trials in lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethnopharmacology; Humans; Immunosuppressive Agents; Lupus Nephritis; Medication Therapy Management; Mycophenolic Acid; Organs at Risk; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisone; Remission Induction; Tacrolimus; Treatment Outcome | 2014 |
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Everolimus; Evidence-Based Medicine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Sirolimus; Tacrolimus; Transplantation Immunology | 2014 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
[Primary and secondary glomerular diseases].
Topics: Abatacept; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoconjugates; Kidney Glomerulus; Lupus Nephritis; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prognosis; Rituximab; Sjogren's Syndrome; Tonsillectomy | 2014 |
Ipilimumab-induced toxicities and the gastroenterologist.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury; Colitis; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Melanoma; Methylprednisolone; Mycophenolic Acid; Patient Care Team; Prednisolone; Pulse Therapy, Drug | 2015 |
Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine.
Topics: Azathioprine; Calcineurin Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Pharmacogenetics; Precision Medicine | 2015 |
Mycophenolate revisited.
Topics: Azathioprine; Clinical Trials as Topic; Drug Monitoring; Drugs, Generic; Genetic Variation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Tablets, Enteric-Coated | 2015 |
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation | 2015 |
Optimizing the use of existing therapies in lupus.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Long-Term Care; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome | 2015 |
Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antihypertensive Agents; Azathioprine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Mycophenolic Acid; Pre-Eclampsia; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2015 |
Treatment of Sarcoidosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Drug Administration Schedule; Granuloma; Humans; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Lung; Methotrexate; Mycophenolic Acid; Prednisone; Respiratory Function Tests; Sarcoidosis; Skin; Tomography, X-Ray Computed | 2015 |
Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisone; Remission Induction; Treatment Outcome | 2015 |
Current State of Immunosuppression: Past, Present, and Future.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2015 |
Mycophenolate mofetil for lupus nephritis: an update.
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Lupus Nephritis; Mycophenolic Acid; Tacrolimus | 2015 |
Treatment Considerations of Lung Involvement in Rheumatologic Disease.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lung Diseases; Lupus Erythematosus, Systemic; Mycophenolic Acid; Polymyositis; Rituximab; Scleroderma, Systemic; Sjogren's Syndrome | 2015 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide | 2015 |
[Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
Topics: Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Clinical Trials as Topic; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Microscopic Polyangiitis; Mycophenolic Acid; Plasmapheresis; Prognosis; Rituximab; Severity of Illness Index; Terminology as Topic | 2015 |
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Topics: Azathioprine; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Randomized Controlled Trials as Topic | 2015 |
The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Randomized Controlled Trials as Topic; Tacrolimus | 2016 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab | 2016 |
Role of Pharmacogenomics in Kidney Disease and Injury.
Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir | 2016 |
Update on the pharmacological treatment of adult myositis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Myositis; Tacrolimus | 2016 |
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Topics: Abatacept; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Everolimus; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Models, Economic; Mycophenolic Acid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Technology Assessment, Biomedical | 2016 |
Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
Topics: Azathioprine; Bayes Theorem; Cyclophosphamide; Humans; Long-Term Care; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome | 2017 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dexamethasone; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Isoxazoles; Leflunomide; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Randomized Controlled Trials as Topic; Remission Induction | 2016 |
Management of pemphigus disease in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Fetal Development; Humans; Immunoglobulins, Intravenous; Infertility, Male; Male; Methotrexate; Mycophenolic Acid; Pemphigus; Pregnancy; Pregnancy Complications; Skin | 2017 |
Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Humans; Methotrexate; Mycophenolic Acid; Polychondritis, Relapsing | 2016 |
It hasn't gone away: the problem of glucocorticoid use in lupus remains.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cataract; Cushing Syndrome; Diabetes Mellitus; Disease Progression; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Osteonecrosis; Osteoporotic Fractures | 2017 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy | 2017 |
The use of immunosuppression in autoimmune hepatitis: A current literature review.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Severity of Illness Index | 2017 |
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Retreatment; Sirolimus; Tacrolimus; Transplantation Immunology | 2017 |
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Discovery; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Methotrexate; Molecular Targeted Therapy; Mycophenolic Acid; Recombinant Fusion Proteins; Rituximab; Ustekinumab; Vitamin D | 2017 |
Vasculitis and Pregnancy.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Contraindications; Cyclophosphamide; Deprescriptions; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Takayasu Arteritis; Tumor Necrosis Factor-alpha; Vasculitis | 2017 |
Pregnancy and fetal outcomes after paternal exposure to azathioprine, methotrexate or mycophenolic acid: a critically appraised topic.
Topics: Abnormalities, Drug-Induced; Antibiotics, Antineoplastic; Azathioprine; Female; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Male; Methotrexate; Mycophenolic Acid; Paternal Exposure; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2017 |
Long-Term Treatment of Atopic Dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Phototherapy; Randomized Controlled Trials as Topic; Skin Cream; Time Factors | 2017 |
Current status of lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Prognosis | 2017 |
Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Topics: Azathioprine; Child; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Induction Chemotherapy; Models, Statistical; Mycophenolic Acid; Pediatrics; Prednisone; Tacrolimus; Treatment Outcome | 2017 |
Atopic dermatitis: phototherapy and systemic therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Interleukin-13; Interleukin-4; Methotrexate; Mycophenolic Acid; Phototherapy | 2017 |
Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.
Topics: Azathioprine; Biological Products; Calcineurin Inhibitors; Cyclophosphamide; Directive Counseling; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Complications; TOR Serine-Threonine Kinases | 2018 |
Treatment of Sarcoidosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis | 2018 |
Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Calcineurin Inhibitors; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Mycophenolic Acid; Myositis; Rituximab | 2018 |
Immunosuppressive treatment for proliferative lupus nephritis.
Topics: Adult; Azathioprine; Calcineurin; Child; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2018 |
Treatment of IgA Nephropathy: Evolution Over Half a Century.
Topics: Adrenal Cortex Hormones; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclophosphamide; Fish Oils; Glomerulonephritis, IGA; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Mycophenolic Acid; Proteasome Inhibitors; Tonsillectomy | 2018 |
Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Mycophenolic Acid | 2019 |
Maintenance therapy for lupus nephritis with mycophenolate mofetil or azathioprine. A meta-analysis
.
Topics: Azathioprine; Creatinine; Disease Progression; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Survival Rate | 2019 |
Autoimmune hepatitis: Current and future therapeutic options.
Topics: Animals; Azathioprine; Disease Management; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Tacrolimus | 2019 |
Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
Topics: Antibiotics, Antineoplastic; Azathioprine; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Treatment Outcome | 2019 |
Treatment of chronic non-infectious uveitis and scleritis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleritis; Uveitis | 2019 |
[Therapy of pemphigus].
Topics: Azathioprine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mycophenolic Acid; Pemphigus; Rituximab | 2019 |
Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Prednisone; Treatment Outcome | 2019 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Churg-Strauss Syndrome; Cyclophosphamide; Drug Substitution; Drug Therapy, Combination; Forecasting; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Leflunomide; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2019 |
Treatment strategies for Graves' ophthalmopathy: a network meta-analysis.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Combined Modality Therapy; Cyclosporine; Glucocorticoids; Graves Ophthalmopathy; Humans; Mycophenolic Acid; Network Meta-Analysis; Radiotherapy; Rituximab; Somatostatin | 2020 |
Immunosuppression and Reproductive Health After Kidney Transplantation.
Topics: Abatacept; Azathioprine; Basiliximab; Breast Feeding; Calcineurin Inhibitors; Contraceptive Agents; Counseling; Decision Making; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Lactation; Male; Mycophenolic Acid; Patient Care Team; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Reproductive Health | 2019 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Clinical management of autoimmune hepatitis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Azathioprine; Disease Progression; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mercaptopurine; Mycophenolic Acid; Prednisolone | 2019 |
TNF-α antagonist infliximab for aseptic abscess syndrome.
Topics: Anti-Bacterial Agents; Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Liver Abscess; Male; Middle Aged; Mycophenolic Acid; Prednisone; Syndrome; Tumor Necrosis Factor-alpha | 2019 |
B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
Topics: Antibodies, Monoclonal; Azathioprine; B-Lymphocytes; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid | 2019 |
Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.
Topics: Antirheumatic Agents; Azathioprine; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rheumatic Diseases; Rheumatology; Tacrolimus | 2020 |
Management of ANCA associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Remission Induction; Rituximab | 2020 |
The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis.
Topics: Adult; Azathioprine; Clinical Trials as Topic; Drug Combinations; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 2020 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Alkylating Agents; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Infant; Levamisole; Mycophenolic Acid; Nephrotic Syndrome; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Ribonucleosides; Rituximab; Secondary Prevention | 2020 |
Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunologic Factors; Mycophenolic Acid; Network Meta-Analysis; Pemphigus; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Steroids | 2021 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Recent updates on the management of autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Mycophenolic Acid; Quality of Life | 2021 |
Refractory palmo-plantar discoid lupus erythematosus successfully treated with mycophenolate mofetil: Unusual localization and literature review.
Topics: Azathioprine; Female; Hand; Humans; Lupus Erythematosus, Discoid; Middle Aged; Mycophenolic Acid; Treatment Outcome | 2021 |
Mycophenolic acid and cancer risk in solid organ transplant recipients: Systematic review and meta-analysis.
Topics: Azathioprine; Graft Rejection; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neoplasms; Organ Transplantation; Risk | 2022 |
[The treatment of lupus nephritis, between consolidated strategies and new therapeutic options: a narrative review].
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Treatment Outcome | 2021 |
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neuromyelitis Optica; Outcome Assessment, Health Care; Rituximab | 2021 |
Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Immunotherapy; Mycophenolic Acid; Neuromyelitis Optica; Rituximab | 2022 |
Adverse Events in NMOSD Therapy.
Topics: Azathioprine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neuromyelitis Optica; Rituximab | 2022 |
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis.
Topics: Antibodies, Viral; Azathioprine; Calcineurin Inhibitors; COVID-19; COVID-19 Vaccines; Humans; Immunosuppressive Agents; Mycophenolic Acid; TOR Serine-Threonine Kinases; Transplant Recipients | 2022 |
Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.
Topics: Azathioprine; Bayes Theorem; Demyelinating Autoimmune Diseases, CNS; Humans; Immunoglobulins, Intravenous; Mycophenolic Acid; Network Meta-Analysis; Recurrence; Rituximab | 2022 |
Recent advances in the diagnosis and management of autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid | 2022 |
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2022 |
[Treatment of Autoimmune Hepatitis].
Topics: Adult; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus | 2023 |
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Bayes Theorem; Humans; Immunosuppressive Agents; Mycophenolic Acid; Network Meta-Analysis; Neuromyelitis Optica; Recurrence; Rituximab; Treatment Outcome | 2023 |
Meta-analysis of the effectiveness of relapse prevention therapy for myelin-oligodendrocyte glycoprotein antibody-associated disease.
Topics: Azathioprine; Cohort Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mycophenolic Acid; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Prospective Studies; Retrospective Studies; Rituximab; Secondary Prevention | 2023 |
A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Topics: Azathioprine; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Skin Neoplasms; Tacrolimus | 2023 |
Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Colombia; Cost-Benefit Analysis; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus | 2023 |
Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
Topics: Adult; Azathioprine; Bone Marrow Diseases; Cyclophosphamide; Glucocorticoids; Herpes Zoster; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Neoplasms; Network Meta-Analysis; Recurrence; Tacrolimus; Treatment Outcome | 2023 |
Treatment of Autoimmune Hepatitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Treatment Outcome | 2024 |
169 trial(s) available for azathioprine and mycophenolic acid
| Article | Year |
|---|---|
Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies | 1995 |
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Topics: Adult; Aged; Azathioprine; Cadaver; Double-Blind Method; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies | 1996 |
Mycophenolate mofetil for maintenance therapy in kidney transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cytomegalovirus Infections; Diarrhea; Double-Blind Method; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Mycophenolic Acid; Nausea; Neoplasms; Opportunistic Infections; Placebos; Purines; Safety; Steroids; Vomiting | 1996 |
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Topics: Azathioprine; Drug Administration Schedule; Drug Monitoring; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Lymphocytes; Mycophenolic Acid; Purine Nucleotides | 1996 |
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Mycophenolic Acid; Nervous System Diseases; Pancreas Transplantation; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous | 1997 |
The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Acute Disease; Azathioprine; Cadaver; Cost-Benefit Analysis; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Opportunistic Infections; Time Factors | 1997 |
Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Black People; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Risk Factors | 1997 |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome | 1997 |
Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Mycophenolic Acid; T-Lymphocytes; Time Factors | 1997 |
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Topics: Adult; Analysis of Variance; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Survival Analysis; Transplantation, Homologous | 1998 |
Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Prospective Studies; Tacrolimus; Transplantation, Homologous | 1998 |
Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation.
Topics: Azathioprine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppressive Agents; Injections, Intravenous; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies | 1998 |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Child; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prospective Studies; Tacrolimus; United States | 1998 |
Mycophenolate mofetil in lung transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Respiratory Tract Infections; Survival Rate | 1998 |
[Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group].
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Treatment Outcome | 1998 |
Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction.
Topics: Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Transplantation, Homologous | 1998 |
Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Topics: Azathioprine; Cohort Studies; Double-Blind Method; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Pilot Projects; Prospective Studies; Treatment Outcome | 1998 |
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
Topics: Aged; Azathioprine; Coronary Angiography; Double-Blind Method; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Ultrasonography | 1998 |
Preliminary experience with mycophenolate mofetil used after lung transplantation.
Topics: Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Time Factors | 1998 |
Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
Topics: Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Time Factors | 1998 |
Evaluation of immunosuppressive induction regimens in renal transplantation. Collaborative Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Reoperation; Tacrolimus; Time Factors | 1998 |
Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Transplantation, Homologous | 1998 |
Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prednisone; Risk Factors | 1998 |
Comparison between mycophenolate mofetil and azathioprine based immunosuppression in pediatric renal transplantation from living related donors.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Family; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Methylprednisolone; Mycophenolic Acid | 1998 |
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Drug Costs; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Survival Analysis; Treatment Outcome | 1999 |
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Prospective Studies | 1999 |
[Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial].
Topics: Adult; Azathioprine; Data Interpretation, Statistical; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Reoperation; Time Factors | 1999 |
Mycophenolate mofetil in pediatric renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prednisone; Survival Analysis; Treatment Outcome | 1999 |
Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Azathioprine; Cadaver; Double-Blind Method; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Opportunistic Infections; Survival Rate | 1999 |
Single-center analysis of the incidence of acute rejection in cadaveric renal allograft recipients induced with low-dose OKT3 with and without mycophenolate mofetil.
Topics: Acute Disease; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid | 1999 |
Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine.
Topics: Azathioprine; Biopsy; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myocardium; Risk Factors | 1999 |
Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.
Topics: Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Regression Analysis; Time Factors | 1999 |
The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation.
Topics: Adolescent; Azathioprine; Child; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Patient Selection; Risk Factors | 1999 |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
Topics: Azathioprine; Blood Pressure; Cholesterol; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Methylprednisolone; Mycophenolic Acid; Risk Factors; Survival Rate; Tacrolimus; Triglycerides | 1999 |
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
Topics: Adult; Analysis of Variance; Antilymphocyte Serum; Azathioprine; Coronary Artery Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intravenous; Lymphocyte Subsets; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; T-Lymphocytes | 1999 |
One and a half years of experience with mycophenolate mofetil (Cellcept) in cardiac transplantation: a prospective, randomized study.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Time Factors | 1999 |
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZA.
Topics: Azathioprine; Creatinine; Cyclosporine; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Mycophenolic Acid; Transforming Growth Factor beta | 2000 |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Care; Prospective Studies; Tacrolimus | 2000 |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Failure; Treatment Outcome | 2000 |
Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Topics: Adult; Aged; Azathioprine; Chronic Disease; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisolone; Remission Induction | 2000 |
Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Corticosterone; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Methylprednisolone; Mycophenolic Acid; Postoperative Complications; Survival Analysis; Transplantation, Homologous | 2000 |
Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.
Topics: Acute Disease; Adult; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Period; Retreatment; Time Factors; Transplantation, Homologous; Treatment Outcome | 2000 |
Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
Topics: Acute Disease; Azathioprine; Biopsy; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Opportunistic Infections; Pancreas Transplantation; Prospective Studies; Transplantation, Homologous | 2000 |
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Prednisolone; Recurrence; Remission Induction | 2000 |
Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Tissue Donors | 2000 |
Clinical study of FK 506 in renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Tacrolimus | 2000 |
Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Topics: Azathioprine; China; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Tacrolimus; Time Factors | 2000 |
Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Creatinine; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Systole; Transplantation, Homologous | 2000 |
Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
Topics: Asian People; Azathioprine; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Hong Kong; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prednisolone; Tacrolimus | 2000 |
Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Topics: Asian People; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukopenia; Methylprednisolone; Muromonab-CD3; Mycophenolic Acid; Singapore | 2000 |
The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Time Factors; Tissue Donors | 2000 |
A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Patient Selection; Postoperative Complications; Prospective Studies; Reoperation; Safety; Survival Rate; Time Factors | 2000 |
Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
Topics: Adult; Azathioprine; Biopsy; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Inulin; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2000 |
Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Receptors, Interleukin-2; Recombinant Fusion Proteins | 2000 |
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
Topics: Azathioprine; Cyclosporine; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pilot Projects; Time Factors | 2000 |
Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Topics: Adenosine Triphosphate; Azathioprine; Chromatography, High Pressure Liquid; Enzyme Induction; Enzyme Inhibitors; Female; Guanosine Triphosphate; Heart Transplantation; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Mycophenolic Acid | 2001 |
Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Cyclosporine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunophenotyping; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins | 2001 |
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Survival Analysis | 2001 |
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Topics: Adrenal Cortex Hormones; Azathioprine; Confidence Intervals; Creatinine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Patient Dropouts; Postoperative Complications; Survival Analysis; Time Factors; Transplantation, Homologous | 2001 |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
Topics: Adult; Analysis of Variance; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Tacrolimus; Time Factors | 2001 |
Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
Topics: Azathioprine; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Time Factors; Transplantation, Homologous; Treatment Outcome | 2001 |
Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Topics: Azathioprine; Biopsy; Blood Pressure; Cholesterol; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Proteinuria; Tacrolimus; Triglycerides | 2001 |
beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression.
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polymerase Chain Reaction; Postoperative Complications; Prednisolone; Recurrence; Virus Activation | 2001 |
Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Analysis; Transplantation, Homologous | 2001 |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Topics: Administration, Oral; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; Child; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Kidney Function Tests; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Mycophenolic Acid; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; United States; White People | 2001 |
Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS/ISHLT Thoracic Registry.
Topics: Adult; Aged; Azathioprine; Female; Heart Transplantation; Hospitalization; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Registries | 2001 |
Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
Topics: Adenosine Triphosphate; Azathioprine; Enzyme Inhibitors; Erythrocytes; Guanosine Triphosphate; Heart Transplantation; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid | 2000 |
Mycophenolate mofetil decreases antibody production after cardiac transplantation.
Topics: Antibody Formation; Azathioprine; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Time; Time Factors; Treatment Outcome; Vimentin | 2002 |
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
Topics: Adult; Azathioprine; Biopsy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Antigens Class II; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Infusions, Intravenous; Isoantigens; Male; Mesna; Middle Aged; Mycophenolic Acid; Myocardium; T-Lymphocytes; Treatment Outcome | 2002 |
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
Topics: Adult; Azathioprine; Cohort Studies; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Failure | 2002 |
Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
Topics: Adult; Azathioprine; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Mycoses; Opportunistic Infections; Prospective Studies; Treatment Outcome; Virus Diseases | 2002 |
Liver function tests in mycophenolate mofetil-treated hepatitis C virus-positive kidney allograft recipients.
Topics: Azathioprine; Brazil; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Mycophenolic Acid | 2002 |
Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Topics: Azathioprine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Time Factors | 2002 |
Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.
Topics: Adult; Azathioprine; Drug Combinations; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Sirolimus | 2002 |
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proteinuria; Racial Groups; Statistics, Nonparametric; Time Factors; Treatment Failure | 2002 |
Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Pilot Projects; Prospective Studies | 2002 |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.
Topics: Administration, Oral; Area Under Curve; Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Clearance Rate; Mycophenolic Acid; Tacrolimus; Time Factors | 2002 |
A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy.
Topics: Adult; Azathioprine; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Time Factors | 2002 |
Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Topics: Azathioprine; Female; Follow-Up Studies; Graft Rejection; Hematocrit; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Time Factors | 2002 |
Mycophenolate mofetil in renal transplantation: five years experience.
Topics: Adult; Azathioprine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Male; Mycophenolic Acid; Survival Analysis; Tissue Donors; Turkey | 2002 |
Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
Topics: Acute Disease; Azathioprine; Creatinine; Cytomegalovirus Infections; Drug Therapy, Combination; Gastrointestinal Diseases; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Transplantation, Homologous | 2002 |
Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience).
Topics: Adult; Azathioprine; Gastrointestinal Diseases; Graft Rejection; Hematologic Diseases; Humans; Immunosuppressive Agents; Iran; Kidney Transplantation; Mycophenolic Acid; Time Factors | 2002 |
Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study.
Topics: Azathioprine; B-Lymphocytes; Cells, Cultured; Coculture Techniques; Cyclosporine; Cytokines; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Interleukin-10; Kidney Transplantation; Mycophenolic Acid; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Tacrolimus; Time Factors | 2002 |
Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study.
Topics: Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies | 2002 |
Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Topics: Adult; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Reoperation; Steroids; Tacrolimus; Tissue Donors | 2002 |
Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Survival Analysis; Tacrolimus; Time Factors | 2002 |
Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
Topics: Acute Disease; Adolescent; Azathioprine; Blood Pressure; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Treatment Outcome | 2003 |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Probability; Racial Groups; Survival Analysis; Tacrolimus; Time Factors; Tissue Donors | 2003 |
36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.
Topics: Adrenal Cortex Hormones; Azathioprine; Creatinine; Diabetes Mellitus; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Survival Analysis; Tacrolimus; Time Factors | 2003 |
Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
Topics: Adult; Alendronate; Azathioprine; Bone Density; Bone Resorption; Calcitriol; Calcium Channel Agonists; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone | 2003 |
Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C-Reactive Protein; Cyclosporine; Female; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Inflammation; Male; Mycophenolic Acid; Pilot Projects; Prednisolone; Prospective Studies; Ultrasonography | 2004 |
Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Topics: Adult; Azathioprine; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Histocompatibility Testing; Humans; Immunosuppressive Agents; Isoantibodies; Kidney Function Tests; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Regression Analysis; Time Factors | 2004 |
Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine.
Topics: Adult; Azathioprine; Female; Humans; IgG Deficiency; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Transplantation, Homologous; Urinary Tract Infections | 2003 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infections; Infusions, Intravenous; Kidney Failure, Chronic; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Recurrence; Remission Induction; Survival Analysis | 2004 |
Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Azathioprine; Chronic Disease; Cytomegalovirus Infections; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Transplantation, Homologous | 2004 |
Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Topics: Agammaglobulinemia; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2005 |
Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Severity of Illness Index | 2005 |
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Steroids; Tacrolimus | 2005 |
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Kidney; Kidney Failure, Chronic; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Time Factors | 2005 |
Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.
Topics: Azathioprine; Coronary Angiography; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies | 2005 |
Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cell Proliferation; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Treatment Outcome | 2005 |
Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.
Topics: Acute Disease; Adult; Analysis of Variance; Azathioprine; Creatinine; Disease Progression; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Renal Dialysis; Transplantation, Homologous; Treatment Failure; Treatment Outcome | 2005 |
Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe.
Topics: Azathioprine; Creatinine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Safety; T-Lymphocytes, Cytotoxic; Time Factors | 2005 |
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
Topics: Azathioprine; Double-Blind Method; Female; Follow-Up Studies; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Transplantation Immunology | 2005 |
A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Creatinine; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prednisone; Transplantation, Homologous; Treatment Failure | 2005 |
[Necessity and safety of conversion from mycophenolate mofetil to AzA thioprine after renal transplantation].
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Safety | 2005 |
Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Reoperation; Retrospective Studies; Treatment Outcome | 2005 |
Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
Topics: Azathioprine; Bacterial Infections; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Virus Diseases | 2005 |
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Time Factors; Tunica Intima; Ultrasonography | 2006 |
Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Bronchiolitis Obliterans; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Mycophenolic Acid; Prospective Studies; Syndrome | 2006 |
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisolone; Remission Induction; Treatment Outcome | 2006 |
Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.
Topics: Adenosine Triphosphate; Adult; Aged; Azathioprine; Enzyme Activation; Female; Guanosine Triphosphate; Heart Transplantation; Humans; Hypoxanthine Phosphoribosyltransferase; Immunosuppressive Agents; IMP Dehydrogenase; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Purine Nucleotides | 2006 |
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.
Topics: Adult; Aged; Azathioprine; B-Lymphocytes; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Killer Cells, Natural; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; T-Lymphocytes; Tacrolimus | 2006 |
Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
Topics: Azathioprine; Drug Therapy, Combination; Erythrocyte Count; Erythropoiesis; Erythropoietin; Follow-Up Studies; Hematocrit; Hemoglobins; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisolone; Transplantation, Homologous | 2006 |
Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.
Topics: Adult; Azathioprine; Chronic Disease; Ethnicity; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Time Factors; Transplantation, Homologous | 2006 |
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Topics: Administration, Oral; Anti-Inflammatory Agents; Azathioprine; Disease-Free Survival; Drug Therapy, Combination; Female; Germany; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pemphigus; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels.
Topics: Azathioprine; Drug Therapy, Combination; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Vascular remodeling 1 year after cardiac transplantation.
Topics: Adult; Azathioprine; Coronary Vessels; Double-Blind Method; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neovascularization, Physiologic; Prognosis; Tunica Intima; Ultrasonography, Interventional | 2007 |
Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.
Topics: Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Recombinant Fusion Proteins; Sirolimus | 2007 |
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Topics: Adult; Azathioprine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Predictive Value of Tests; Proteinuria; Risk Assessment; Transplantation, Homologous; Treatment Outcome | 2007 |
Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation.
Topics: Azathioprine; Child; Disease-Free Survival; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Patient Dropouts; Time Factors; Treatment Outcome | 2007 |
Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Treatment Outcome | 2007 |
Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
Topics: Adult; Azathioprine; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methotrexate; Mycophenolic Acid; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome | 2007 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2007 |
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Compliance; Pemphigoid, Bullous; Recurrence; Remission Induction | 2007 |
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
Topics: Acute Disease; Adult; Azathioprine; Belgium; Cardiomyopathy, Dilated; Coronary Disease; Cost of Illness; Double-Blind Method; Everolimus; Female; Graft Rejection; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Survival Analysis; Treatment Failure | 2007 |
Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial.
Topics: Adult; Antibodies, Viral; Antibody Formation; Azathioprine; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Kidney Transplantation; Male; Mycophenolic Acid; Vaccination | 2008 |
Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Prospective Studies; Tacrolimus; Transplantation, Homologous | 2008 |
Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
Topics: Adult; Azathioprine; Costs and Cost Analysis; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Sirolimus | 2009 |
[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Autoantigens; Azathioprine; Cyclophosphamide; Desmoglein 1; Desmoglein 3; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nausea; Pemphigus; Remission Induction | 2009 |
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2010 |
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
Topics: Adult; Antiviral Agents; Azathioprine; Chemoprevention; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Renal Insufficiency; Risk Factors; Tacrolimus; Treatment Outcome | 2010 |
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Secondary Prevention; Treatment Outcome; Young Adult | 2010 |
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Female; Glomerular Filtration Rate; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Microscopic Polyangiitis; Middle Aged; Mycophenolic Acid; Prednisolone; Proteinuria; Secondary Prevention | 2010 |
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Diltiazem; Drug Combinations; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Young Adult | 2011 |
Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.
Topics: Adult; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Cytokines; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-10; Interleukin-2; Interleukin-4; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tacrolimus; Treatment Outcome | 2011 |
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
Topics: Aged; Azathioprine; C-Reactive Protein; Calcineurin Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Scandinavian and Nordic Countries; Sirolimus; Ultrasonography, Interventional; Vascular Cell Adhesion Molecule-1; Vascular Diseases; von Willebrand Factor | 2011 |
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Postoperative Complications; Risk Factors; Sirolimus | 2011 |
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Egypt; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Topics: Adolescent; Adult; Aged; Azathioprine; Female; Humans; Immunosuppressive Agents; Infections; Kaplan-Meier Estimate; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Patient Dropouts; Secondary Prevention; Young Adult | 2011 |
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
Topics: Adolescent; Adult; Azathioprine; Biopsy; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Pain; Treatment Outcome; Young Adult | 2012 |
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Risk Assessment; Risk Factors; Steroids; Tacrolimus | 2012 |
Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.
Topics: Adult; Azathioprine; Creatinine; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2012 |
Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.
Topics: Administration, Oral; Adolescent; Age Factors; Asia; Azathioprine; Biomarkers; Creatinine; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Odds Ratio; Prednisone; Prospective Studies; Proteinuria; South America; Time Factors; Treatment Outcome; United States | 2012 |
[Mycophenolate mofetil seems to be superior to azothioprine in maintenance therapy of lupus nephritis].
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Placebo Effect; Treatment Outcome; Young Adult | 2012 |
[Recent clinical trials on treatment of myasthenia gravis].
Topics: Azathioprine; Humans; Myasthenia Gravis; Mycophenolic Acid; Tacrolimus | 2012 |
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Treatment Outcome | 2013 |
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up.
Topics: Adult; Azathioprine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Steroids; Tacrolimus | 2013 |
Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols.
Topics: Azathioprine; B-Lymphocytes; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tacrolimus; Treatment Outcome | 2013 |
Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Topics: Administration, Oral; Adult; Azathioprine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Recurrence | 2014 |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Single-Blind Method; Surveys and Questionnaires; T-Lymphocytes, Regulatory; Tacrolimus; Th17 Cells; Treatment Outcome | 2015 |
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Creatinine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Induction Chemotherapy; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Proteinuria; Recurrence; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2016 |
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.
Topics: Adult; Azathioprine; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Longitudinal Studies; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Treatment Outcome | 2016 |
Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Costs; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Methylprednisolone; Mycophenolic Acid; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Topics: Adult; Azathioprine; Cyclosporins; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome | 2016 |
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hispanic or Latino; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
Topics: Adult; Antimalarials; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Remission Induction; Tablets, Enteric-Coated | 2017 |
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.
Topics: Adult; Azathioprine; Blood Pressure; Brazil; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisone; Proteinuria; Severity of Illness Index | 2018 |
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome; Young Adult | 2019 |
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
Topics: Adolescent; Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Male; Mycophenolic Acid; Recurrence; Treatment Outcome | 2019 |
Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
Topics: Adult; Azathioprine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Symptom Flare Up; Tacrolimus; Time; Treatment Outcome | 2020 |
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Creatinine; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intention to Treat Analysis; Lupus Nephritis; Male; Mycophenolic Acid; Remission Induction | 2020 |
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Italy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Time Factors; Treatment Outcome | 2021 |
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Logistic Models; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Propensity Score; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial.
Topics: Azathioprine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Recurrence; Treatment Outcome; Weaning | 2022 |
Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up.
Topics: Adult; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Prednisone; Prospective Studies; Serum Albumin; Treatment Outcome | 2022 |
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Topics: Adult; Azathioprine; End Stage Liver Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Mycophenolic Acid; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2022 |
538 other study(ies) available for azathioprine and mycophenolic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.
Topics: Alprostadil; Animals; Azathioprine; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hepatectomy; Immunosuppressive Agents; Liver; Liver Regeneration; Male; Methylprednisolone; Mycophenolic Acid; Rats; Rats, Inbred F344; Ribonucleosides | 1992 |
Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Topics: Azathioprine; Cell Division; Guanosine; Humans; Immunosuppressive Agents; Ionomycin; Lymphocyte Activation; Mercaptopurine; Mycophenolic Acid; Purine Nucleotides; Receptors, Antigen, T-Cell; Ribonucleosides; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1992 |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
Topics: Animals; Azathioprine; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lethal Dose 50; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Homologous | 1994 |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Topics: Animals; Azathioprine; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Homologous | 1995 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments.
Topics: Animals; Azathioprine; Cyclosporine; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscles; Muscular Dystrophy, Animal; Mycophenolic Acid; Polyenes; Sirolimus; Transplantation, Homologous | 1994 |
Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine.
Topics: Animals; Azathioprine; Cell Division; Cell Survival; Cells, Cultured; DNA; Hepatectomy; Immunosuppressive Agents; Liver; Liver Regeneration; Male; Methylprednisolone; Mitosis; Mycophenolic Acid; Rats; Rats, Inbred F344; Reference Values; Ribonucleosides | 1993 |
RS-61443 for treatment-resistant human liver rejection.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Resistance; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Pilot Projects; Prednisolone | 1993 |
Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Female; Graft Rejection; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisone | 1993 |
[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver].
Topics: Adult; Ambulatory Care; Azathioprine; Cadaver; Costs and Cost Analysis; Graft Rejection; Hospitalization; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Placebos; Postoperative Complications; Time Factors | 1996 |
Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation.
Topics: Adjuvants, Immunologic; Animals; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Hydroxyquinolines; Immunosuppressive Agents; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; Rats, Inbred WKY | 1997 |
Evolving strategies in immunosuppressive therapy: the Emory experience.
Topics: Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Georgia; Graft Survival; Hospitals, Pediatric; Hospitals, University; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Prednisone; Racial Groups; Retrospective Studies; Survival Rate; Tissue Donors; Transplantation, Homologous | 1996 |
Maintenance pharmacological immunosuppressive strategies in renal transplantation.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polyenes; Postoperative Care; Sirolimus; Steroids; Tacrolimus | 1997 |
The impact of pre-transplant obesity on renal transplant outcomes.
Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Obesity; Obesity, Morbid; Prednisone; Surgical Wound Infection; Survival Rate; Transplantation, Homologous; Treatment Outcome; Weight Gain | 1997 |
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
Topics: Administration, Oral; Age Factors; Aged; Azathioprine; Cadaver; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 1997 |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Topics: Azathioprine; Black or African American; Black People; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Mycophenolic Acid; Philadelphia; Retrospective Studies; Tacrolimus; Tissue Donors; White People | 1997 |
Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
Topics: Adult; Azathioprine; Black People; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Likelihood Functions; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Proportional Hazards Models; Regression Analysis; Risk Factors; Transplantation Immunology; White People | 1998 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Methyltransferases; Mycophenolic Acid; Polyenes; Ribosomal Protein S6 Kinases; Sirolimus | 1998 |
Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
Topics: Azathioprine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Transplantation, Homologous; Treatment Outcome | 1998 |
Selective CellCept therapy in high-risk renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Prednisone; Reoperation; Retrospective Studies; Survival Rate | 1998 |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Tacrolimus | 1998 |
Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisolone; Retrospective Studies; Transplantation, Homologous | 1998 |
Long-term steroid side effects in renal transplantation need a safe steroid withdrawal: a single-center experience.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Mycophenolic Acid; Retrospective Studies | 1998 |
Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Retrospective Studies; Risk Factors; Survival Rate; Treatment Failure | 1998 |
Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Premedication; Retrospective Studies | 1998 |
Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Postoperative Complications; Retrospective Studies; Survival Rate | 1998 |
Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Treatment Outcome | 1998 |
Mycophenolate mofetil in pancreas transplantation.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Rate; Tacrolimus | 1998 |
Tubular damage and impairment of renal function in transplanted kidneys.
Topics: Acetylglucosaminidase; Adult; Aged; Albuminuria; Azathioprine; Biomarkers; Creatinine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; L-Lactate Dehydrogenase; Male; Middle Aged; Mycophenolic Acid; Prednisone; Regional Blood Flow; Renal Circulation; Tacrolimus | 1998 |
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
Topics: Adult; Azathioprine; Cyclosporine; Databases as Topic; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Tacrolimus | 1998 |
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation?
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Vasoconstriction; Vasodilation | 1998 |
Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Mycophenolic Acid; Opportunistic Infections; Prednisone; Risk Factors | 1998 |
Mycophenolate mofetil in patients with Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retreatment; Treatment Outcome | 1998 |
Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
Topics: Adult; Aged; Azathioprine; Cholesterol; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Prednisolone; Sirolimus; Triglycerides | 1998 |
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Topics: Azathioprine; Cadaver; Costs and Cost Analysis; Graft Rejection; Hospitals, University; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Ohio; Postoperative Complications; Tissue Donors | 1998 |
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
Topics: Azathioprine; Costs and Cost Analysis; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Reoperation; Survival Rate; Switzerland; Treatment Outcome | 1998 |
A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Topics: Acute Disease; Adult; Azathioprine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Pancreas Transplantation; Retrospective Studies; Transplantation, Homologous | 1998 |
Mycophenolate is effective in the treatment of pemphigus vulgaris.
Topics: Adult; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Treatment Outcome | 1999 |
Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells.
Topics: Animals; Azathioprine; Cells, Cultured; Cytokines; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Spleen; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1998 |
Long-term results of pancreas transplantation under tacrolius immunosuppression.
Topics: Actuarial Analysis; Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 1999 |
Trends in immunosuppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Utilization; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Transplantation; Male; Mycophenolic Acid; North America; Practice Patterns, Physicians'; Prednisone; Racial Groups; Registries; Treatment Outcome | 1999 |
Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.
Topics: Adolescent; Adult; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunoglobulins, Thyroid-Stimulating; Immunosuppressive Agents; IMP Dehydrogenase; Incidence; Leukocyte Count; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Survival Rate; Treatment Outcome | 1999 |
Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil.
Topics: Adult; Apoptosis; Azathioprine; Cell Division; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Middle Aged; Mycophenolic Acid; Retrospective Studies | 1999 |
Optimization of the immunosuppressive protocol after lung transplantation.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rabbits; Retrospective Studies; Tacrolimus | 1999 |
Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chronic Disease; Female; Graft Rejection; Hemoglobins; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid | 1999 |
Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine.
Topics: Adolescent; Adult; Aged; Azathioprine; Cardiovascular Agents; Child; Cyclosporine; Diuretics; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney Transplantation; Magnesium; Male; Middle Aged; Mycophenolic Acid; Prednisone; Reference Values | 1999 |
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
Topics: Aged; Azathioprine; Biopsy; Blood Pressure; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lipids; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Renal Insufficiency; Retrospective Studies; Tacrolimus; Treatment Outcome; Urea | 1999 |
The effect of different immunosuppression on the outcome of pediatric renal transplants.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 1999 |
Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Retrospective Studies | 1999 |
Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
Topics: Azathioprine; Cardiomyopathy, Dilated; Coronary Disease; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies | 1999 |
Usefulness of quantitative cytomegalovirus antigenemia determinations in heart transplantation.
Topics: Antigens, Viral; Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Fluorescent Antibody Technique, Indirect; Heart Transplantation; Humans; Immunosuppressive Agents; Muromonab-CD3; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies | 1999 |
Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Communicable Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Postoperative Complications; Risk Factors | 1999 |
Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
Topics: Aged; Azathioprine; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Mycoses; Postoperative Complications; Prednisone; Retrospective Studies; Survival Rate; Time Factors | 1999 |
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Topics: Animals; Azathioprine; Cell Division; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Mycophenolic Acid; Phytohemagglutinins; Sirolimus; Species Specificity; Swine; Tacrolimus; Transplantation, Homologous | 1999 |
[Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Analysis; Tacrolimus; Treatment Outcome | 1999 |
Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Tuberculosis, Lymph Node | 2000 |
Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Mercaptopurine; Middle Aged; Mycophenolic Acid; Retrospective Studies; Treatment Failure | 2000 |
Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.
Topics: Acyclovir; Adult; Antiviral Agents; Azathioprine; Case-Control Studies; Cohort Studies; Cytomegalovirus Infections; Enteritis; Female; Ganciclovir; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Mycophenolic Acid; Pneumonia, Viral; Risk Factors; Severity of Illness Index | 2000 |
New immunosuppressive treatment in kidney transplantation.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Rate | 2000 |
Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies | 2000 |
Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy.
Topics: Adult; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Mycophenolic Acid; Prednisone; Risk Factors | 2000 |
Effect of mycophenolate mofetil in heart transplantation.
Topics: Animals; Anti-Inflammatory Agents; Antilymphocyte Serum; Azathioprine; CD2 Antigens; CD4 Lymphocyte Count; CD8 Antigens; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lymphocyte Count; Lymphocyte Subsets; Mycophenolic Acid; Prednisone; Rabbits; Retrospective Studies; Survival Analysis; Treatment Outcome | 2000 |
Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes.
Topics: Antigens, CD; Azathioprine; Cell Differentiation; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes; Mycophenolic Acid; Tacrolimus | 2000 |
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Period; Predictive Value of Tests; Prednisone; Sirolimus; Time Factors | 2000 |
Immunosuppression in the post-adaptation period.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid | 2000 |
Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection.
Topics: Adolescent; Antibodies; Azathioprine; Child; Child, Preschool; Chronic Disease; Graft Rejection; Histocompatibility Antigens Class I; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Lymphocyte Subsets; Mycophenolic Acid; T-Lymphocytes, Cytotoxic | 2000 |
Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Corneal Ulcer; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Mycophenolic Acid; Oral Ulcer; Pemphigus; Prednisolone | 2000 |
Isolated intestinal versus composite visceral allografts: causes of graft failure.
Topics: Adult; Azathioprine; Child; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Intestines; Muromonab-CD3; Mycophenolic Acid; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Time Factors; Transplantation, Homologous; Treatment Failure; Viscera | 2000 |
[Early treatment of IgA nephritis is indicated by prognostic factors].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azathioprine; Cyclophosphamide; Cyclosporins; Female; Fish Oils; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors | 2000 |
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationship, Drug; Drug Resistance; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Leukocyte Count; Liver; Mycophenolic Acid; Prednisone | 2000 |
Treatment of lupus nephritis--a work in progress.
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisolone | 2000 |
Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
Topics: Adult; Azathioprine; Black or African American; Black People; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Risk Factors; Treatment Outcome; White People | 2000 |
Photo quiz. Drug-induced pemphigus foliaceus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Azathioprine; Calcium Channel Blockers; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Minocycline; Mycophenolic Acid; Nifedipine; Pemphigus; Penicillamine; Skin | 2000 |
Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients.
Topics: Adult; Anemia; Antibodies, Viral; Azathioprine; Bone Marrow Cells; DNA, Viral; Drug Therapy, Combination; Erythrocyte Transfusion; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Parvoviridae Infections; Parvovirus B19, Human; Polymerase Chain Reaction; Postoperative Complications; Reticulocyte Count | 2000 |
Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patients.
Topics: Adult; Azathioprine; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Time Factors; Treatment Failure | 2000 |
Conversion from tacrolimus to neoral for postrenal transplant diabetes.
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus | 2000 |
Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
Topics: Azathioprine; Cohort Studies; Drug Interactions; Female; Graft Survival; Histocompatibility Testing; HLA-A Antigens; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Proportional Hazards Models; Retrospective Studies; Transplantation, Homologous | 2001 |
Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
Topics: Adult; Azathioprine; Chronic Disease; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Remission Induction; Retreatment; Retrospective Studies; Time Factors | 2001 |
[Acute pancreatitis after kidney transplantation].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multiple Organ Failure; Mycophenolic Acid; Pancreatitis; Peritonitis; Retrospective Studies; Risk Factors | 2001 |
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy.
Topics: Azathioprine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Culture Test, Mixed; Mycophenolic Acid; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Tetanus Toxoid; Time Factors; Tissue Donors | 2001 |
Tolerability of mycophenolate mofetil in organ transplant recipients.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Medical Records; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 2001 |
Evaluation of various immunosuppressive regimes in second renal transplants.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Prednisolone; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Immunocompetence assay for net effect of combined immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunocompetence; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mycophenolic Acid; Tacrolimus | 2001 |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Research Design; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2001 |
Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Azathioprine; Chronic Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications | 2001 |
Uric acid or urate nephropathy?
Topics: Allopurinol; Azathioprine; Biopsy; Diagnosis, Differential; Drug Interactions; Humans; Kidney; Kidney Diseases; Mycophenolic Acid; Uric Acid | 2001 |
Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
Topics: Adult; Aged; Azathioprine; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Reoperation | 2001 |
Measurement of mycophenolate mofetil effect in transplant recipients.
Topics: Azathioprine; Cell Division; Cells, Cultured; Cyclosporine; Drug Combinations; Enterotoxins; Humans; Immunocompetence; Immunosuppressive Agents; Kidney; Kidney Transplantation; Liver; Liver Transplantation; Lymphocytes; Mycophenolic Acid; Reference Values | 2001 |
Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
Topics: Acute Disease; Adult; Azathioprine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Rate | 2001 |
Treatment of lupus nephritis: art or science?
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Prednisolone; Risk Factors | 2001 |
[Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
Topics: Adolescent; Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Risk Factors; Time Factors; Transplantation, Homologous | 2001 |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
Topics: Aged; Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2002 |
Results of renal transplantation with different immunosuppressive regimens.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies | 2002 |
Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Sirolimus; Steroids; Treatment Failure | 2002 |
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia.
Topics: Azathioprine; Humans; Kidney Transplantation; Leukopenia; Mycophenolic Acid | 2002 |
Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.
Topics: Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Mycophenolic Acid; Nuclear Family; Pilot Projects; Postoperative Complications; Prednisone; Steroids; Time Factors | 2001 |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous | 2002 |
Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Reoperation; Retrospective Studies; Time Factors | 2002 |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisolone; Prednisone; Tacrolimus; Time Factors; Treatment Failure; Treatment Outcome | 2002 |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Cadaver; California; Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Living Donors; Male; Medical Records; Mycophenolic Acid; Racial Groups; Retrospective Studies; Tacrolimus; Tissue Donors | 2002 |
Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Topics: Adult; Aged; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Transplantation, Homologous | 2002 |
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcineurin Inhibitors; Child; Creatinine; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Renal Insufficiency; Tacrolimus | 2002 |
Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome | 2002 |
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression.
Topics: Adolescent; Antihypertensive Agents; Azathioprine; Child; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppression Therapy; Kidney Transplantation; Morbidity; Mycophenolic Acid; Prevalence; Recurrence; Retrospective Studies | 2002 |
Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction.
Topics: Adult; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Mycophenolic Acid | 2002 |
An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.
Topics: Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis; Glomerulonephritis, IGA; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Renal Insufficiency | 2002 |
[Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
Topics: Acute Disease; Antiviral Agents; Azathioprine; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cytokines; Cytomegalovirus Infections; Drug Therapy, Combination; gamma-Globulins; Ganciclovir; Graft Rejection; Heart Transplantation; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Models, Biological; Mycophenolic Acid; Postoperative Complications; Ursodeoxycholic Acid | 2003 |
[Chronically active Crohn's disease].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Chronic Disease; Contraindications; Crohn Disease; Endoscopy; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nutritional Physiological Phenomena; Placebos; Prednisone; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Ultrasonography | 2003 |
Effects of selected immunouppressive drugs on prostaglandin release, protein synthesis and cell proliferation in human gingival fibroblasts and on the growth of plaque bacteria.
Topics: Actinomyces viscosus; Aggregatibacter actinomycetemcomitans; Azathioprine; Capnocytophaga; Cell Division; Cells, Cultured; Cyclosporine; Dental Plaque; Dinoprostone; Fibroblasts; Gingiva; Humans; Immunosuppressive Agents; Mycophenolic Acid; Peptostreptococcus; Protein Biosynthesis; Streptococcus mutans; Tacrolimus | 2003 |
Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy.
Topics: Animals; Azathioprine; Collagen; Fibronectins; Fibrosis; Immunohistochemistry; Kidney Diseases; Mycophenolic Acid; Rats; Rats, Wistar; Transforming Growth Factor beta; Ureteral Obstruction | 2003 |
Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil.
Topics: Azathioprine; Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisolone; Retrospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.
Topics: Acute Disease; Adult; Aged; Autoantibodies; Azathioprine; B-Lymphocytes; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; T-Lymphocytes | 2003 |
Predicting long-term kidney graft survival: can new trials be performed?
Topics: Azathioprine; Creatinine; Forecasting; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Predictive Value of Tests; Survival Analysis; Time Factors | 2003 |
Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation.
Topics: Adolescent; Adult; Analysis of Variance; Azathioprine; Cadaver; Child; Child, Preschool; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Risk Factors; Survival Analysis | 2003 |
Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.
Topics: Azathioprine; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Databases, Factual; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 2003 |
Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients.
Topics: Antigens, CD; Azathioprine; CD4-CD8 Ratio; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Subsets; Monitoring, Immunologic; Mycophenolic Acid; Prednisone | 2003 |
Report of a renal transplanted patient with fibroadenoma occurring in a short time.
Topics: Adult; Azathioprine; Breast Neoplasms; Creatinine; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Steroids | 2003 |
[Indication and effect of immunosuppression in patients with scleritis].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleritis; Treatment Outcome | 2003 |
Pathophysiological insights from a case of reversible pulmonary arterial hypertension.
Topics: Azathioprine; Echocardiography; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; POEMS Syndrome; Prednisolone; Treatment Outcome | 2003 |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.
Topics: Adolescent; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 2003 |
Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients.
Topics: Azathioprine; Creatinine; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Emulsions; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Clearance Rate; Mycophenolic Acid | 2003 |
Renal transplantation in a case of acute intermittent porphyria.
Topics: Aminolevulinic Acid; Azathioprine; Creatinine; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Porphobilinogen; Porphyria, Acute Intermittent; Prednisolone; Renal Dialysis; Sweden; Treatment Outcome | 2003 |
Mycophenolate mofetil severely depresses antibody response to CMV infection in early posttransplant period.
Topics: Antibody Formation; Azathioprine; B-Lymphocytes; Cytomegalovirus Infections; Humans; Immunoglobulin G; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Prednisone; Retrospective Studies | 2003 |
[Can we predict the risk of malignancy associated with dermatomyositis?].
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Ovarian Neoplasms; Polymyositis; Prednisone; Risk Factors; Time Factors | 2003 |
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
Topics: Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Treatment Outcome; Uveitis | 2003 |
Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report.
Topics: Adult; Azathioprine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Time Factors; Tuberculosis | 2003 |
Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Retrospective Studies; Safety | 2003 |
Lichen planus pemphigoides evolving into pemphigoid nodularis.
Topics: Autoantigens; Azathioprine; Carrier Proteins; Collagen Type XVII; Cytoskeletal Proteins; Dystonin; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lichen Planus; Male; Middle Aged; Mycophenolic Acid; Nerve Tissue Proteins; Non-Fibrillar Collagens; Pemphigoid, Bullous; Treatment Outcome | 2003 |
Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.
Topics: Azathioprine; Biopsy; Drug Administration Schedule; Expert Testimony; Fluorescent Antibody Technique; Glucocorticoids; Health Care Surveys; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pemphigus; Prednisolone; Referral and Consultation; Telephone | 2003 |
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Time Factors; Wound Healing | 2003 |
Gastric emptying time in renal transplant recipients treated with cyclosporine.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Reference Values; Time Factors | 2003 |
The effect of maintenance immunosuppression medication on the change in kidney allograft function.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Databases, Factual; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2004 |
Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Drug Administration Schedule; Enzyme Inhibitors; Female; Guanosine Triphosphate; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Failure, Chronic; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Mycophenolic Acid; Postoperative Period; Purine Nucleotides; Pyrimidine Nucleotides | 2004 |
Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Topics: Adult; Azathioprine; Creatinine; Enzyme Inhibitors; Erythrocytes; Female; Guanosine Triphosphate; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Period | 2004 |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus | 2004 |
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.
Topics: Administration, Oral; Adolescent; Anticholesteremic Agents; Area Under Curve; Azathioprine; Calcineurin Inhibitors; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Interactions; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Mycophenolic Acid; Pravastatin; Tacrolimus; Triglycerides | 2004 |
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection.
Topics: Azathioprine; Creatinine; Cross-Over Studies; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Viral Load | 2004 |
Heart transplantation in patients with previous Fontan operations.
Topics: Adolescent; Adult; Azathioprine; Biomarkers; Blood Proteins; Cardiac Output, Low; Child; Child, Preschool; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Fontan Procedure; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Italy; Length of Stay; Male; Mycophenolic Acid; Postoperative Complications; Reoperation; Retrospective Studies; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
Pemphigus vulgaris with nail involvement presenting with vegetating and verrucous lesions.
Topics: Aged; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Diabetes Mellitus, Type 1; Disease Progression; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Insulin; Methylprednisolone; Mycophenolic Acid; Nail Diseases; Pemphigus; Skin | 2003 |
Maintenance therapy for lupus nephritis--something old, something new.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Survival Analysis | 2004 |
Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus.
Topics: Animals; Antimetabolites; Antiviral Agents; Azathioprine; Cattle; Cell Line; Diarrhea Viruses, Bovine Viral; Dose-Response Relationship, Drug; Hepacivirus; Immunosuppressive Agents; Mercaptopurine; Mycophenolic Acid; Replicon; Ribavirin; Thioguanine; Virus Replication | 2004 |
Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Topics: Azathioprine; Female; Hepatitis, Autoimmune; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Prednisone | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Data Interpretation, Statistical; Drug Administration Schedule; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Severity of Illness Index; Time Factors | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Multivariate Analysis; Mycophenolic Acid; Remission Induction; Risk | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisone; Recurrence; Severity of Illness Index | 2004 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosin; Drug Therapy, Combination; Famotidine; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Male; Muscular Diseases; Mycophenolic Acid; Pneumonia, Bacterial; Postoperative Complications; Prednisone; Sirolimus | 2004 |
[Can platelets be synthetized from nucleotides?].
Topics: Adolescent; Adult; Aged; Azathioprine; Blood Platelets; Case-Control Studies; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nucleotides; Renal Dialysis | 2004 |
Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Survival Analysis; Time Factors | 2004 |
Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Daclizumab; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Sirolimus; Tacrolimus; Treatment Outcome | 2004 |
Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.
Topics: Adult; Azathioprine; Blood Cell Count; Creatinine; Female; Genetic Variation; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methyltransferases; Middle Aged; Mycophenolic Acid; Polymerase Chain Reaction; Retrospective Studies; Spinal Cord | 2004 |
Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
Topics: Aged; Azathioprine; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Multivariate Analysis; Mycophenolic Acid; Proportional Hazards Models | 2004 |
Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
Topics: Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Transplantation, Homologous | 2004 |
IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.
Topics: Adult; Analysis of Variance; Azathioprine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunosorbent Techniques; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid; Patient Selection; Prospective Studies; Statistics, Nonparametric | 2005 |
Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Mycophenolic Acid; Netherlands; Outcome Assessment, Health Care; Time Factors | 2005 |
Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
Topics: Albuminuria; Azathioprine; Body Weight; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Isoantigens; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Proteinuria | 2004 |
Tuberculosis in renal transplant recipients on various immunosuppressive regimens.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Tacrolimus; Tuberculosis | 2005 |
The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation.
Topics: ABO Blood-Group System; Adult; Azathioprine; Body Weight; Cadaver; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunophenotyping; Immunosuppressive Agents; Ischemia; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Time Factors; Tissue Donors; Treatment Outcome | 2005 |
Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
Topics: Antibody Formation; Azathioprine; Blood Transfusion; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA Antigens; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Reoperation; Steroids; Tacrolimus | 2005 |
Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.
Topics: Azathioprine; Calcineurin Inhibitors; Creatinine; Diabetes Complications; Enzyme Inhibitors; Female; Follow-Up Studies; Forecasting; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; IMP Dehydrogenase; Kidney; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Safety; Time Factors; Treatment Outcome | 2005 |
Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Black People; Cause of Death; Diabetes Complications; Female; Graft Rejection; Graft Survival; Heart Diseases; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Infections; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Survival Rate; United States; White People | 2005 |
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Clinical Trials, Phase III as Topic; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional | 2005 |
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
Topics: Adult; Age Factors; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Tacrolimus | 2005 |
Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Topics: Adult; Azathioprine; Glomerulonephritis, IGA; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Retrospective Studies; Secondary Prevention; Transplantation, Homologous | 2005 |
Rapamycin successfully treats post-transplant autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Biopsy; Calcineurin Inhibitors; Child; Child, Preschool; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Infant, Newborn; Liver; Liver Diseases; Male; Mycophenolic Acid; Postoperative Complications; Prednisolone; Sirolimus; Time Factors; Transaminases; Treatment Outcome | 2005 |
Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients.
Topics: Adult; Azathioprine; Case-Control Studies; Female; Humans; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Lymphocyte Activation; Lymphocytes; Male; Mercaptopurine; Middle Aged; Mycophenolic Acid; Nucleic Acid Synthesis Inhibitors; Ribonucleosides | 2005 |
Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Time Factors | 2005 |
Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.
Topics: Acute Disease; Argentina; Azathioprine; Costs and Cost Analysis; Cyclosporine; Decision Support Techniques; Drug Therapy, Combination; Emulsions; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Time Factors | 2005 |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
Topics: Adoptive Transfer; Animals; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Dendritic Cells; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-2; Isoantigens; Mice; Mycophenolic Acid; Sirolimus; Spleen; Tacrolimus; Time Factors; Tissue Donors; Trachea; Transplantation | 2005 |
Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression.
Topics: Azathioprine; Costs and Cost Analysis; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Spain; Tacrolimus; Time Factors | 2005 |
The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Topics: Adult; Area Under Curve; Azathioprine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2005 |
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Choroid Diseases; Cyclosporine; Daclizumab; Disease Progression; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; HLA-A Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retinal Diseases; Retrospective Studies; Treatment Outcome; Visual Acuity | 2005 |
Mycophenolate mofetil: a magic bullet for lupus?
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2005 |
Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Proteinuria; Retrospective Studies; Severity of Illness Index; Survival Rate | 2005 |
Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
Topics: Adrenal Cortex Hormones; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Time Factors | 2005 |
Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols.
Topics: Adolescent; Adult; Aged; Azathioprine; Chagas Cardiomyopathy; Dose-Response Relationship, Drug; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Recurrence; Survival Rate; Treatment Outcome | 2005 |
Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation.
Topics: Adult; Animals; Antibody Formation; Azathioprine; Base Sequence; CHO Cells; Cricetinae; DNA Primers; Endothelium, Vascular; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Male; Middle Aged; Mutation, Missense; Mycophenolic Acid | 2005 |
Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Body Mass Index; Case-Control Studies; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Pilot Projects; Recombinant Fusion Proteins; Retrospective Studies; Steroids; Survival Rate; Tacrolimus | 2005 |
Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use?
Topics: Azathioprine; Biopsy; Drug Monitoring; Drug Therapy, Combination; Everolimus; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Mycophenolic Acid; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography | 2005 |
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
Topics: Adrenal Cortex Hormones; Adult; Aspartate Aminotransferases; Azathioprine; Bilirubin; Biomarkers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; gamma-Globulins; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
Ultra-late antibody-mediated rejection 30 years after a living-related renal allograft.
Topics: Adolescent; Antibodies; Antibody Formation; Azathioprine; Biopsy; Complement C4b; Female; Flow Cytometry; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Histocompatibility Testing; HLA Antigens; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Kidney; Kidney Transplantation; Living Donors; Lymphocytes; Methylprednisolone; Microscopy, Electron; Microscopy, Fluorescence; Mycophenolic Acid; Peptide Fragments; Phenotype; Prednisone; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Mycophenolate mofetil in pediatric renal transplantation.
Topics: Azathioprine; Child; Chronic Disease; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Retrospective Studies | 2005 |
Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Topics: Acute Disease; Antibody Formation; Antilymphocyte Serum; Azathioprine; Cadaver; Down-Regulation; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Mycophenolic Acid; Risk Factors; Urologic Diseases | 2005 |
The role of immunosuppressive drugs in transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Muromonab-CD3; Mycophenolic Acid; Tacrolimus; Transplantation Immunology | 1998 |
Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lupus Nephritis; Mycophenolic Acid | 2005 |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
Topics: Adiponectin; Adult; Azathioprine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; Female; Genes, MDR; Humans; Immunosuppressive Agents; Incidence; Ion Channels; Kidney Transplantation; Male; Membrane Transport Proteins; Middle Aged; Mitochondrial Proteins; Multivariate Analysis; Mycophenolic Acid; Peptidyl-Dipeptidase A; Polymorphism, Genetic; PPAR gamma; Receptors, Calcitriol; Risk Factors; Tacrolimus; Uncoupling Protein 2 | 2005 |
Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient.
Topics: Antitubercular Agents; Azathioprine; Humans; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Treatment Outcome; Tuberculosis | 2005 |
Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.
Topics: Adult; Azathioprine; Biopsy; Calcineurin Inhibitors; Creatinine; Cyclosporine; Delayed Graft Function; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2006 |
[Inhibition of phosphatidylethanolamine and phosphatidylinositol synthesis, alteration of the G0 and G1 cell cycle phases and spontaneous apoptosis in lymphocytes from patients under immunosuppressive treatment].
Topics: Apoptosis; Azathioprine; Cells, Cultured; Concanavalin A; Culture Media; Flow Cytometry; G1 Phase; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Membrane Lipids; Mycophenolic Acid; Phosphatidylethanolamines; Phosphatidylinositols; Resting Phase, Cell Cycle; S Phase; Tacrolimus | 2005 |
[Bullous pemphigoid: diagnostics and new therapeutic strategies].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Blotting, Western; Child; Clobetasol; Cyclophosphamide; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Niacinamide; Pemphigoid, Bullous; Pregnancy; Skin; Vitamin B Complex | 2006 |
American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid | 2006 |
Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.
Topics: Adolescent; Azathioprine; Biopsy; Black or African American; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Disease Progression; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
Cyclosporine drug monitoring with C0 and C2 concentrations in children with stable renal allograft function.
Topics: Adolescent; Adult; Azathioprine; Child; Creatinine; Cyclosporine; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Time Factors; Transplantation, Homologous | 2006 |
Compensatory enlargement in transplant coronary artery disease: an intravascular ultrasound study.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Female; Heart Transplantation; Humans; Hyperplasia; Male; Middle Aged; Mycophenolic Acid; Tunica Intima; Ultrasonography, Interventional | 2006 |
Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity.
Topics: Aged; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome | 2006 |
Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Azathioprine; Coronary Disease; Disease Progression; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis | 2006 |
Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
Topics: Adult; Aged; Azathioprine; Blood Urea Nitrogen; Calcineurin Inhibitors; Creatinine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2006 |
Guidelines for the treatment of autoimmune neuromuscular transmission disorders.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases of the Nervous System; Azathioprine; Humans; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; MEDLINE; Myasthenia Gravis; Mycophenolic Acid; Neuromuscular Junction Diseases; Plasma Exchange; Thymectomy | 2006 |
[Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs].
Topics: Azathioprine; Cyclosporine; DNA Repair; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neoplasms; Tacrolimus; Transplantation | 2005 |
Treatment of proliferative lupus nephritis: a changing landscape.
Topics: Anti-Inflammatory Agents; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Prednisolone; Randomized Controlled Trials as Topic | 2006 |
HPLC/tandem ion trap mass detector methods for determination of inosine monophosphate dehydrogenase (IMPDH) and thiopurine methyltransferase (TPMT).
Topics: Azathioprine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Erythrocytes; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Ions; Leukocytes, Mononuclear; Mass Spectrometry; Methyltransferases; Mycophenolic Acid; Research Design | 2006 |
Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.
Topics: Adult; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Female; Humans; Lupus Nephritis; Male; Mycophenolic Acid; Nephritis; Rituximab; Treatment Outcome | 2007 |
Evolutional changes in maintenance immunosuppression following heart transplantation.
Topics: Azathioprine; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Survivors | 2006 |
Is mycophenolate mofetil better than azathioprine in organ transplantation?
Topics: Azathioprine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid | 2006 |
Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Topics: Adult; Anemia, Megaloblastic; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Blood Proteins; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrotic Syndrome; Plasmapheresis; Proteinuria; Sepharose; Staphylococcal Protein A; Tacrolimus | 2006 |
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Azathioprine; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Forkhead Transcription Factors; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lung Transplantation; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Mycophenolic Acid; Steroids; T-Lymphocytes, Regulatory; Tacrolimus | 2006 |
Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: impact of acute disease versus subclinical infection.
Topics: Adult; Aged; Azathioprine; Case-Control Studies; Cohort Studies; Cytomegalovirus; Cytomegalovirus Infections; Diagnosis, Differential; DNA, Viral; Female; Heart Transplantation; Hemoglobins; Humans; Immunosuppressive Agents; Leukocyte Count; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Platelet Count; Retrospective Studies | 2006 |
Successful treatment of oral linear IgA disease using mycophenolate.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Female; Fluorescent Antibody Technique; Fluorescent Antibody Technique, Direct; Gingival Diseases; Humans; Immunoglobulin A; Immunosuppressive Agents; Mycophenolic Acid; Oral Ulcer; Prednisolone; Skin Diseases, Vesiculobullous | 2007 |
[Cryptosporidiosis. A rare infection in renal transplantation].
Topics: Adult; Animals; Azathioprine; Cryptosporidiosis; Cryptosporidium; Cyclosporine; Female; Gastroscopy; Humans; Immunocompromised Host; Immunosuppressive Agents; Intestinal Diseases, Parasitic; Intestinal Mucosa; Kidney Transplantation; Malnutrition; Methylprednisolone; Mycophenolic Acid; Opportunistic Infections; Postoperative Complications; Spiramycin | 2006 |
CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.
Topics: Antigens, CD; Azathioprine; CD4 Antigens; Drug Therapy, Combination; Flow Cytometry; Graft Survival; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Isoantibodies; Kidney Transplantation; Living Donors; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Mycophenolic Acid; Prednisone; T-Lymphocytes, Regulatory; Transplantation, Homologous | 2006 |
Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Azathioprine; Erythropoietin; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Care; Predictive Value of Tests | 2007 |
Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Metabolic Clearance Rate; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Survival Analysis; Ventricular Function, Left | 2007 |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
Topics: ABO Blood-Group System; Azathioprine; Blood Grouping and Crossmatching; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Methylprednisolone; Mycophenolic Acid; Tacrolimus; Time Factors; Treatment Outcome | 2007 |
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone.
Topics: Actins; Azathioprine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclosporine; Epithelial Cells; Fibroblasts; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules, Proximal; Methylprednisolone; Mycophenolic Acid; Sirolimus; Transforming Growth Factor beta; Versicans | 2007 |
Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.
Topics: Area Under Curve; Azathioprine; Cyclosporine; Drug Therapy, Combination; Drugs, Generic; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Treatment Outcome | 2007 |
Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India.
Topics: Adolescent; Adult; Azathioprine; Child; Drug Therapy, Combination; Family; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Tacrolimus | 2007 |
[Clinical application and side effects of immunosuppressant].
Topics: Adjuvants, Immunologic; Azathioprine; Cyclosporine; Glucocorticoids; Humans; Mycophenolic Acid; Tacrolimus | 2007 |
Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections.
Topics: Azathioprine; Cohort Studies; Communicable Disease Control; Graft Survival; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Mycophenolic Acid; Patient Readmission; Postoperative Complications; Retrospective Studies; Survival Analysis; Survivors; Treatment Failure | 2007 |
Anemia in the period immediately following renal transplantation.
Topics: Adult; Anemia; Azathioprine; Blood Transfusion; Cytomegalovirus Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Postoperative Period; Retrospective Studies | 2007 |
Six-year follow-up of azathioprine and mycophenolate mofetil use during the first 6 months of renal transplantation.
Topics: Azathioprine; Cause of Death; Follow-Up Studies; Graft Rejection; Hemoglobins; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Conjunctival Diseases; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Sulfapyridine; Treatment Outcome; Visual Acuity | 2008 |
Role of maintenance immunosuppressive regimen in kidney transplant outcome.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome | 2006 |
Selective late steroid withdrawal after renal transplantation.
Topics: Adolescent; Adolescent Development; Azathioprine; Blood Pressure; Child; Child Development; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Steroids | 2007 |
Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2007 |
[Interdisciplinary consensus to management of lupus nephritis in Germany].
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisone | 2007 |
Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.
Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Biopsy; Celiac Disease; Child, Preschool; Coombs Test; Cyclosporine; Diagnosis, Differential; Follow-Up Studies; Glucocorticoids; Hepatitis; Humans; Immunologic Factors; Immunosuppressive Agents; Infant; Liver; Liver Function Tests; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Rare Diseases; Remission Induction; Rituximab | 2007 |
Sirolimus and cardiac transplantation: is it the "magic bullet"?
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2007 |
Novel methods for tracking long-term maintenance immunosuppression regimens.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Data Collection; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Medical Records Systems, Computerized; Medicare; Mycophenolic Acid; Pharmacies; Prevalence; Sirolimus; Tissue and Organ Procurement; United States | 2008 |
Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.
Topics: Azathioprine; Drug Therapy, Combination; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Tacrolimus; Treatment Outcome | 2007 |
[Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Mycophenolic Acid; Skin Diseases | 2007 |
Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.
Topics: Adult; Azathioprine; Cadaver; Case-Control Studies; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Tissue Donors | 2007 |
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Topics: Administration, Oral; Adult; Antibodies; Antimetabolites; Australia; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New Zealand; Practice Patterns, Physicians'; Prednisolone; Protein Kinases; Registries; Sirolimus; Steroids; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases | 2008 |
Prostate cancer in renal transplant recipients.
Topics: Aged; Azathioprine; Calcineurin Inhibitors; France; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mass Screening; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Prostatic Neoplasms; Retrospective Studies; Risk Factors | 2008 |
Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.
Topics: Adolescent; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid | 2008 |
The role of heparin in alleviating complement-mediated acute intravascular haemolysis.
Topics: 3' Untranslated Regions; Acute Disease; Adult; Anemia, Hemolytic, Autoimmune; Azathioprine; Combined Modality Therapy; Complement Activation; Enoxaparin; Female; Hemolysis; Heparin; Humans; Immunosuppressive Agents; Mycophenolic Acid; Plasma Exchange; Prednisolone; Prothrombin; Splenectomy; Thrombophilia; Venous Thrombosis | 2008 |
De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease.
Topics: Adult; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Hepatitis; Histocompatibility Testing; HLA Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver; Liver Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Pulse Therapy, Drug; Steroids; Time Factors; Treatment Outcome | 2008 |
Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
Topics: Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Peroxidase; Vasculitis | 2008 |
Tapering immunosuppressive therapy significantly improves in vivo cutaneous delayed type hypersensitivity responses.
Topics: Antigens, Bacterial; Azathioprine; Female; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunosuppression Therapy; Kidney Transplantation; Male; Monitoring, Immunologic; Mycophenolic Acid; Prospective Studies; Skin Tests | 2008 |
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Azathioprine; Daclizumab; Databases, Factual; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammation; Longitudinal Studies; Methotrexate; Mycophenolic Acid; Neoplasms; Risk Factors; Tumor Necrosis Factor-alpha; Uveitis | 2008 |
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Azathioprine; Child; Female; Glucocorticoids; Humans; Inflammation; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Scleritis; Uveitis | 2008 |
Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Bullous; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Maintaining remission in a patient with vasculitis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Mycophenolic Acid; Plasma Exchange; Prednisolone; Recurrence; Remission Induction; Rituximab | 2008 |
Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Ocular cicatricial pemphigoid.
Topics: Azathioprine; Conjunctival Diseases; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane; Sulfapyridine; Treatment Outcome; Visual Acuity | 2008 |
Optimal C2 concentration of cyclosporin corrected with good efficacy and safety in Asian kidney transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Asian People; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Safety; Time Factors | 2008 |
Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
Topics: Adult; Azathioprine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Transplantation, Homologous | 2008 |
Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult | 2008 |
The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Transplantation, Homologous; Treatment Outcome; United Kingdom | 2008 |
Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
Topics: Adult; Azathioprine; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Reoperation; Reproducibility of Results; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Immunosuppressive therapy and post-transplant malignancy.
Topics: Azathioprine; Calcineurin Inhibitors; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neoplasms; Organ Transplantation; Propylene Glycols; Protein Kinases; Sphingosine; TOR Serine-Threonine Kinases | 2009 |
Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis.
Topics: Adult; Azathioprine; Cyclophosphamide; Drug Costs; Female; Hospital Costs; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Infections; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Pneumonia; Young Adult | 2009 |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Survival; Humans; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet's disease, evaluated with enteroscopy.
Topics: Anti-Inflammatory Agents; Azathioprine; Behcet Syndrome; Colonoscopy; Crohn Disease; Humans; Male; Middle Aged; Mycophenolic Acid; Prednisone | 2008 |
Spinal cord sarcoidosis: report of seven cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclophosphamide; Female; Fungemia; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sarcoidosis; Severity of Illness Index; Spinal Cord; Spinal Cord Diseases | 2009 |
Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Urinary Bladder Neoplasms; Urothelium | 2009 |
[A 55-year-old woman with thymoma and hypogammaglobulinemia (Good syndrome), ulcerative colitis, and cytomegalovirus infection].
Topics: Agammaglobulinemia; Antiviral Agents; Azathioprine; Cidofovir; Colitis, Ulcerative; Cytomegalovirus Infections; Cytosine; Enteritis; Female; Humans; Immunization, Passive; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Leukopenia; Middle Aged; Mycophenolic Acid; Neoplasm Staging; Opportunistic Infections; Organophosphonates; Postoperative Complications; Syndrome; Thymectomy; Thymoma; Thymus Neoplasms | 2009 |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Regression Analysis; Reoperation; Retrospective Studies; Tacrolimus; Treatment Outcome | 2009 |
The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?
Topics: Azathioprine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
Topics: Adult; Azathioprine; Child; Drug Administration Schedule; Family; Female; Granzymes; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-10; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Reoperation; T-Lymphocytes; Tetanus Toxoid; Young Adult | 2009 |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.
Topics: Adult; Azathioprine; Cyclosporine; Female; Glomerulonephritis; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Markov Chains; Middle Aged; Monte Carlo Method; Mycophenolic Acid; Recurrence; Risk Factors; Tacrolimus; Transplantation, Homologous; Treatment Failure | 2009 |
Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cohort Studies; Female; Humans; Immunosuppressive Agents; Iran; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Young Adult | 2008 |
A case report of successful long-term relapse control by protein-a immunoadsorption in an immunosuppressive-treated patient with end-stage renal disease due to Wegener's granulomatosis.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Kidney Failure, Chronic; Mycophenolic Acid; Prednisone; Remission Induction; Renal Dialysis; Staphylococcal Protein A | 2009 |
Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: implications for protocol biopsy policy.
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Biopsy; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Prednisolone; Recombinant Fusion Proteins; Tacrolimus | 2009 |
[Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cushing Syndrome; Drug Therapy, Combination; Female; Hospitals, University; Hospitals, Urban; Humans; Hypertension; Immunosuppressive Agents; Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigus; Retrospective Studies; Spain | 2009 |
Micophenolat Mofetil versus Azathioprine: effects on renal graft function in early posttransplant period.
Topics: Adult; Azathioprine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2009 |
Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Intracranial Hypertension; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Survival Analysis; Young Adult | 2009 |
Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
Topics: Adult; Aged; Azathioprine; Biopsy; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2; Lung; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Treatment Outcome | 2009 |
Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.
Topics: Animals; Azathioprine; Blood Pressure; Cytokines; Desoxycorticosterone; Disease Models, Animal; Endothelium, Vascular; Female; Fetal Growth Retardation; Hypertension, Pregnancy-Induced; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Pregnancy; Proteinuria; Rats; Rats, Sprague-Dawley | 2009 |
Mycophenolate mofetil as second line immunosuppressant in Myasthenia gravis--a long-term prospective open-label study.
Topics: Adult; Aged; Azathioprine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Prospective Studies | 2009 |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients.
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Databases, Factual; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Living Donors; Male; Middle Aged; Mycophenolic Acid; Risk; Tacrolimus; Time Factors; Treatment Outcome | 2009 |
The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
Topics: Adolescent; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Outcome | 2010 |
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Black People; Creatinine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Remission Induction; Retrospective Studies; White People; Young Adult | 2009 |
Modifying cyclosporine associated renal allograft dysfunction.
Topics: Adolescent; Adult; Azathioprine; Biopsy; Case-Control Studies; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Time Factors; Transplantation Tolerance; Transplantation, Homologous; Treatment Outcome; Young Adult | 2009 |
[The effect of mycophenolate mofetil and azathioprine on gingival enlargement associated with cyclosporin A use in kidney transplant patients].
Topics: Adult; Azathioprine; Cross-Sectional Studies; Cyclosporine; Female; Gingival Hypertrophy; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Severity of Illness Index | 2009 |
Graves' disease associated with primary systemic sclerosis.
Topics: Azathioprine; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Graves Disease; Humans; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Proteinuria; Raynaud Disease; Scleroderma, Systemic; Sulfonamides | 2009 |
Mycophenolate mofetil versus azathioprine in organ transplantation.
Topics: Azathioprine; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid | 2009 |
Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
Topics: Adult; Age Factors; Azathioprine; Cyclosporine; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Living Donors; Male; Middle Aged; Mycophenolic Acid; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2009 |
Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantation.
Topics: Algorithms; Austria; Azathioprine; Europe; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Proportional Hazards Models; Registries; Retrospective Studies; Time Factors | 2009 |
Pharmacokinetic interaction between sodium valproate and mycophenolate in renal allograft recipients.
Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Azathioprine; Female; Glucocorticoids; Graft Rejection; Humans; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Seizures; Transplantation, Homologous; Valproic Acid | 2009 |
Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Topics: Adolescent; Azathioprine; Child; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Mycophenolic Acid; Prednisone; Secondary Prevention | 2009 |
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Mycophenolic Acid; Patient Selection; Predictive Value of Tests; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Failure | 2010 |
Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocele; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisolone; Retrospective Studies; Risk Factors; Wound Healing | 2010 |
Successful treatment of aortic root dilatation in a patient with relapsing polychondritis.
Topics: Aorta; Aortic Diseases; Aortic Valve Insufficiency; Azathioprine; Cyclophosphamide; Dilatation, Pathologic; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Polychondritis, Relapsing; Prednisolone | 2013 |
Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Metronidazole; Mycophenolic Acid; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Sirolimus; Tacrolimus; Tomography, X-Ray Computed | 2010 |
Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
Topics: Adult; Azathioprine; Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Inflammation; Lung Transplantation; Macrophages, Alveolar; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Pulmonary Alveoli; Treatment Outcome | 2010 |
Clinical and immunopathological evaluation of epidermolysis bullosa acquisita.
Topics: Adult; Aged; Azathioprine; Brazil; Child; Child, Preschool; Dapsone; Epidermolysis Bullosa Acquisita; Female; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Mycophenolic Acid; Prednisone; Treatment Outcome; Young Adult | 2011 |
Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes.
Topics: Adult; Azathioprine; DNA; Female; Genotype; Graft Rejection; Graft Survival; Histocompatibility Antigens Class I; HLA-DR Antigens; Humans; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Reference Values; Treatment Outcome | 2010 |
Pemphigus vulgaris--still a difficult disease to treat.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Azathioprine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Male; Mycophenolic Acid; Pemphigus; Prednisone; Retreatment; Risk Assessment; Rituximab; Severity of Illness Index; Treatment Outcome | 2010 |
Incidence, severity, and etiology of drug-induced acute pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Child, Preschool; Crohn Disease; Cytarabine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Incidence; Male; Mesalamine; Middle Aged; Mycophenolic Acid; Pancreatitis; Ramipril; Retrospective Studies; Risk Factors; Severity of Illness Index; Valproic Acid; Young Adult | 2010 |
Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors.
Topics: Adalimumab; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patch Tests; Prospective Studies; Tacrolimus; Treatment Outcome | 2010 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic Agents; Desmoglein 3; Female; Humans; Immunosuppressive Agents; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Pemphigus; Tacrolimus; Treatment Outcome | 2010 |
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Gingival Diseases; Hepatitis, Autoimmune; Herpesvirus 4, Human; Hodgkin Disease; Humans; Iatrogenic Disease; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Mandibular Diseases; Mycophenolic Acid; Oral Ulcer; Prednisone; Remission Induction; Rituximab; Virus Activation | 2010 |
Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient.
Topics: Adult; Azathioprine; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Neutropenia | 2010 |
Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
Topics: Azathioprine; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Creatinine; Female; Humans; Kidney Transplantation; Lipids; Male; Methylprednisolone; Mycophenolic Acid; Osteonecrosis; Osteoporosis; Sirolimus; Vitamin D | 2010 |
Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.
Topics: Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Exanthema; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Pruritus; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Gene Expression Regulation; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Neprilysin; Prospective Studies; Risk Assessment; Tablets, Enteric-Coated; Transplantation Immunology; Treatment Outcome | 2010 |
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Microvessels; Mycophenolic Acid; Prospective Studies; Treatment Outcome; Vasculitis, Central Nervous System | 2010 |
Long-term care following paediatric liver transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Child; Continuity of Patient Care; Glucocorticoids; Graft Rejection; Hepatic Artery; Humans; Immunosuppressive Agents; Liver Transplantation; Long-Term Care; Monitoring, Physiologic; Mycophenolic Acid; Portal Vein; Postoperative Complications; Primary Graft Dysfunction; Recurrence; Survivors; Venous Thrombosis; Virus Diseases | 2011 |
Herpetic necrotizing retinitis following flucinolone acetonide intravitreal implant.
Topics: Acyclovir; Antiviral Agents; Azathioprine; Cataract; Drug Implants; Eye Infections, Viral; Herpes Simplex; Herpesvirus 2, Human; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Panuveitis; Pregnadienetriols; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Valacyclovir; Valine; Visual Acuity; Young Adult | 2011 |
Therapeutic interventions for systemic vasculitis.
Topics: Antirheumatic Agents; Azathioprine; Clinical Trials as Topic; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Microscopic Polyangiitis; Mycophenolic Acid | 2010 |
Circulating cytokines are associated with human islet graft function in type 1 diabetes.
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Female; Graft Rejection; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kidney Transplantation; Male; Mycophenolic Acid | 2011 |
Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Topics: Adolescent; Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Germany; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Skin Neoplasms; Survival Rate; Time Factors; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Cohort Studies; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Young Adult | 2010 |
Steroid withdrawal in kidney transplantation: the subgroup fallacy.
Topics: Azathioprine; Contraindications; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Steroids; Tacrolimus; Time Factors; Withholding Treatment | 2011 |
Preventing relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antirheumatic Agents; Area Under Curve; Azathioprine; Dose-Response Relationship, Drug; Humans; Mycophenolic Acid; Reproducibility of Results; Secondary Prevention; Treatment Outcome | 2011 |
Hematologic side effects of azathioprine and mycophenolate in kidney transplantation.
Topics: Adult; Azathioprine; Bone Marrow; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Leukocytes; Male; Middle Aged; Models, Statistical; Mycophenolic Acid; Platelet Count; Time Factors | 2011 |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Diabetic Nephropathies; Female; Graft Rejection; Hip Fractures; Histocompatibility Testing; HLA-DR Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Treatment Outcome | 2011 |
Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Topics: Adolescent; Aged; Antibodies, Viral; Azathioprine; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Steroids; Tacrolimus | 2011 |
Everolimus for cardiac allograft vasculopathy--every patient, at any time?
Topics: Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Disease Progression; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Muscle, Smooth, Vascular; Mycophenolic Acid; Risk Factors; Sirolimus; Vascular Diseases | 2011 |
Mild rhabdomyolysis after renal transplantation.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Rhabdomyolysis; Tacrolimus | 2011 |
Mycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience.
Topics: Adult; Azathioprine; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Ireland; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Care; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Transplantation Immunology; Treatment Outcome | 2012 |
How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?
Topics: Allopurinol; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Drug Therapy, Combination; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methyltransferases; Mycophenolic Acid; Practice Patterns, Physicians'; Surveys and Questionnaires; Sweden; Tacrolimus; Thioguanine; Tumor Necrosis Factor-alpha | 2011 |
Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.
Topics: Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Calcineurin Inhibitors; Creatinine; Delayed Graft Function; Developing Countries; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; India; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Steroids; Treatment Outcome | 2012 |
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-alpha; Interferon-beta; Italy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Azathioprine; Cataract; Cataract Extraction; Cyclosporine; Expert Testimony; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Macular Edema; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Surveys and Questionnaires; Uveitis; Young Adult | 2011 |
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Desmogleins; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Pilot Projects; Rituximab; Treatment Outcome | 2012 |
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Prognosis; Republic of Korea; Retrospective Studies; Rituximab; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2011 |
Toward better treatment for lupus nephritis.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid | 2011 |
Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison.
Topics: Abortion, Spontaneous; Adult; Azathioprine; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Stillbirth; Tacrolimus; Transplantation Conditioning; Young Adult | 2012 |
[Immunosuppressive treatment].
Topics: Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Evidence-Based Medicine; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Mycophenolic Acid; Postoperative Care; Tacrolimus; Treatment Outcome | 2011 |
The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; Secondary Prevention; Survival Rate; Tissue Donors; Young Adult | 2012 |
[Allergo-immunology. Clinical immunology].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Severity of Illness Index; Treatment Outcome | 2012 |
[Nephrology].
Topics: Anticholesteremic Agents; Azathioprine; Azetidines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Nephrology; Renal Dialysis; Secondary Prevention; Simvastatin; Treatment Outcome | 2012 |
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
Topics: Adult; Ambulatory Care; Azathioprine; Cyclosporine; Drug Costs; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Practice Patterns, Physicians'; Prednisolone; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
Topics: Azathioprine; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; National Health Programs; Practice Patterns, Physicians'; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Mycophenolate or azathioprine maintenance in lupus nephritis.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid | 2012 |
Mycophenolate or azathioprine maintenance in lupus nephritis.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid | 2012 |
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Autoimmunity; Azathioprine; Disabled Persons; Drug Administration Schedule; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interferon-beta; Kaplan-Meier Estimate; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Mycophenolic Acid; Neuromyelitis Optica; Predictive Value of Tests; Prednisolone; Prognosis; Republic of Korea; Rituximab | 2012 |
Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents.
Topics: Adolescent; Adult; Azathioprine; Blepharitis; Child; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Mycophenolic Acid; Phenotype; Prednisolone; Visual Acuity; White People; Young Adult | 2012 |
Autoimmune hepatitis: current knowledge.
Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Azathioprine; Child; Cyclosporine; Genetic Predisposition to Disease; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Muscle, Smooth; Mycophenolic Acid; Prednisone | 2012 |
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Azathioprine; B-Lymphocytes; Cell Proliferation; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Middle Aged; Mycophenolic Acid; Plasma Cells; Retrospective Studies; Young Adult | 2012 |
Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.
Topics: Azathioprine; Drug Therapy, Combination; Ear Diseases; Endoscopy; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Mouth Diseases; Mycophenolic Acid; Nose Diseases; Pemphigus; Pharyngeal Diseases; Prospective Studies; Severity of Illness Index | 2012 |
Vasculitis associated with tumor necrosis factor-α inhibitors.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Etanercept; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyneuropathies; Prednisone; Proteinuria; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis; Young Adult | 2012 |
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Topics: Adult; Azathioprine; Biopsy; Child; Cyclophosphamide; Disease Management; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Evidence-Based Medicine; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Pregnancy | 2012 |
Urinary tract infections following renal transplantation: a single-center experience.
Topics: Adult; Azathioprine; Chi-Square Distribution; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Multivariate Analysis; Mycophenolic Acid; Retrospective Studies; Risk Assessment; Risk Factors; Tunisia; Urinary Tract Infections; Young Adult | 2012 |
Cancer after heart transplant: implications for practice.
Topics: Azathioprine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisone; Sirolimus; Skin Neoplasms; Tacrolimus | 2012 |
Lupus nephritis: keeping the wolf at bay.
Topics: Azathioprine; Drug Resistance; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Mycophenolic Acid | 2013 |
Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Topics: Adult; Antimalarials; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Glucocorticoids; Hodgkin Disease; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Young Adult | 2014 |
Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2013 |
Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Pregnancy; Pregnancy Outcome; Retreatment; Treatment Outcome | 2013 |
Two cases of refractory thrombocytopenia in systemic lupus erythematosus that responded to intravenous low-dose cyclophosphamide.
Topics: Azathioprine; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Middle Aged; Mycophenolic Acid; Platelet Count; Thrombocytopenia; Young Adult | 2013 |
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Dyspnea; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Polymyositis; Prednisone; Pulmonary Diffusing Capacity; Retrospective Studies; Treatment Outcome; Vital Capacity | 2013 |
Refractory bullous pemphigoid with fatal outcome in a young patient.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Drug Resistance; Drug Therapy, Combination; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Mycophenolic Acid; Pemphigoid, Bullous; Prednisolone; Rituximab | 2013 |
Basiliximab induction in renal transplantation: long-term outcome.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Odds Ratio; Proportional Hazards Models; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Steroids; Time Factors; Treatment Outcome | 2013 |
Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome; Young Adult | 2013 |
Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2013 |
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; B-Lymphocyte Subsets; Cyclophosphamide; Female; Homeostasis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Rituximab | 2013 |
Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Topics: Anemia, Hemolytic, Autoimmune; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Glucocorticoids; Immunoglobulins; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies | 2013 |
Hickam's dictum in a patient with diarrhea.
Topics: Antiviral Agents; Azathioprine; Colitis; Cytomegalovirus Infections; Diarrhea; Female; Ganciclovir; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Treatment Outcome | 2013 |
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Biomarkers; Blood Proteins; Case-Control Studies; Child; Child, Preschool; Combined Modality Therapy; Complement C3b Inactivator Proteins; Cyclophosphamide; Drug Therapy, Combination; Female; Gene Deletion; Hemolytic-Uremic Syndrome; Homozygote; Humans; Immunosuppressive Agents; India; Infant; Male; Mycophenolic Acid; Plasma Exchange; Prednisolone; Recurrence; Risk Factors; Rituximab; Time Factors; Time-to-Treatment; Treatment Outcome | 2014 |
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
Topics: Antibodies, Viral; Azathioprine; Brazil; Cyclosporine; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Kidney Transplantation; Male; Mycophenolic Acid; Pandemics; Prospective Studies; Risk Factors; Sex Factors; Sirolimus; Tacrolimus; White People | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.
Topics: Adult; Aged; Anti-Infective Agents; Azathioprine; Cohort Studies; Cyclosporine; Dapsone; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Methemoglobinemia; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Prevalence; Regression Analysis; Risk Factors; Tacrolimus | 2014 |
Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade III for a period 2003-2011.
Topics: Adult; Azathioprine; Biomarkers; Calcineurin Inhibitors; Creatinine; Cytomegalovirus Infections; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Renal Insufficiency, Chronic; Sirolimus; Time Factors; Treatment Outcome | 2013 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Failure; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2014 |
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Treatment Failure; Treatment Outcome; Young Adult | 2014 |
Conversion to mycophenolate mofetil from azathioprine shows significant positive effect on graft function in long-term past-kidney transplantation stable-state patients.
Topics: Adolescent; Adult; Azathioprine; Child; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Young Adult | 2014 |
[Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France].
Topics: Azathioprine; France; Humans; Immunosuppressive Agents; Internal Medicine; Lupus Nephritis; Mycophenolic Acid; Nephrology; Practice Patterns, Physicians'; Surveys and Questionnaires | 2014 |
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans; Immunologic Factors; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy | 2014 |
Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.
Topics: Adolescent; Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Pregnancy; Retreatment; Treatment Failure; Treatment Outcome; Young Adult | 2014 |
Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome | 2014 |
Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Drug Resistance; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus; Young Adult | 2014 |
Success with single-agent immunosuppression for multifocal choroidopathies.
Topics: Adolescent; Adult; Aged; Azathioprine; Chorioretinitis; Choroiditis; Drug Therapy, Combination; Electroretinography; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Multifocal Choroiditis; Mycophenolic Acid; Panuveitis; Prednisone; Retrospective Studies; Tacrolimus; Visual Acuity; Visual Fields | 2014 |
Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment.
Topics: Adult; Azathioprine; Biopsy; Cyclophosphamide; Cyclosporine; Cytomegalovirus Infections; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Real-Time Polymerase Chain Reaction; Retrospective Studies; Risk Factors; Turkey | 2014 |
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Kidney Failure, Chronic; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisone; Quality of Life; Recurrence; Survival Rate; Young Adult | 2014 |
Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Drug Therapy, Combination; Endotamponade; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Tomography, Optical Coherence; Uveitis; Visual Acuity; Vitrectomy; Young Adult | 2015 |
[Remission maintenance with methotrexate, azathioprine or mycophenolate-mofetil after induction therapy with rituximab for granulomatosis with polyangiitis].
Topics: Antirheumatic Agents; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Methotrexate; Mycophenolic Acid; Remission Induction; Rituximab; Treatment Outcome | 2015 |
Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Retrospective Studies; Rituximab; Treatment Outcome | 2015 |
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Melanoma; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasms; Risk Factors; Skin Neoplasms; Survival Analysis; Tacrolimus | 2015 |
Celebrating the ACP centennial: from the Annals archive.
Topics: Azathioprine; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Tacrolimus | 2015 |
Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; CD4 Lymphocyte Count; Cohort Studies; Diabetes Mellitus; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Induction Chemotherapy; Kidney Transplantation; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Perioperative Care; Prednisone; Rabbits; Recombinant Fusion Proteins | 2015 |
Systemic treatment of papular dermatitis: A retrospective study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Dermatitis; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Treatment Outcome | 2015 |
Analysis of the treatment of neuromyelitis optica.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunologic Factors; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Outcome Assessment, Health Care; Recurrence; Retrospective Studies; Rituximab; Young Adult | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Tacrolimus; Young Adult | 2015 |
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome | 2015 |
Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Azathioprine; Drug Resistance, Multiple; Everolimus; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tertiary Care Centers; Treatment Outcome; Young Adult | 2015 |
Risk factors and incidence for lipid abnormalities in kidney transplant patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Cyclosporine; Dyslipidemias; Everolimus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Risk Factors; Tacrolimus | 2015 |
Reply: To PMID 24943239.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Mycophenolic Acid | 2015 |
Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Mycophenolic Acid | 2015 |
[Uveitic macular edema and the pharmacotherapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Azathioprine; Bevacizumab; Cyclosporine; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Mycophenolic Acid; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2015 |
Lupus nephritis: MAINTAINing perspective in lupus nephritis trials.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid | 2015 |
Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Inflammation; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Mycophenolic Acid; Predictive Value of Tests; Prednisolone; Prognosis; Proportional Hazards Models; Retrospective Studies; Time Factors | 2015 |
[The influence of maintenance immunosuppression scheme on D4d urinary excretion in kidney graft recipients].
Topics: Adult; Allografts; Azathioprine; Complement C4b; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Peptide Fragments; Treatment Outcome | 2014 |
Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
Topics: ABO Blood-Group System; Adult; Azathioprine; Blood Group Incompatibility; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Rituximab; Young Adult | 2015 |
Eosinophilia associated with disease exacerbations in a patient with pyostomatitis vegetans.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dapsone; Eosinophilia; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Stomatitis | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Argentina; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prognosis; Retrospective Studies; Socioeconomic Factors | 2016 |
Successful Treatment of Lupus Cerebrovascular Disease with Mycophenolate Mofetil.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Interleukin-6; Ischemic Attack, Transient; Lupus Vasculitis, Central Nervous System; Mycophenolic Acid; Treatment Outcome | 2015 |
Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Analysis of Variance; Azathioprine; Biopsy, Needle; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Hospitals, Teaching; Humans; Immunohistochemistry; Immunosuppressive Agents; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney Function Tests; Lupus Nephritis; Male; Mexico; Multivariate Analysis; Mycophenolic Acid; Proportional Hazards Models; Remission Induction; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Renal flare prediction and prognosis in lupus nephritis Hispanic patients.
Topics: Adolescent; Adult; Azathioprine; Biomarkers; Chi-Square Distribution; Creatinine; Disease Progression; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lupus Nephritis; Male; Mexico; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2016 |
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholangitis, Sclerosing; Cyclosporine; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Mycophenolic Acid; Prednisolone; Retreatment; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2016 |
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult | 2015 |
Immunosuppressive drugs affect induction of IFNy+ Treg in vitro.
Topics: Antigens, CD; Azathioprine; Cells, Cultured; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interferon-gamma; Kidney Transplantation; Lymphocyte Activation; Methylprednisolone; Mycophenolic Acid; T-Box Domain Proteins; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2016 |
Standard Treatment in Adults: Which Steroid? Or without Steroids?
Topics: Adult; Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Treatment Outcome | 2015 |
Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Drug Resistance; Drug Substitution; Female; Humans; Kaplan-Meier Estimate; Male; Mycophenolic Acid | 2016 |
Autoimmune atypical parkinsonism - A group of treatable parkinsonism.
Topics: Aged; Autoimmune Diseases; Azathioprine; Female; Glutamate Decarboxylase; Humans; Immunosuppressive Agents; Immunotherapy; Intracellular Signaling Peptides and Proteins; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; N-Methylaspartate; Parkinson Disease; Proteins; Retrospective Studies | 2016 |
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2016 |
[Applied pharmacogenetic].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azathioprine; Cyclosporine; Everolimus; Genotype; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; Neoplasms; Nephrology; Pharmacogenetics; Polymorphism, Genetic; Tacrolimus; Treatment Outcome | 2016 |
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Remission Induction; Treatment Outcome | 2016 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Incidence; Maintenance Chemotherapy; Menopause; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Primary Ovarian Insufficiency; Remission Induction; Retrospective Studies; Risk Factors; Rituximab; Young Adult | 2016 |
Preemptive Renal Transplantation-The Best Treatment Option for Terminal Chronic Renal Failure.
Topics: Adult; Aged; Azathioprine; Bolivia; Costs and Cost Analysis; Cyclosporine; Developing Countries; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Renal Dialysis; Renal Replacement Therapy; Retrospective Studies; Transplantation, Homologous | 2016 |
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Antibodies, Antineutrophil Cytoplasmic; Asia; Azathioprine; Canada; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Europe; Female; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Lung Diseases; Male; Methotrexate; Microscopic Polyangiitis; Mycophenolic Acid; Nephrotic Syndrome; Oxygen Inhalation Therapy; Plasmapheresis; Proteinuria; Renal Dialysis; Respiratory Insufficiency; Rituximab; United States | 2016 |
Successful Pregnancy and Delivery in a Heart Transplantation Recipient.
Topics: Adult; Azathioprine; Drug Substitution; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Monitoring, Physiologic; Mycophenolic Acid; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Tacrolimus | 2016 |
Single-dose rituximab in refractory lupus nephritis.
Topics: Adrenal Cortex Hormones; Adult; Australia; Azathioprine; B-Lymphocytes; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Function Tests; Lupus Nephritis; Lymphocyte Count; Male; Mycophenolic Acid; Off-Label Use; Prospective Studies; Remission Induction; Rituximab; Treatment Outcome; Young Adult | 2016 |
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Topics: Alanine Transaminase; Alopecia; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Liver; Middle Aged; Mycophenolic Acid; Pancytopenia; Prednisolone | 2016 |
Repeat Conjunctival Biopsy after Immunomodulatory Therapy for Ocular Mucous Membrane Pemphigoid.
Topics: Aged; Aged, 80 and over; Azathioprine; Biopsy; Conjunctiva; Conjunctival Diseases; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunomodulation; Immunosuppressive Agents; Male; Microscopy, Fluorescence; Middle Aged; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane | 2018 |
Associations of Selected Cytokines Levels in Organ Transplant Recipients Without and With Malignant Skin Neoplasms.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytokines; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-2; Male; Middle Aged; Mycophenolic Acid; Organ Transplantation; Postoperative Complications; Skin Neoplasms; Transforming Growth Factor beta | 2016 |
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Klebsiella Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pneumocystis Infections; Prednisolone; Retrospective Studies; Uveitis | 2018 |
Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Topics: Adult; Azathioprine; Cohort Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Infections; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Severity of Illness Index | 2017 |
Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Kidney; Lupus Nephritis; Mycophenolic Acid | 2016 |
A case of refractory dermatomyositis responsive to tofacitinib.
Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Failure; Treatment Outcome | 2017 |
Oral Ulcerations Induced by Mycophenolate Mofetil Following Cardiac Transplant.
Topics: Azathioprine; Cardiomyopathy, Dilated; Drug Substitution; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Mycophenolic Acid; Oral Ulcer; Treatment Outcome | 2016 |
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Topics: Adult; Azathioprine; Cyclophosphamide; Disability Evaluation; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Mycophenolic Acid; Neuromyelitis Optica; Prednisolone; Prospective Studies; Recurrence; Treatment Outcome | 2016 |
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Recurrence; Retrospective Studies; Treatment Outcome | 2017 |
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.
Topics: Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Mycophenolic Acid; Prednisone; Pulmonary Diffusing Capacity; Retrospective Studies; Treatment Outcome; Vital Capacity | 2017 |
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescriptions; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pediatrics; Practice Patterns, Physicians'; Severity of Illness Index; United States | 2017 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Leflunomide; Long-Term Care; Male; Methotrexate; Mycophenolic Acid; Prednisolone; Registries; Treatment Outcome | 2017 |
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Topics: Adult; Aged; Azathioprine; Connective Tissue Diseases; Cross-Over Studies; Female; Hospitalization; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Pulmonary Diffusing Capacity; Registries; Retrospective Studies; Vital Capacity | 2016 |
Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Biomarkers; Cohort Studies; Cyclophosphamide; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor, Type II; Renal Insufficiency, Chronic; Rituximab; Severity of Illness Index; Young Adult | 2017 |
Expert clinical management of autoimmune hepatitis in the real world.
Topics: Azathioprine; Biopsy; Budesonide; Cyclosporine; Health Care Surveys; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Methyltransferases; Mycophenolic Acid; Rituximab; Tacrolimus | 2017 |
Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders.
Topics: Adult; Age of Onset; Azathioprine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Outcome Assessment, Health Care; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2017 |
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Mycophenolic Acid; Myelodysplastic Syndromes; Odds Ratio; Psoriasis; Retrospective Studies; Risk Factors; United States | 2017 |
Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; B-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Retrospective Studies; Rituximab | 2018 |
Diarrhea in a Long-Term Kidney-Pancreas Recipient.
Topics: Adult; Azathioprine; Diarrhea; Drug Substitution; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Time Factors | 2017 |
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Diseases; Male; Methotrexate; Mycophenolic Acid; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Rituximab | 2017 |
The Effect of Immunosuppression on Airway Integrity.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin-8; Lung; Lung Transplantation; Microcirculation; Mycophenolic Acid; Permeability; Tacrolimus; Tight Junctions | 2017 |
Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
Topics: Adult; Azathioprine; Disease Progression; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Remission Induction; Treatment Outcome; Young Adult | 2017 |
Enzymatic Activity of Candida spp. from Oral Cavity and Urine in Children with Nephrotic Syndrome.
Topics: Adolescent; Azathioprine; Bacteriuria; Candida; Candidiasis, Oral; Child; Child, Preschool; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mouth; Mycophenolic Acid; Nephrotic Syndrome | 2017 |
Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
Topics: Adolescent; Adult; Aged; Azathioprine; China; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus; Treatment Outcome; Young Adult | 2017 |
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
Topics: Adrenal Cortex Hormones; Age of Onset; Antirheumatic Agents; Azathioprine; Child; Cyclophosphamide; Disease Management; Europe; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Practice Guidelines as Topic; Remission Induction; Treatment Outcome | 2017 |
The Best Choice for Second-line Agent in Standard Treatment-refractory Children With Autoimmune Hepatitis.
Topics: Azathioprine; Child; Hepatitis, Autoimmune; Humans; Mycophenolic Acid | 2018 |
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Topics: Autoantibodies; Cohort Studies; Disability Evaluation; Europe; Female; Humans; Immunologic Factors; International Cooperation; Male; Mercaptopurine; Mycophenolic Acid; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Recurrence; Rituximab; Treatment Outcome | 2018 |
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder.
Topics: Adult; Aquaporin 4; Azathioprine; B-Lymphocytes; Cohort Studies; Disability Evaluation; Enzyme Inhibitors; Female; Humans; Immunoglobulin G; Immunologic Factors; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Rituximab; Treatment Outcome | 2018 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Topics: Adult; Aged; Azathioprine; Biomarkers; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunologic Factors; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome | 2018 |
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Prescriptions; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Netherlands | 2018 |
Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study.
Topics: Adult; Azathioprine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Lupus Nephritis; Male; Mycophenolic Acid; Prednisolone; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2019 |
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Glycosides; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome; Young Adult | 2018 |
Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Carcinoma, Squamous Cell; Child; Drug Substitution; Female; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Risk Assessment; Risk Factors; Skin Neoplasms; Time Factors; Young Adult | 2018 |
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
Topics: Azathioprine; Dermatitis, Atopic; Follow-Up Studies; Humans; Methotrexate; Mycophenolic Acid | 2018 |
Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Fertilization; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Pregnancy; Prenatal Exposure Delayed Effects; Renal Insufficiency, Chronic; Retrospective Studies | 2018 |
Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Logistic Models; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Medicaid; Medication Adherence; Middle Aged; Mycophenolic Acid; Racial Groups; Sex Factors; United States | 2019 |
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Azathioprine; Drug Monitoring; Drug Resistance; Drug Substitution; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Maintenance Chemotherapy; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Sweden; Treatment Outcome | 2019 |
Commonly used medication for Lupus.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Disease Management; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2018 |
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis, Sclerosing; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Mycophenolic Acid; Prednisone; Remission Induction; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome | 2019 |
Recurrent arterial ischemic stroke with good response to mycophenolate mofetil.
Topics: Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Prednisolone; Recurrence; Stroke; Vasculitis, Central Nervous System | 2019 |
Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis.
Topics: Abatacept; Adult; Azathioprine; Calcineurin Inhibitors; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk; TOR Serine-Threonine Kinases; Treatment Outcome; Tuberculosis | 2019 |
Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.
Topics: Adult; Autoantibodies; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Liver Function Tests; Male; Methylprednisolone; Multiple Sclerosis; Mycophenolic Acid; Prednisolone | 2019 |
Effect of immunosuppressive drugs on cytokine production in canine whole blood stimulated with lipopolysaccharide or a combination of ionomycin and phorbol 12-myristate 13-acetate.
Topics: Animals; Azathioprine; Cyclosporine; Dogs; Immunosuppressive Agents; Interferon-gamma; Interleukins; Ionomycin; Leflunomide; Lipopolysaccharides; Mycophenolic Acid; Prednisone; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2019 |
Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Lupus Nephritis; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Propensity Score; Remission Induction; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome; Young Adult | 2019 |
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.
Topics: Adult; Allografts; Azathioprine; Female; Genotype; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Mycophenolic Acid; Polymorphism, Single Nucleotide; Solute Carrier Organic Anion Transporter Family Member 1B3; Transplant Recipients | 2020 |
Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Topics: Adult; Aged; Allografts; Antibiotic Prophylaxis; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Tacrolimus; Young Adult | 2019 |
The profile and clinical outcomes of patients with renal involvement due to IgA vasculitis: is azathioprine a good option for treatment?
Topics: Adolescent; Antirheumatic Agents; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Female; Hematuria; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephritis; Proteinuria; Retrospective Studies; Treatment Outcome | 2019 |
Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Topics: Azathioprine; Enzyme Inhibitors; Female; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoids; Humans; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Myositis; Prednisone; Respiratory Function Tests; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
The Prevalence and Causes of Non-adherence to Immunosuppressive Medications in Patients with Lupus Nephritis Flares.
Topics: Adult; Azathioprine; Disease Progression; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Health Expenditures; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Medication Adherence; Mycophenolic Acid; Risk Factors; Symptom Flare Up; Time Factors; Young Adult | 2020 |
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Scleroderma, Systemic; Treatment Outcome; Vital Capacity | 2020 |
Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus.
Topics: Antimalarials; Azathioprine; B-Cell Activating Factor; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid | 2019 |
Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
Topics: Adrenal Cortex Hormones; Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Vital Capacity | 2019 |
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cholinesterase Inhibitors; Cross-Sectional Studies; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Pyridostigmine Bromide; Quality of Life; Registries | 2019 |
Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study.
Topics: Adult; Azathioprine; Cohort Studies; Female; Humans; Lymphocytes; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Prospective Studies; Stroke Volume; Troponin T; Ventricular Function, Left | 2020 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study.
Topics: Adrenal Cortex Hormones; Azathioprine; Disabled Persons; Follow-Up Studies; Humans; Immunosuppressive Agents; Immunotherapy; Mycophenolic Acid; Neuromyelitis Optica; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Secondary Prevention | 2020 |
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder.
Topics: Adult; Age Factors; Aquaporin 4; Azathioprine; Disease Progression; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunologic Factors; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Outcome Assessment, Health Care; Recurrence; Registries; Rituximab; Severity of Illness Index; Time Factors | 2020 |
Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center.
Topics: Adult; Azathioprine; Biopsy; Complement C3; Complement C4; Creatinine; Cyclophosphamide; Delayed Diagnosis; Early Diagnosis; Female; Hemoglobin A; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Erythematosus, Systemic; Lupus Nephritis; Maintenance Chemotherapy; Male; Mycophenolic Acid; Proteinuria; Retrospective Studies; Time Factors; Young Adult | 2020 |
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
Topics: Adult; Aged; Azathioprine; Canes; Cyclophosphamide; Female; Foot Orthoses; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Middle Aged; Mobility Limitation; Mycophenolic Acid; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Quadriplegia; Rituximab; Treatment Failure; Treatment Outcome; Walkers | 2020 |
Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
Topics: Azathioprine; Cost-Benefit Analysis; Drug Costs; Drug Resistance; Health Care Surveys; Humans; Markov Chains; Mycophenolic Acid; Neuromyelitis Optica; Patient Outcome Assessment; Quality-Adjusted Life Years; Rituximab; Thailand | 2020 |
Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.
Topics: Administration, Oral; Animals; Azathioprine; Cross-Over Studies; Cyclosporine; Dogs; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Leflunomide; Male; Mycophenolic Acid; Prednisone; Random Allocation; T-Lymphocytes | 2020 |
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monitoring; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; United States | 2020 |
Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Topics: Adult; Age Factors; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
Topics: Adult; Aged; Azathioprine; Basiliximab; Drug Administration Schedule; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Postoperative Care; Postoperative Complications; Prednisolone; Receptors, Interleukin-2; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Tacrolimus; Young Adult | 2020 |
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Topics: Adult; Antibodies; Aquaporin 4; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Recurrence; Rituximab | 2020 |
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Topics: Antirheumatic Agents; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Europe; Glomerular Filtration Rate; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Proteinuria; Societies, Medical | 2020 |
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study.
Topics: Abortion, Spontaneous; Adolescent; Adult; Azathioprine; Child; Databases, Factual; Female; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Pregnancy; Retrospective Studies; Risk Assessment; Risk Factors; Stillbirth; Young Adult | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Topics: Adult; Azathioprine; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; India; Infusions, Intravenous; Kidney; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Male; Mycophenolic Acid; Prednisone; Remission Induction; Retrospective Studies; Young Adult | 2020 |
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Retrospective Studies; Treatment Outcome | 2021 |
Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
Topics: Azathioprine; B-Lymphocytes, Regulatory; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-10; Lymphocyte Count; Mycophenolic Acid; Pemphigus; Rituximab; Treatment Outcome | 2021 |
Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
Topics: Adult; Aged; Azathioprine; B-Lymphocyte Subsets; B-Lymphocytes; Cell Proliferation; Cytokines; Female; Flow Cytometry; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Interleukin-6; Male; Mercaptopurine; Middle Aged; Mycophenolic Acid | 2020 |
Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Retrospective Studies; Transaminases; Treatment Outcome | 2021 |
Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Azathioprine; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Humans; Immunosuppressive Agents; Infliximab; Lung Neoplasms; Male; Mycophenolic Acid | 2020 |
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Topics: Adolescent; Adult; Azathioprine; Common Variable Immunodeficiency; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Mycophenolic Acid; Respiratory Function Tests; Retrospective Studies; Rituximab; Young Adult | 2021 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Time Factors | 2021 |
Giant Gastric Ulcers: An Unusual Culprit.
Topics: Azathioprine; Drug Substitution; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Risk Factors; Stomach Ulcer; Treatment Outcome | 2020 |
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Fever; Filgrastim; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Hematologic Agents; Humans; Immunologic Factors; Incidence; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nephrosis, Lipoid; Neutropenia; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Sepsis | 2021 |
Chronic inflammatory axonal polyneuropathy.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Male; Middle Aged; Mycophenolic Acid; Neural Conduction; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve; Young Adult | 2020 |
Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Azathioprine; Electronic Health Records; Female; Humans; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Recovery of Function; Retrospective Studies; Sjogren's Syndrome; Time Factors; Treatment Outcome | 2020 |
Immunotherapy choice and maintenance for generalized myasthenia gravis in China.
Topics: Adult; Aged; Azathioprine; China; Clinical Decision-Making; Cohort Studies; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Immunotherapy; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Retrospective Studies; Rituximab; Tacrolimus | 2020 |
Continuous function of 80 primary renal allografts for 30-47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long-term successes.
Topics: Adolescent; Adult; Allografts; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Young Adult | 2021 |
Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
Topics: Adult; Aged; Azathioprine; Choroid; Cyclosporine; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2021 |
The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
Topics: Adult; Aged; Antimetabolites; Azathioprine; Female; Humans; Male; Middle Aged; Mycophenolic Acid; Poland; Uveitis; Young Adult | 2020 |
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Azathioprine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Microscopy, Electron; Middle Aged; Mycophenolic Acid; Podocytes; Rituximab; Treatment Outcome; Young Adult | 2021 |
Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
Topics: Adult; Azathioprine; Cardiovascular Diseases; Cause of Death; Coronary Artery Bypass; Cyclophosphamide; Female; Heart Disease Risk Factors; Heart Failure; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Mortality; Mycophenolic Acid; Myocardial Infarction; Percutaneous Coronary Intervention; Propensity Score; Proportional Hazards Models; Protective Factors; Risk Factors; Stroke; Young Adult | 2021 |
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cause of Death; Cohort Studies; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Infections; Lupus Erythematosus, Systemic; Male; Middle Aged; Morbidity; Mortality, Premature; Mycophenolic Acid; Neoplasms; Retrospective Studies; Risk Factors; Rituximab; Steroids; Survival Rate; Time Factors; United Kingdom | 2021 |
Refractory ascites induced by mycophenolate in a pediatric kidney transplant patient.
Topics: Ascites; Azathioprine; Child; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid | 2021 |
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
[Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment].
Topics: Adult; Aged; Azathioprine; Europe; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Reference Standards; Treatment Outcome | 2021 |
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Outpatients; Patient Satisfaction; Probability; Proportional Hazards Models; Retrospective Studies; Young Adult | 2021 |
The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
Topics: Azathioprine; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Microscopic Polyangiitis; Mycophenolic Acid; Treatment Outcome | 2021 |
Granulomatous nephritis: A rare presentation of juvenile-onset sarcoidosis.
Topics: Adolescent; Azathioprine; Child; Female; Humans; Mycophenolic Acid; Nephritis, Interstitial; Prednisolone; Sarcoidosis | 2022 |
Efficacy of azathioprine, mycophenolate mofetil, and rituximab in the treatment of neuromyelitis optica spectrum disorder and analysis of prognostic factors.
Topics: Azathioprine; Disabled Persons; Humans; Immunosuppressive Agents; Middle Aged; Motor Disorders; Mycophenolic Acid; Neuromyelitis Optica; Prognosis; Retrospective Studies; Rituximab | 2022 |
Topics: Animals; Azathioprine; Drug Therapy, Combination; Embryonic Development; Female; Glucocorticoids; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Pregnancy; Prodrugs; Rats | 2022 |
Recurrent lupus nephritis in renal allograft triggered by pregnancy.
Topics: Adult; Allografts; Azathioprine; Cesarean Section; Female; Humans; Kidney Transplantation; Lupus Nephritis; Male; Mycophenolic Acid; Pregnancy | 2022 |
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Mycophenolic Acid; Neoplasms | 2022 |
Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR.
Topics: Adult; Azathioprine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Retrospective Studies; Tacrolimus; United States | 2022 |
Prevalent Drug Usage Practices in Adults and Children With Idiopathic Inflammatory Myopathies: Registry-Based Analysis From the MyoCite Cohort.
Topics: Adult; Azathioprine; Child; Female; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Myositis; Pharmaceutical Preparations; Registries; Treatment Outcome | 2022 |
Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Recurrence; Tacrolimus; Treatment Outcome | 2022 |
What is the ideal duration of maintenance therapy for lupus nephritis?
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid | 2022 |
Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder.
Topics: Autoantibodies; Azathioprine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neoplasm Recurrence, Local; Neuromyelitis Optica; Retrospective Studies; Rituximab | 2022 |
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
Topics: Abatacept; Adolescent; Arthritis; Autoantibodies; Azathioprine; Calcinosis; Child; Cyclophosphamide; Dermatomyositis; Female; Humans; Hyperplasia; Hypertension, Portal; Liver; Male; Methotrexate; Mycophenolic Acid; Prednisone; Rituximab; Splenomegaly; Thrombocytopenia; Transaminases; Young Adult | 2022 |
The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients.
Topics: Azathioprine; Humans; Mycophenolic Acid; Neuromyelitis Optica; Recurrence; Retrospective Studies; Thailand; Treatment Outcome | 2022 |
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19.
Topics: Azathioprine; Calcineurin Inhibitors; COVID-19; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Technique; Dermatitis, Atopic; Expert Testimony; Humans; Janus Kinase Inhibitors; Janus Kinases; Methotrexate; Mycophenolic Acid; Quality of Life | 2022 |
Lymphocyte subsets and Langerhans cells in the skin of kidney transplant recipients under three different immunosuppressive regimens.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Langerhans Cells; Lymphocyte Subsets; Mycophenolic Acid | 2022 |
The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China.
Topics: Antibodies, Antinuclear; Aquaporin 4; Autoantibodies; Azathioprine; Female; Humans; Iodide Peroxidase; Male; Mycophenolic Acid; Myelitis; Neuromyelitis Optica; Pregnancy; Recurrence; Registries; Retrospective Studies; Rituximab; Rivers | 2022 |
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Topics: Adolescent; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Mycophenolic Acid | 2022 |
Management of Hepatic Sarcoidosis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Digestive System Diseases; Humans; Hydroxychloroquine; Mycophenolic Acid; Sarcoidosis | 2022 |
Association of mycophenolate and azathioprine use with cognitive function in systemic lupus.
Topics: Adult; Azathioprine; Cognition; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2023 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide | 2022 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myocardial Infarction; Pemphigus; Peripheral Vascular Diseases; Retrospective Studies; Rituximab; Stroke | 2023 |
Rituximab and risk of infections in patients with pemphigus: answers from a global population-based cohort study.
Topics: Azathioprine; Cohort Studies; Humans; Mycophenolic Acid; Pemphigus; Rituximab; Treatment Outcome | 2023 |
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.
Topics: Azathioprine; Cohort Studies; COVID-19; Cytomegalovirus Infections; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigus; Rituximab | 2023 |
Pregnancy after kidney transplantation: Ibn Sina Rabat University hospital experience
Topics: Azathioprine; Cesarean Section; Child; Child, Preschool; Creatinine; Female; Graft Rejection; Hospitals; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2023 |
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study.
Topics: Aquaporin 4; Azathioprine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Neuromyelitis Optica; Recurrence; Retrospective Studies; Rituximab | 2023 |
Pregnancy after kidney transplantation: Ibn Sina Rabat University hospital experience
Topics: Azathioprine; Cesarean Section; Child; Child, Preschool; Creatinine; Female; Graft Rejection; Hospitals; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2023 |
Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India.
Topics: Adolescent; Adult; Azathioprine; Behcet Syndrome; Biological Products; Cyclosporins; Female; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Steroids; Uveitis; Young Adult | 2023 |
Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series.
Topics: Abatacept; Azathioprine; Calcineurin Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Outcome; Transplant Recipients | 2023 |
Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients.
Topics: Azathioprine; Child; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Patient Discharge; Retrospective Studies; Tacrolimus; Transplant Recipients | 2023 |
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.
Topics: Adalimumab; Alkylating Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Methotrexate; Mycophenolic Acid; Neoplasms; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2023 |
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Topics: Adolescent; Adult; Azathioprine; Budesonide; Child; Child, Preschool; Cohort Studies; Female; Hepatitis, Autoimmune; Humans; Infant; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Retrospective Studies; Switzerland | 2023 |
Association of patient copayment and medication adherence in systemic lupus erythematosus.
Topics: Adult; Aged; Azathioprine; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2023 |
Survival of Heart Transplant Patients with Chagas' Disease Under Different Antiproliferative Immunosuppressive Regimens.
Topics: Azathioprine; Chagas Disease; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2023 |